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MOUSE DEVELOPMENT, GENETICS & GENOMICS 
Tuesday, October 26 – Saturday, October 30, 2010 
 
 
Tuesday 7:30 pm 1  Human Disease and Cancer 
   
Wednesday 9:00 am 2  Organogenesis 
   
Wednesday 2:00 pm 3  Poster Session I 
   
Wednesday 4:30 pm Wine and Cheese Party * 
   
Wednesday 7:30 pm 4  Technology 
   
Thursday 9:00 am 5  Patterning 
   
Thursday 2:00 pm 6  Poster Session II 
   
Thursday 4:30 pm Keynote Speaker 
   
Thursday 7:30 pm 7  Neurobiology 
   
Friday 9:00 am 8  Epigenetics 
   
Friday 2:00 pm 9  Genetics and Genomics 
   
Friday 4:30 pm Rosa Beddington Lecture 
   
Friday 6:00 pm Banquet 
   
Saturday 9:00 am 10  Germ Cells and Stem Cells 
 
Poster sessions are located in Bush Lecture Hall 
* Airslie Lawn, weather permitting 
Mealtimes at Blackford Hall are as follows:   
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Dinner       5:30 pm-7:00 pm 
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PROGRAM 
 
 
TUESDAY, October 26—7:30 PM 
 
 
SESSION 1 HUMAN DISEASE AND CANCER 
 
Chairperson: G. Karsenty, Columbia University, New York, New York 
 
 
Genetic and molecular direction of serotonin signaling in the 
hypothalamus 
Gerard Karsenty. 
Presenter affiliation: Columbia University, New York, New York. 
 
 
 
1 
  
Threshold levels of Tbx5 ensure symmetrical formation of the left 
and right forelimb 
Fatima A. Sulaiman, Malcolm P. Logan. 
Presenter affiliation: National Institute for Medical Research, London, 
United Kingdom. 
 
 
 
 
2 
  
An unexpected role for Tbx5 in the second heart field for cardiac 
septation 
Linglin Xie, Joshua Friedland-Little, Andrew Hoffmann, Ivan Moskowitz. 
Presenter affiliation: The University of Chicago, Chicago, Illinois. 
 
 
 
3 
  
Identification of Sox3/SOX3 as a XX male sex reversal gene in 
mice and humans 
Edwina Sutton, James Hughes, Stefan White, Ryohei Sekido, 
Jacqueline Tan, Valerie Arboleda, Vincent Harley, Eric Vilain, Andrew 
Sinclair, Robin Lovell-Badge, Paul Thomas. 
Presenter affiliation: University of Adelaide, Adelaide, Australia. 
 
 
 
 
 
4 
  
ERK1 and ERK2 have a redundant role in promoting embryonic 
fibroblasts proliferation 
Laure Voisin, Marc K. Saba-El-Leil, Catherine Julien, Christophe 
Frémin, Sylvain Meloche. 
Presenter affiliation: Institut de Recherche en Immunologie et 
Cancérologie, Montréal, Canada. 
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 vi 
The p63R279H mouse model mimics the human Ectrodactyly-
Ectodermal dysplasia-Clefting (EEC) syndrome 
Emma Vernersson-Lindahl, Elvin Garcia, Guy Horev, Hans van 
Bokhoven, Alea A. Mills. 
Presenter affiliation: Cold Spring Harbor Laboratory, Cold Spring 
Harbor, New York. 
 
 
 
 
 
6 
  
Mouse models of skin cancer 
Fiona M. Watt. 
Presenter affiliation: CRUK Cambridge Research Institute, Cambridge, 
United Kingdom. 
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WEDNESDAY, October 27—9:00 AM 
 
 
SESSION 2 ORGANOGENESIS 
 
Chairperson: K. Kaestner, University of Pennsylvania Medical School,  
  Philadelphia 
 
 
Klaus Kaestner 
Presenter affiliation: University of Pennsylvania Medical School, 
Philadelphia, Pennsylvania. 
 
  
Enforced Tbx1 expression in fetal thymus is incompatible with 
TEC differentiation 
Kim T. Cardenas, Zhijie Liu, Micheline Laurent, Carla Carter, Nancy 
Manley, Ellen Richie. 
Presenter affiliation: MD Anderson Cancer Center, Smithville, Texas. 
 
 
 
 
8 
  
γ-glutamyl carboxylase regulates whole body energy metabolism 
through its expression in osteoblasts 
Mathieu Ferron, Gerard Karsenty. 
Presenter affiliation: Columbia University, New York, New York. 
 
 
 
9 
  
Cooperative action of Wnt4 and germ cells in maintaining ovarian 
cell fate during mouse embryogenesis 
Danielle Maatouk, Blanche Capel. 
Presenter affiliation: Duke University, Durham, North Carolina. 
 
 
 
10 
 
 
 
 vii 
Antagonism between Wnt/β-catenin signaling and Six2 in the cell 
fate decision of nephron progenitors 
Joo-Seop Park, Wenxiu Ma, Wing H. Wong, Andrew P. McMahon. 
Presenter affiliation: Harvard University, Cambridge, Massachusetts. 
 
 
 
11 
  
SIX1 initiates branching morphogenesis by regulating gremlin-
BMP4 signaling 
Pin-Xian Xu. 
Presenter affiliation: Mount Sinai School of Medicine, New York, New 
York. 
 
 
 
 
12 
  
Nick Hastie 
Presenter affiliation: Western General Hospital, Edinburgh, United 
Kingdom. 
 
 
 
WEDNESDAY, October 27—2:00 PM 
 
 
SESSION 3 POSTER SESSION I 
 
  
The role of heterochromatin protein 1 (HP1) Γ in primordial germ 
cells 
Kanae Abe, Chie Naruse, Tomoaki Kato, Takumi Nishiuchi, Mitinori 
Saitou, Masahide Asano. 
Presenter affiliation: Kanazawa University, Kanazawa, Japan. 
 
 
 
 
13 
  
Endothelial overexpression of LOX-1 increases aortic LDL uptake, 
induces endothelial dysfunction and plaque formation in vivo—
Role of transcription factors NFκB and Oct-1 
Alexander Akhmedov, Izabela Rozenberg, Yi Shi, Carola Doerries, 
Pavani Mocharla, Alexander Breitenstein, Christine Lohmann, 
Sokrates Stein, Tobias von Lukowicz, Jan Borén, Michael O. Kurrer, 
Felix C. Tanner, Ulf Landmesser, Christian M. Matter, Thomas F. 
Lüscher. 
Presenter affiliation: University of Zurich, Zurich, Switzerland; 
University Hospital Zurich, Zurich, Switzerland. 
 
 
 
 
 
 
 
 
 
14 
  
Role of Keratin14 in the development of stratified epithelia—A 
prospect for in vivo studies 
Hunain Alam, Samrat Kundu, Sorab N. Dalal, Milind M. Vaidya. 
Presenter affiliation: ACTREC, Navi Mumbai, India. 
 
 
 
15 
  
 viii 
Fgf3 is required in the normal termination of embryonic axis 
extension 
Matthew J. Anderson, Thomas Schimmang, Mark Lewandoski. 
Presenter affiliation: NCI, Frederick, Maryland. 
 
 
 
16 
  
A mouse model for juvenile hydrocephalus 
Oliver K. Appelbe, Elena A. Glick, Jenniffer R. Ramalie, Ekaterina Y. 
Steshina, Jennifer V. Schmidt. 
Presenter affiliation: University of Illinois at Chicago, Chicago, Illinois. 
 
 
 
17 
  
Fibronectin and integrin alpha 5 play essential roles in 
development of left-right asymmetry in mice 
Maria Pulina, Ashok Mittal, Shuan-Yu Hou, Dorthe Julich, Scott Holley, 
Sophie Astrof. 
Presenter affiliation: Thomas Jefferson University, Philadelphia, 
Pennsylvania. 
 
 
 
 
 
18 
  
The cre portal—A new information resource for conditional 
mutagenesis in the mouse (www.creportal.org) 
Randy Babiuk, Steven Murray, Caleb Heffner, Martin Ringwald, 
Michael Sasner, Janan T. Eppig. 
Presenter affiliation: The Jackson Laboratory, Bar Harbor, Maine. 
 
 
 
 
19 
  
Sonic hedgehog’s role as a regulator of third pharyngeal pouch 
fate 
Virginia Bain, Nancy Manley. 
Presenter affiliation: University of Georgia, Athens, Georgia. 
 
 
 
20 
  
Mouse models for translational control—Study of the RACK1-eIF6 
axis in development and cancer 
Stefano Biffo, Simone Gallo, Anne Beugnet, Viviana Volta, Annarita 
Miluzio. 
Presenter affiliation: San Raffaele Scientific Institute, Milano, Italy; 
University of Easetrn Piedmont, Alessandria, Italy. 
 
 
 
 
 
21 
  
Variable craniofacial defects in Twsg1 mutant mice correlate with 
transcriptome changes in association with repetitive DNA 
sequence environment 
Charles J. Billington, Wuming Gong, Brandon C. Ng, Cynthia L. 
Forsman, Brian A. Schmidt, Rajaram Gopalakrishnan, Aaron L. Sarver, 
York Marahrens, Anna Petryk. 
Presenter affiliation: University of Minnesota, Minneapolis, Minnesota. 
 
 
 
 
 
 
22 
  
 ix 
Integration of pathways mediating chondrocyte adaptation to ER 
stress in vivo  
Kathryn S. Cheah, Zhijia Tan, Ben Niu, Maggie W. Cheng, Kwok 
Yeung Tsang, Michael Zhang, David Ron, Danny Chan. 
Presenter affiliation: University of Hong Kong, Hong Kong, Hong Kong. 
 
 
 
 
23 
  
Interaction of SPINDLIN and SERBP1 suggests a translational 
role of SPINDLIN during the mouse oocyte-to-embryo transition 
TingGang Chew, Chanchao Lorthongpanich, Davor Solter, Barbara 
Knowles. 
Presenter affiliation: Institute of Medical Biology, Singapore. 
 
 
 
 
24 
  
A new allele of Zbtb16 separating skeletal patterning and 
spermatogonial renewal functions 
Yung-Hao Ching, Lawriston A. Wilson, John C. Schimenti. 
Presenter affiliation: National Laboratory Animal Center, Taipei, 
Taiwan. 
 
 
 
 
25 
  
Expression of Na+-K+-2Cl- cotransporter 1 is epigenetically 
regulated during postnatal development of hypertension 
Hyun-Min Cho, In Kyeom Kim. 
Presenter affiliation: Kyungpook National University School of 
Medicine, Daegu, South Korea. 
 
 
 
 
26 
  
A novel mutation in the mouse DEAD/H-box helicase DDX11 
disrupts cell cycle progression and causes early embryonic 
lethality 
Christina D. Cota, Maria J. Garcia-Garcia. 
Presenter affiliation: Cornell University, Ithaca, New York. 
 
 
 
 
27 
  
PRC2-dependent and –independent deposition of Ring1B-
mediated uH2A at developmental gene promoters in ES cells 
Mitsuhiro Endoh, Takaho A. Endo, Tamie Endoh, Miguel Vidal, Bradley 
E. Bernstein, Haruhiko Koseki. 
Presenter affiliation: RIKEN, Yokohama, Japan. 
 
 
 
 
28 
  
The Polycomb complex in mammalian skin development and 
stem cells 
Elena Ezhkova, Nicole Stokes, Elaine Fuchs. 
Presenter affiliation: Howard Hughes Medical Institute, Rockefeller 
University, New York, New York. 
 
 
 
 
29 
  
 x 
Development of genomic resources for Peromyscus research 
Adrienne Lewandowski, Jane Kenney-Hunt, Travis Glenn, Chin-Fu 
Chen, Michael J. Dewey, Gabor Szalai, Paul B. Vrana, Michael R. 
Felder. 
Presenter affiliation: University of South Carolina, Columbia, South 
Carolina. 
 
 
 
 
 
30 
  
p63-dependent transcriptional regulation and function is 
essential for pregnancy-induced mammary gland development 
Nicole Forster, Lei He, Matthew R. Ramsey, Leif W. Ellisen. 
Presenter affiliation: Massachusetts General Hospital and Harvard 
Medical School, Boston, Massachusetts. 
 
 
 
 
31 
  
Overexpression of nucleosome binding protein HMGN5 in 
cardiomyocytes leads to altered chromatin organization and 
cardiac malfunction 
Takashi Furusawa, Mark Rochman, Michael Busutin. 
Presenter affiliation: National Institutes of Health, Bethesda, Maryland. 
 
 
 
 
32 
  
The atypical cadherin Celsr1 non-cell autonomously regulates the 
directionality of facial branchiomotor neuron migration in the 
mouse hindbrain 
Derrick M. Glasco, Anagha Sawant, Yibo Qu, Bernd Fritzsch, Jennifer 
N. Murdoch, Fadel Tissir, Anand Chandrasekhar. 
Presenter affiliation: University of Missouri, Columbia, Missouri. 
 
 
 
 
 
33 
  
The Wnt/PCP protein Vangl2 is necessary for migration of facial 
branchiomotor neurons in mice, and functions independent of 
Dishevelled function 
Derrick M. Glasco, Vinoth Sittaramane, Mi-Ryoung Song, Anagha 
Sawant, Bernd Fritzsch, Goncalo C. Vilhais-Neto, Olivier Pourquie, 
Jennifer N. Murdoch, Anand Chandrasekhar. 
Presenter affiliation: University of Missouri, Columbia, Missouri. 
 
 
 
 
 
 
34 
  
Characterization of PDCD2 expression during mouse ontogenic 
development 
Celine J. Granier, Katherine Piso, Catherine Liu, Hatem E. Sabaawy, 
Arnold B. Rabson. 
Presenter affiliation: UMDNJ-RWJMS Child Health Institute of New 
Jersey, New Brunswick, New Jersey. 
 
 
 
 
 
35 
  
 xi 
Controlling endogenous promoter activity through reversible 
epigenetic silencing in vivo 
Anna C. Groner, Patrick Tschopp, Jens E. Dietrich, Sandra Offner, 
Sonia Verp, Isabelle Barde, Takashi Hiiragi, Didier Trono. 
Presenter affiliation: Frontiers-in-Genetics National Center of 
Competence in Research, École Polytechnique Fédérale de Lausanne 
(EPFL) , Lausanne, Switzerland. 
 
 
 
 
 
 
36 
  
Temporal and functional requirements for SOX10 during the 
establishment and maintenance of the follicular melanocyte 
system 
Melissa L. Harris, Kristina Buac, Arturo Incao, William J. Pavan. 
Presenter affiliation: NHGRI, National Institutes of Health, Bethesda, 
Maryland. 
 
 
 
 
 
37 
  
Size regulation of early mouse embryo in vitro 
Tomoka Hisaki, Ikuma Kawai, Sakiko Kobayashi, Kunihiko Naito, 
Kiyoshi Kano. 
Presenter affiliation: University of Tokyo Graduate School of 
Agricultural and Life Science, Tokyo, Japan. 
 
 
 
 
38 
  
The role of System A amino acid transporters SNAT1 & SNAT2 in 
placental and fetal growth and development 
Katharina Hoelle, Ionel Sandovici, Ilona Zvetkova, Miguel Constância. 
Presenter affiliation: University of Cambridge, Cambridge, United 
Kingdom. 
 
 
 
 
39 
  
Altered gene expression and spongiotrophoblast differentiation 
in diabetic mouse placenta 
J. Michael Salbaum, Claudia Kruger, XiaoYing Zhang, Gabriela 
Pavlinkova, David H. Burk, Claudia Kappen. 
Presenter affiliation: Pennington Biomedical Research Center, Baton 
Rouge, Louisiana. 
 
 
 
 
 
40 
  
Role of discoidin domain receptor 2 (DDR2) in mouse growth 
Ikuma Kawai, Hirokazu Matsumura, Tomoka Hisaki, Sakiko Kobayashi, 
Kunihiko Naito, Kiyoshi Kano. 
Presenter affiliation: University of Tokyo, Bunkyoku, Japan. 
 
 
 
41 
  
Analysis of heart defects in the Nipbl+/- mouse, a model for 
Cornelia de Lange syndrome 
S Kawauchi, R Santos, M Lopez-Burks, A D. Lander, A L. Calof. 
Presenter affiliation: University of California-Irvine, Irvine, California. 
 
 
 
42 
  
 xii 
Mouse models made easier—Development of new C57BL/6J ES 
cell lines facilitate tetraploid complementation 
Sang-Yong Kim. 
Presenter affiliation: Cold Spring Harbor Laboratory, Cold Spring 
Harbor, New York. 
 
 
 
 
43 
  
The histone demethylase LSD1/KDM1 reprograms epigenetic 
memory to re-establish totipotency between generations 
Ashley L. King, William G. Kelly, David J. Katz. 
Presenter affiliation: Emory University, Atlanta, Georgia. 
 
 
 
44 
  
Comprehensive analysis of ICSI induced transcriptome 
perturbation in the mouse 
Takashi Kohda, Narumi Ogonuki, Kimiko Inoue, Tamio Furuse, Hideki 
Kaneda, Tomohiro Suzuki, Tomoko Kaneko-Ishino, Teruhiko 
Wakayama, Shigeharu Wakana, Atsuo Ogura, Fumitoshi Ishino. 
Presenter affiliation: Tokyo Medical and Dental University, Tokyo, 
Japan. 
 
 
 
 
 
 
45 
  
Differential functions of MAPK and PI3K pathways in the 
development of the Schwann cell lineage 
Maria E. Kolanczyk, Katja S. Grossmann, Walter Birchmeier, Carmen 
Birchmeier. 
Presenter affiliation: Max Delbruck Center For Molecular Medicine, 
Berlin, Germany. 
 
 
 
 
 
46 
  
Regulation of organ size—Dual role of Pbx in the control of 
spleen expansion by activation of Nkx2.5 and repression of 
p15ink4b 
Matthew Koss, Andrea Brendolan, Matilde Saggese, Terence Capellini, 
Richard Harvey, Licia Selleri. 
Presenter affiliation: Weill Cornell Medical College, New York, New 
York. 
 
 
 
 
 
 
47 
  
Ultrasonic-range vibratory microinjection raises efficiency of 
pronuclear microinjection 
Dilidaer Kudereti, Fujio Miyawaki. 
Presenter affiliation: Tokyo Denki University, Saitama, Japan. 
 
 
 
48 
  
BMP2 expression in the visceral endoderm directs anterior 
morphogenesis during gastrulation 
Elizabeth Lacy, Mary Madabhushi. 
Presenter affiliation: Sloan-Kettering Institute, New York, New York. 
 
 
 
49 
  
 xiii 
A Genetic Inducible Mosaic Analysis (GIMA) to mark and mutate 
cells in mice with conditional floxed alleles 
Zhimin Lao, Praveen G. Raju, Brian Bai, Alexandra L. Joyner. 
Presenter affiliation: Memorial Sloan-Kettering Cancer Center, New 
York, New York. 
 
 
 
 
50 
  
The DLX5/DLX6 locus—A new candidate for non-syndromic 
familial premature ovarian failure 
Kamal Bouhali, Sandrine Caburet, Aurelie Dipietromaria, Anastasia 
Fontaine, Marc Fellous, Giovanni Levi. 
Presenter affiliation: CNRS/MNHN UMR7221, Paris, France. 
 
 
 
 
51 
  
Disruption of chromodomain helicase DNA binding protein 5 
(Chd5) impairs spermatogenesis 
Wangzhi Li, Sang Yong Kim, Alea Mills. 
Presenter affiliation: Cold Spring Harbor Laboratory, Cold Spring 
Harbor, New York. 
 
 
 
 
52 
  
Specific expression of heparan sulfate glycosaminoglycan chains 
is crucial for local distribution of FGF signaling during early 
mammalian embryogenesis 
Kayo Shimokawa, Chiharu Kimura-Yoshida, Kyoko Mochida, Isao 
Matsuo. 
Presenter affiliation: Osaka Medical Center and Research Institute for 
Maternal and Child Health, Osaka, Japan. 
 
 
 
 
 
 
53 
  
Lineage mapping the pre-implantation mouse embryo by two-
photon microscopy, new insights into the segregation of cell 
fates 
Katie McDole, Yuan Xiong, Pablo A. Iglesias, Yixian Zheng. 
Presenter affiliation: Johns Hopkins University, Baltimore, Maryland; 
Carnegie Institution for Science, Baltimore, Maryland. 
 
 
 
 
 
54 
  
Imprinting analysis in the Acrodysplasia region of mouse 
chromosome 12 
Erin N. McMurray, Eric D. Rogers, Jennifer V. Schmidt. 
Presenter affiliation: University of Illinois at Chicago, Chicago, Illinois. 
 
 
 
55 
  
A bioluminescent transgenic mouse model to monitor CREB 
transcriptional activation 
Kenneth Miller, Susan Bove, Robin Kleiman, Wenning Qin. 
Presenter affiliation: Pfizer Research, Groton, Connecticut. 
 
 
 
56 
  
 xiv 
Individual effects of ingredients of DNA solution on embryonic 
development in culture after pronuclear microinjection 
Fujio Miyawaki, Dilidaer Kudereti, Risa Shimizu, Hiroki Haremaki, 
Tomohiro Yoshizawa. 
Presenter affiliation: Tokyo Denki University, Saitama, Japan. 
 
 
 
 
57 
  
Transcriptional regulation of Myf5 expression in the branchial 
arches 
Natalia Moncaut, Christine Siligan, Ricardo Ribas, Kevin Taylor, Jaime 
J. Carvajal, Peter W. Rigby. 
Presenter affiliation: The Institute of Cancer Research, London, United 
Kingdom. 
 
 
 
 
 
58 
  
The histone demethylase LSD1/KDM1 reprograms epigenetic 
memory during the specification of new cell fates 
Dexter A. Myrick, William G. Kelly, David J. Katz. 
Presenter affiliation: Emory University, Atlanta, Georgia. 
 
 
 
59 
 
 
WEDNESDAY, October 27—4:30 PM 
 
Wine and Cheese Party 
 
 
 
WEDNESDAY, October 27—7:30 PM 
 
 
SESSION 4 TECHNOLOGY 
 
Chairperson: A. Nagy, Samuel Lunenfeld Research Institute,  
Mt. Sinai Hospital, Toronto, Canada 
 
 
Andras Nagy 
Presenter affiliation: Samuel Lunenfeld Research Institute, Mt. Sinai 
Hospital, Toronto, Canada. 
 
  
Large-scale in vivo analysis of the regulatory architecture of the 
mouse genome with a transposon-associated regulatory sensor 
system 
Sandra Ruf, Orsolya Symmons, Chloe Hot, Dirk Dolle, Laurence 
Ettwiller, Francois Spitz. 
Presenter affiliation: EMBL, Heidelberg, Germany. 
 
 
 
 
 
60 
  
 xv 
Dual RMCE permits efficient re-engineering of mutant alleles in 
mouse ES cells 
Javier Lopez-Rios, Marco Osterwalder, Antonella Galli, Barry Rosen, 
William C. Skarnes, Rolf Zeller. 
Presenter affiliation: University of Basel, Basel, Switzerland. 
 
 
 
 
61 
  
High efficiency targeting of an inducible expression system to the 
Rosa26 locus in embryonic stem cells 
Samuel Wormald, Daniel Turner, Mahalia Page, Shih-pei Shen, 
Wensheng Zhang, Peri Tate, William C. Skarnes. 
Presenter affiliation: The Wellcome Trust Sanger Institute, Cambridge, 
United Kingdom. 
 
 
 
 
 
62 
  
COIN (Conditional by Inversion)—A better type of conditional 
knock-out allele that is universally applicable regardless of gene 
structure 
Aris N. Economides, David Frendewey, Peter Yang, David M. 
Valenzuela, Andrew J. Murphy, George D. Yancopoulos. 
Presenter affiliation: Regeneron Pharmaceuticals, Inc., Tarrytown, New 
York. 
 
 
 
 
 
 
63 
  
Engineering ES cells for epigenetic studies 
Maria Rostovskaya, Andrea Kranz, Konstantinos Anastassiadis, 
Francis Stewart. 
Presenter affiliation: Technische Universität Dresden, Dresden, 
Germany. 
 
 
 
 
64 
 
 
 
THURSDAY, October 28—9:00 AM 
 
 
SESSION 5 PATTERNING 
 
Chairperson: P. Soriano, Mount Sinai School of Medicine, New York,  
  New York 
 
  
Ephrin-B signaling in development 
Philippe Soriano, Jeffrey O. Bush. 
Presenter affiliation: Mt. Sinai School of Medicine, New York, New 
York. 
 
 
 
65 
  
 xvi 
An interplay between anterior and posterior visceral endoderm 
controls anteriorposterior formation in mouse 
Tingting Huang, Maki Wakamiya, Richard Behringer, Jaime Rivera. 
Presenter affiliation: University of Massachusetts Medical School, 
Worcester, Massachusetts. 
 
 
 
 
66 
  
Non-cell autonomous role for Sox17 transcription factor in the 
morphogenesis and identity of gut endoderm in the mouse 
gastrula 
Manuel Viotti, Kat Hadjantonakis. 
Presenter affiliation: Sloan-Kettering Institute, New York, New York; 
Weill Graduate School of Cornell University, New York, New York. 
 
 
 
 
 
67 
  
Fgf4 and Fgf8 comprise the wavefront activity that controls 
somitogenesis 
L. A. Naiche, Nakisha Holder, Mark Lewandoski. 
Presenter affiliation: National Cancer Institute, Frederick, Maryland. 
 
 
 
68 
  
Brachyury represses Mesp2 expression in mouse tailbud in 
somitegenesis 
Yukuto Yasuhiko, Jun Kanno, Yumiko Saga. 
Presenter affiliation: National Institute of Health Sciences, Tokyo, 
Japan. 
 
 
 
 
69 
  
Sonic hedgehog signalling coordinates antero-posterior with 
proximo-distal limb bud development by ensuring retinoic acid 
clearance 
Simone Probst, Conradin Kraemer, Philippe Demougin, Rushikesh 
Sheth, Gail R. Martin, Hidetaka Shiratori, Hiroshi Hamada, Dagmar 
Iber, Rolf Zeller, Aimée Zuniga. 
Presenter affiliation: University of Basel, Basel, Switzerland. 
 
 
 
 
 
 
70 
  
From progenitor to product—Assembly and repair of the 
mammalian kidney 
Andrew P. McMahon. 
Presenter affiliation: Harvard University, Cambridge, Massachusetts. 
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 xvii 
THURSDAY, October 28—2:00 PM 
 
 
SESSION 6 POSTER SESSION II 
 
  
Involvement of the Reck tumor suppressor protein in maternal 
and embryonic vascular remodeling in mice 
Ediriweera P. S. Chandana, Mako Yamamoto, Yoko Yoshida, Hitoshi 
Kitayama, Tomoko Matsuzaki, Makoto Noda. 
Presenter affiliation: Kyoto University Graduate School of Medicine, 
Kyoto, Japan. 
 
 
 
 
 
72 
  
The IKMC mouse knockout portal—Sharing and integrating 
related data 
Darren Oakley, Vivek Iyer, Sébastien Briois, Damian Smedley, Martin 
Ringwald, Jim Kadin, Jeremy Mason, Bill Skarnes. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, 
Cambridge, United Kingdom. 
 
 
 
 
 
73 
  
Redundant control of actin dynamics in vivo—The case of the 
Eps8L family 
Nina Offenhauser, Charlotte B. Ekalle Soppo, Pier P. Di Fiore. 
Presenter affiliation: IFOM, Milano, Italy. 
 
 
 
74 
  
Mouse targeted transgenesis through pronuclear injection 
Masato Ohtsuka, Hiromi Miura, Minoru Kimura, Hidetoshi Inoko. 
Presenter affiliation: Tokai University, School of Medicine, Isehara, 
Kanagawa, Japan. 
 
 
 
75 
  
The GDNF target - Visinin like 1 is a new ureteric tip marker 
upregulated in the WD prior to budding 
Roxana Ola, Madis Jakobson, Jouni Kvist, Nina Perälä, Satu Kuure, 
Karl-Heinz Braunewell, Darren Bridgewater, Norman Roselund, Dmitri 
Chilov, Tiina Immonen, Kirsi Sainio, Hannu Sariola. 
Presenter affiliation: University of Helsinki, Helsinki, Finland. 
 
 
 
 
 
76 
  
Cell dynamics directing gut endoderm morphogenesis in the 
mouse embryo 
Gloria Kwon, Maria Pulina, Yvonne Pao, Kat Hadjantonakis. 
Presenter affiliation: Sloan Kettering Institute, New York, New York. 
 
 
 
77 
  
 xviii 
The Gene Teashirt1 (Tshz1) is essential for the development of 
olfactory bulb granular cell interneurons 
Daniela Ragancokova, Elena Rocca, Thomas Müller, Hagen Wende, 
Carmen Birchmeier, Alistair Garratt. 
Presenter affiliation: Max-Delbrück-Center for Molecular Medicine, 
Berlin, Germany. 
 
 
 
 
 
78 
  
The Sanger Institute Mouse Genetics Programme 
Ramiro Ramirez-Solis, Ed Ryder, Jacqui White, Richard Houghton, 
Joanna Bottomley. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, 
Cambridgeshire, United Kingdom. 
 
 
 
 
79 
  
KTELC1, a novel protein glucosyltransferse, is required for 
mouse embryonic morphogenesis and Notch signaling 
Nitya Ramkumar, Jeffrey D. Lee, Kathryn V. Anderson. 
Presenter affiliation: Sloan-Kettering Institute, New York, New York; 
Weill Graduate School of Medical Sciences of Cornell University, New 
York, New York. 
 
 
 
 
 
80 
  
Mechanisms underlying spina bifida in the Zic2 loss-of-function 
mutant, Kumba 
Saba R. Raza, Valentina Massa, Dawn Savery, Nicholas D. Greene, 
Andrew J. Copp. 
Presenter affiliation: UCL Institute of Child Health, London, United 
Kingdom. 
 
 
 
 
 
81 
  
Innovative mouse models for target discovery 
Gesa Rickheit, Jost Seibler, Nico Scheer, Branko Zevnik, Gunther 
Kauselmann. 
Presenter affiliation: TaconicArtemis GmbH, Cologne, Germany. 
 
 
 
82 
  
The Gene Expression Database for Mouse Development (GXD) 
Constance M. Smith, Jacqueline H. Finger, Terry F. Hayamizu, 
Ingeborg J. McCright, Janan T. Eppig, James A. Kadin, Joel E. 
Richardson, Martin Ringwald. 
Presenter affiliation: The Jackson Laboratory, Bar Harbor, Maine. 
 
 
 
 
83 
  
The circadian rhythm related Aryl hydrocarbon receptor nuclear 
translocator-like 2 protects against type 1 diabetes 
Chenxia He, Nicolas Prevot, Christian Boitard, Philip Avner, Ute C. 
Rogner. 
Presenter affiliation: Institut Pasteur, CNRS, Paris, France. 
 
 
 
 
84 
  
 xix 
Analysis of mice lacking folate receptor 4. 
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Genetic analysis of signaling pathways controlling motor neuron 
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Chromatin and transcriptional signatures for the SMAD2/3 
complex 
Se Jin Yoon, Andrea Wills, Si Wan KIm, Edward Chuong, Julie Baker. 
Presenter affiliation: Stanford University, Stanford, California. 
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Using forward genetics to advance our understanding of mouse 
limb development. 
Kasey Basch, Emily Mis, Sunjin Lee, Scott Weatherbee. 
Presenter affiliation: Yale University, New Haven, Connecticut. 
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Control of oncomir miR-155 by tumor suppressor BRCA1 and its 
impact on tumorigenesis 
Suhwan K. Chang, Shyam K. Sharan. 
Presenter affiliation: National Cancer Institute, NIH, Frederick, 
Maryland. 
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Developmental stage-specific binding of HNF4a and FOXA2 
revealed by ChIP-seq demonstrates dynamic transcription factor 
binding during in vivo hepatoblast maturation 
Olivia Alder, Sam Lee, Rebecca Cullum, Gordon Robertson, Nina 
Thiessen, Yongjun Zhao, Steven Jones, Marco A. Marra, Pamela A. 
Hoodless. 
Presenter affiliation: BC Cancer Agency, Vancouver, Canada. 
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PTIP is critical for histone methylation, germline transcription, 
and enhancer-promoter interactions during immunoglobulin 
heavy chain (IgH) class switch recombination (CSR) 
Kristopher R. Schwab, Sanjeevkumar R. Patel, Inna Levitan, Gregory 
R. Dressler. 
Presenter affiliation: University of Michigan, Ann Arbor, Michigan. 
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Pkd1l1 establishes left-right asymmetry and physically interacts 
with Pkd2 
Sarah Field, Kerry-Lyn Riley, Daniel T. Grimes, Helen Hilton, Michelle 
Simon, Nicola Powles-Glover, Pam Siggers, Debora Bogani, Andy 
Greenfield, Dominic P. Norris. 
Presenter affiliation: MRC Harwell, Oxfordshire, United Kingdom. 
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Robert Williams 
Presenter affiliation: University of Tennessee, Memphis, Tennessee. 
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ROSA BEDDINGTON LECTURE 
 
  
Straightening out Notch 
Gavin Chapman, Duncan B. Sparrow, Sally L. Dunwoodie. 
Presenter affiliation: Victor Chang Cardiac Research Institute, Sydney, 
Australia. 
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FRIDAY, October 29—6:00 PM 
 
CONCERT 
Grace Auditorium 
 
Aaron Goldberg Trio 
 
 For the Boston-born, New York-based Aaron Goldberg, Worlds is an 
encyclopedic circumnavigation of his ever-evolving musicality, which began with 
piano lessons at the age of seven. In high school Aaron got hooked on jazz by 
Bob Sinicrope of Milton Academy and continued his pursuit with saxophonist 
Jerry Bergonzi, two master educators. "At first improvisation was a mystery and a 
puzzle, but soon it became a profound inner and outer journey as life and music 
entwined." After receiving awards from Berklee School of Music and DownBeat, 
Aaron left at age 17 for NYC. At the New School for Jazz and Contemporary 
Music in 1991 he had his first taste of jazz in the big city, and at school he met 
many of his current contemporaries and friends, including Omer Avital, Brad 
Mehldau, Roy Hargrove, Ali Jackson and others. 
 
 In 1992 he returned to Boston and enrolled at Harvard College. While at 
Harvard, Aaron worked with a wide variety of artists from nearby Berklee and 
beyond, and won the International Association of Jazz Educators' prestigious 
Clifford Brown/Stan Getz Fellowship award as well as first place in National 
Foundation for Advancement in the Arts Recognition and Talent Search in 1993. 
Soon he was discovered by vocalist and first lady of jazz Betty Carter and was a 
founding member of her historic Jazz Ahead program. He continued to perform at 
clubs around both New York and Boston, often commuting in the wee hours, and 
it was not long before he met Rogers and Harland. Aaron graduated magna cum 
laude from Harvard in 1996 with a degree in History and Science and a 
concentration in Mind, Brain and Behavior. On the weekends he held a long-time 
residence at Wally's Cafe in Boston, and the fall after graduation he moved to 
Brooklyn. Aaron wasted no time in the Big Apple. He quickly established himself 
as a stellar sideman, performing with a vast array of leaders including Al Foster, 
Nicholas Payton, Stefon Harris, Tom Harrell, Freddie Hubbard, Mark Turner, and 
others. In 1998 he joined the band of Joshua Redman, with whom he toured for 4 
years and recorded two albums (Beyond, 2001 and Passage of Time, 2002). 
 
 Most recently, in addition to leading his telepathic trio Aaron has been 
touring and recording with young guitar guru Kurt Rosenwinkel. In 2005 he also 
toured South America with Madeleine Peyroux and spent 6 months performing 
with Wynton Marsalis in his quartet as well as with the Lincoln Center Jazz 
Orchestra. Aaron's long and impressive list of recorded credits includes work with 
a diverse spectrum of artists ranging from Guillermo Klein to Terry Gibbs/Buddy 
DeFranco, as well as with fellow leaders of the next generation including John 
Ellis, Jimmy Greene and Eli Degibri. In 2004, Aaron produced and performed in 
Jazz for America's Future, a fundraising concert for John Kerry's presidential 
campaign that also featured Savion Glover, Brad Mehldau, Michael Brecker, Dee 
Dee Bridgewater, Christian McBride and others. He is currently the musical 
director of All Souls at Sundown, a jazz and poetry series at Manhattan's All 
Souls Church. His first recording as a leader, Turning Point, was released on the 
J Curve imprint in 1999, followed by Unfolding in 2002. He's also a member of 
the OAM Trio, which recorded Trilingual (1999) and Flow (2002) for the Fresh 
Sound/New Talent label, as well as two collaborations with saxophonist Mark 
Turner: an upcoming studio project and the acclaimed Live in Sevilla (2003) on 
Lola Records. 
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Chairperson: K. Hochedlinger, Massachusetts General Hospital, 
Boston 
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Yumiko Saga. 
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Jerome Artus, Kat Hadjantonakis. 
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Cdx2 mRNA transport in mouse embryo depends on actin and 
microtubule network and a zip code identified in the coding 
sequence 
Maria Skamagki, Krzysztof B. Wicher, Sujoy Ganguly, Alexander W. 
Bruce, Magdalena Zernicka-Goetz. 
Presenter affiliation: Wellcome Trust/Cancer Research UK Gurdon 
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Presenter affiliation: Sloan-Kettering Institute, New York, New York. 
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Satellite cells require Notch signals to recognize their 'niche' 
Dominique Broehl, Elena Vasyutina, Carmen Birchmeier. 
Presenter affiliation: Max Delbrück Centrum, Berlin, Germany. 
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Distinct stem/progenitor cell populations control skeletal muscle 
development 
Ramkumar Sambasivan, Danielle Gomés, Gérard Dumas, Clémire 
Cimper, Shahragim Tajbakhsh. 
Presenter affiliation: Institut Pasteur, Paris, France. 
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Dissecting the mechanisms of cellular reprogramming 
Konrad Hochedlinger. 
Presenter affiliation: Massachusetts General Hospital, Boston, 
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 1 
GENETIC AND MOLECULAR DIRECTION OF SEROTONIN 
SIGNALING IN THE HYPOTHALAMUS 
 
Gerard Karsenty  
 
Columbia University, Genetics & Development, New York, NY, 10032 
 
Serotonin is a bioamine synthesized in the brain where it acts as a 
neurotransmitter and the gut where it acts as a hormone. Serotonin does not 
cross the blood brain barrier hence each pool of this molecule may have 
different functions. We have shown earlier that brain-derived serotonin 
favors bone mass accrual and appetite by signaling through distinct 
receptors in the ventromedial (VMH) and arcuate neurons of the 
hypothalamus respectively. These two functions of serotonin are inhibited 
by leptin which signals in serotonergic neurons of the brainstem to inhibit 
serotonin synthesis and release. To better understand how leptin and 
serotonin coordinate the regulation of bone mass and energy metabolism we 
studied the signal transduction and transcriptional cascades elicited by 
serotonin in VMH and arcuate neurons of the hypothalamus. We show that 
in both nuclei serotonin uses CREB as a transcriptional mediator of its 
function and identified genes expressed in these neurons and whose 
expression is under the positive and negative control of serotonin and leptin 
respectively. Lastly, we will present proof of principle evidence that 
modulating the serotonin pathway can treat obesity. 
 2 
THRESHOLD LEVELS OF TBX5 ENSURE SYMMETRICAL 
FORMATION OF THE LEFT AND RIGHT FORELIMB  
 
Fatima A Sulaiman, Malcolm P Logan  
 
Developmental Biology, National Institute for Medical Research, London, 
NW7 1AA, United Kingdom 
 
Although there is no obvious communication between the left and right 
limb buds they develop to form bilaterally symmetrical structures of equal 
size (Summerbell & Wolpert, 1973). The underlying mechanisms that 
ensure symmetrical limb formation are unknown. We present the results of 
a study using the mouse model as a genetic tool showing a role for the 
transcription factor Tbx5 in ensuring the symmetrical formation of the left 
and right forelimb.  
Holt-Oram Syndrome (HOS) [OMIM 142900] is a congenital syndrome 
associated with mutations in TBX5 that lead to heart and upper limb defects. 
Strikingly, over 70% of HOS patients have left-biased upper limb defects. 
We show that hypomorphic levels of Tbx5 in both the left and right 
forelimb buds produces forelimb defects that are consistently more severe 
in the left limb than the right, thus phenocopying the left-biased upper limb 
defects seen in HOS patients. Using the INV/INV mutant background in 
which the left-right axis is reversed, we show that the laterality of these 
defects is reversed in Tbx5 hypomorphic mutants with situs inversus. 
Additionally, we also show that transgenic expression of equal levels of 
Fgf10 in the forelimb buds of these Tbx5 hypomorphs can rescue outgrowth 
defects but not the left-bias asymmetry of their presentation. Together, our 
data suggest that Tbx5 has a role in ensuring symmetrical forelimb 
formation and that this is independent of its transcriptional regulation of 
Fgf10. 
 3 
AN UNEXPECTED ROLE FOR TBX5 IN THE SECOND HEART FIELD 
FOR CARDIAC SEPTATION 
 
Linglin Xie, Joshua Friedland-Little, Andrew Hoffmann, Ivan Moskowitz  
 
The University of Chicago, Pediatrics and Pathology, Chicago, IL, 60637 
 
Cardiac septation is an essential specialization of tetrapod cardiac 
morphogenesis; congenital heart disease (CHD) results when cardiac 
septation is compromised. Our understanding of the molecular mechanisms 
driving atrioventricular septation has undergone recent revision, including a 
novel paradigm relying on the extra-cardiac specification of cardiac 
progenitors for the atrial septum (e.g. Hoffmann et al., 2009). While Tbx5 is 
a well studied cardiogenic transcription factor implicated in Holt–Oram 
syndrome with atrioventricular septal defects in humans, the basis for its 
requirement in atrioventricular septation remains unknown. We found that 
Tbx5 is required in cardiac progenitors but not in the heart for 
atrioventricular septation. Germline Tbx5 haploinsufficiency caused 
atrioventricular septal defects in 40% of late gestation mouse embryos. Yet 
Tbx5 haploinsufficiency in myocardial cells, using Tnt:Cre, or in 
endocardial cells, using Tie2:Cre, resulted in normal septation, suggesting 
that the Tbx5 activity which required cardiac septation lay outside the heart. 
We observed Tbx5 expression in progenitors for the atrial septum outside of 
the heart in the posterior second heart field. Conditional Tbx5 
haploinsufficiency in the posterior second heart field using the Hedgehog 
(Hh) signaling-responsive Gli1:Cre caused atrioventricular septal defects in 
40% of embryos, demonstrating a requirement for Tbx5 outside the heart in 
the second heart field. We found that Tbx5 and Hh-signaling components 
genetically interact: decreasing Hh signaling caused increased penetrance of 
atrioventricular septal defects in Tbx5 mutant mice. Furthermore, 
constitutive activation of Hh-signaling rescued atrioventricular septation in 
Tbx5 mutant mice, placing Hh signaling downstream of Tbx5 in a pathway 
required for atrial septation. Finally, using Genetic Inducible Fate Mapping, 
we demonstrated that Tbx5 is specifically required for proliferation of atrial 
septum progenitor cells in the posterior second heart field. We present a 
molecular pathway including Tbx5 and Hh signaling required for cardiac 
progenitor cell specification and morphogenesis of cardiac septation that 
informs the ontogeny of atrial septal defects.  
 4 
IDENTIFICATION OF SOX3/SOX3 AS A XX MALE SEX REVERSAL 
GENE IN MICE AND HUMANS. 
 
Edwina Sutton1, James Hughes1, Stefan White2, Ryohei Sekido3, Jacqueline 
Tan2, Valerie Arboleda4, Vincent Harley5, Eric Vilain4, Andrew Sinclair2, 
Robin Lovell-Badge3, Paul Thomas1  
 
1University of Adelaide, School of Molecular & Biomedical Science, 
Adelaide, 5005, Australia, 2Murdoch Childrens Research Institute , Early 
Development and Disease Theme, Melbourne, 3052, Australia, 3MRC 
National Institute for Medical Research, Division of Developmental 
Genetics, London, NW7 1AA, United Kingdom, 4UCLA, Department of 
Human Genetics, Los Angeles, CA, 90095-7088, 5Prince Henry's Institute 
of Medical Research, Molecular Genetics and Development , Melbourne, 
5152, Australia 
 
Therian mammals utilise an XX/XY system of sex determination in which 
the Y-linked gene Sry (Sex-determining region Y) exerts a dominant 
masculinising influence on sexual development. Sex chromosome 
homology and comparative sequence studies suggest that Sry evolved from 
the related Sox3 gene on the X chromosome, although there is no direct 
functional evidence to support this hypothesis. Indeed, loss of function 
mutations show that SOX3 is not required for sex determination in mice or 
humans, but it is critical for normal CNS and pituitary development. To 
investigate the developmental consequences of overexpression, we created 
Sox3 transgenic mice. One of these lines expressed Sox3 ectopically in the 
bipotential gonad due to a position effect and frequently exhibited complete 
XX male sex reversal. Morphological, gene expression and cell co-
transfection studies indicate that SOX3 induces testis differentiation in this 
particular line of mice by activation of Sox9 via a similar mechanism to 
SRY. In addition, array-Comparative Genomic Hybridisation analysis of 
sixteen SRY-negative XX males revealed three patients with rearrangements 
of the SOX3 regulatory region, indicating that SOX3 gain-of-function in 
humans also causes XX male sex reversal. Together, these data suggest that 
SOX3 and SRY proteins are functionally interchangeable in sex 
determination and support the notion that Sry evolved from Sox3 via a 
regulatory mutation that led to its de novo expression in the early gonad. 
These data also provide novel insight into the mechanism that underpins 
XX male sex reversal in humans in the absence of SRY. 
 5 
ERK1 AND ERK2 HAVE A REDUNDANT ROLE IN PROMOTING 
EMBRYONIC FIBROBLASTS PROLIFERATION. 
 
Laure Voisin*, Marc K Saba-El-Leil*, Catherine Julien, Christophe Frémin, 
Sylvain Meloche  
 
Institut de Recherche en Immunologie et Cancérologie, Université de 
Montréal, Montréal, H3C3J7, Canada 
 
The ERK1/2 mitogen-activated protein (MAP) kinase signaling pathway 
plays a critical role in the proliferative response of mammalian cells to 
mitogenic factors. However, the individual contribution of the isoforms 
ERK1 and ERK2 to cell proliferation control remains unclear. The two 
proteins have similar biochemical properties, recognize the same primary 
sequence determinants on substrates and are ubiquitously expressed in cell 
lines and tissues, although their relative abundance is variable. However, 
analysis of mice lacking individual ERK genes suggests that ERK1 and 
ERK2 may have evolved unique functions. Mice homozygous for Erk2 
mutation die in utero around day e6.5 due to a defect in trophoblast 
development. On the other hand, ERK1-deficient mice are viable, fertile 
and of normal size. Finally, it has been recently proposed that ERK1 and 
ERK2 exert antagonistic effects on cell proliferation.  
 
In this study, we have used a genetic approach to analyze the individual 
roles of ERK1 and ERK2 in cell proliferation control using genetically 
matched primary embryonic fibroblasts. We show that loss of ERK1 
reduces mitogenic signaling and significantly slows down the proliferation 
rate of fibroblasts. To circumvent the early embryonic lethality associated 
with a null mutation of Erk2, we have generated ERK2-deficient embryos 
using two approaches: tetraploid aggregation with Erk2 null embryos and 
the generation of mice carrying a conditional Erk2 allele. We found that 
Erk2-/-fibroblasts are also impaired in the activation of signaling effectors 
and proliferate slower. The decline in proliferation is more important in 
ERK2-deficient cells, consistent with the higher level of expression of 
ERK2 in these cells. To further analyze the specific contribution of ERK1 
and ERK2, we evaluated the impact of silencing the expression of ERK1 or 
ERK2 by RNA interference in cells genetically disrupted for the other 
isoform. Lowering the level of either remaining ERK isoform similarly 
resulted in a marked decrease in cell proliferation. Finally, we generated 
fibroblasts genetically deficient in both Erk1 and Erk2 by infecting Erk1-/-; 
Erk2f/f primary MEFs with a retroviral vector expressing the Cre 
recombinase. Combined loss of ERK1 and ERK2 function resulted in a 
complete arrest of cell proliferation.  
 
Altogether, these findings provide compelling genetic evidence for a 
redundant role of ERK1 and ERK2 in promoting cell proliferation. 
 
* L.V. and M.K.S.-E.-L. contributed equally to this work. 
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THE P63R279H MOUSE MODEL MIMICS THE HUMAN 
ECTRODACTYLY-ECTODERMAL DYSPLASIA-CLEFTING (EEC) 
SYNDROME 
 
Emma Vernersson-Lindahl 1, Elvin Garcia1, Guy Horev1, Hans van 
Bokhoven 2, Alea A Mills1  
 
1Cold Spring Harbor Laboratory, Cancer Research Center, Cold Spring 
Harbor, NY, 11743, 2Radboud University , Nijmegen Medical Centre, GD 
Nijmegen, 6525, Netherlands 
 
The p63 gene has a complex structure with two promoters giving rise to the 
TAp63 and ∆Np63 transcripts. Alternative splicing further diversifies the 
TAp63 and ∆Np63 isoform classes into α, β and γ isoforms. The prominent 
phenotypes observed in the p63 deficient mouse models have clearly 
established p63 as a master regulator of epidermal development. Further, 
p63 deficient mice provided clues that led to the discovery that p63 
mutations are the cause of several different human developmental 
syndromes. We have established a mouse model for one of these human 
syndromes – Ectrodactyly-Ectodermal dysplasia-Clefting (EEC) syndrome 
– by knocking in the R279H mutation causative of human EEC. This 
model, referred to as p63R279H, has severe phenotypes comparable to those 
found in human EEC patients, including craniofacial clefting and defects in 
skin and skin related appendages.  
 
We have found that primary keratinocytes from p63R279H/+ mice exhibit 
decreased proliferation and enhanced senescence. This phenotype is not 
present in the p63 deficient model (p63Brdm3) indicating a unique role for the 
R279H point mutation in modulating keratinocyte biology. Further, 
p63R279H homozygous mice, although lacking a mature skin layer at birth, 
still express markers of keratinocyte differentiation that are not detectable in 
the p63Brdm3 homozygous mutants, indicating that the R279H allele is 
distinct from the null allele. We used cDNA microarray analyses to identify 
gene expression profiles within primary p63R279H/+ keratinocytes. 
Furthermore, by integrating a microarray analysis performed on human 
EEC patients carrying the R279H mutation, we have identified a number of 
potential candidate genes that link the mouse p63R279H model with the 
human EEC syndrome. By analyzing expression of these candidates in the 
EEC mouse model, we are currently identifying molecular signatures 
responsible for the pathogenesis of human EEC syndrome.  
 
 
 7 
MOUSE MODELS OF SKIN CANCER 
 
Fiona M Watt  
 
CRUK, Cambridge Research Institute, Robinson Way, Cambridge, CB2 
0RE, United Kingdom 
 
Mice have been used to model skin cancer for many decades. However, as 
we learn more about stem cells in the epidermis and about how 
environmental signals regulate their behaviour, the question we face is: 
which is the most appropriate model? Transgenic mice that develop all the 
major types of epidermal cancer are available and have the advantage that 
tumour formation can be monitored and manipulated within the context of a 
fully functional immune system. Nevertheless, tumours can also be built 
from human cells via xenografts in immunocompromised animals. Unlike 
autochthonous mouse models, xenografts allow quantitative evaluation of 
the relative tumour-initiating capacity of different stem cell populations. I 
will discuss the different types of information that are obtained from the 
different models and will suggest that it is important to compare data 
obtained from multiple models in order to obtain clinically relevant data. 
 8 
ENFORCED TBX1 EXPRESSION IN FETAL THYMUS IS 
INCOMPATIBLE WITH TEC DIFFERENTIATION 
 
Kim T Cardenas1, Zhijie Liu2, Micheline Laurent1, Carla Carter1, Nancy 
Manley2, Ellen Richie1  
 
1MD Anderson Cancer Center, Molecular Carcinogenesis, Smithville, TX, 
78957, 2University of Georgia, Department of Genetics, Athens, GA, 30602 
 
The thymus and parathyroid glands originate from organ-specific domains 
of 3rd pharyngeal pouch (PP) endoderm. At embryonic day 11.5 (E11.5), 
the ventral thymus and dorsal parathyroid domains can be identified by 
Foxn1 and Gcm2 expression respectively. We have shown that neural crest 
cells (NCCs) play a role in regulating patterning of 3rd PP endoderm. In 
addition, pharyngeal endoderm influences fate determination via secretion 
of Sonic hedgehog (Shh), a morphogen required for Gcm2 expression and 
generation of the parathyroid domain. Gcm2 is a downstream target of the 
transcription factor Tbx1, which in turn is positively regulated by Shh. 
Although initially expressed throughout pharyngeal pouch endoderm, Tbx1 
expression is excluded from the thymus-specific domain of the 3rd PP by 
E10.5, but persists in the parathyroid domain. Based on these observations, 
we hypothesized that Tbx1 expression is non-permissive for thymus fate 
specification and that enforced expression of Tbx1 in the fetal thymus 
would impair thymus development. 
To test this hypothesis, we generated knock-in mice containing a Cre-
inducible allele that allows temporal and spatial control of Tbx1 expression. 
Expression of the R26iTbx1 allele in fetal and adult thymus using Foxn1-
Cre resulted in severe thymus hypoplasia throughout ontogeny that 
persisted in the adult. Thymic epithelial cell (TEC) development was 
impaired as determined by immunohistochemical and FACS analysis of 
various differentiation markers. The relative level of Foxn1 expression in 
fetal TECs was significantly reduced. TECs in R26iTbx1/+ thymi assumed an 
almost universal expression of Plet-1, a marker associated with a TEC 
stem/progenitor cell fate. In addition, embryonic R26iTbx1/+ mice develop a 
perithymic mesechymal capsule that appears expanded compared to control 
littermates. Interestingly, thymi from neonatal and adult R26iTbx1/+ but not 
R26+/+ mice were encased in adipose tissue. This thymic phenotype also 
correlated with a decrease in thymocyte cellularity and aberrant thymocyte 
differentiation. The results to date support the conclusion that enforced 
expression of Tbx1 in TECs antagonizes their differentiation and prevents 
normal organogenesis via both direct and indirect effects. Supported by 
NIH HD056315 to ER and HD035920 to NM. 
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γ-GLUTAMYL CARBOXYLASE REGULATES WHOLE BODY 
ENERGY METABOLISM THROUGH ITS EXPRESSION IN 
OSTEOBLASTS 
 
Mathieu Ferron, Gerard Karsenty  
 
Columbia University, Genetics and Development, New York, NY, 10032 
 
Osteocalcin is a hormone produced by osteoblast, the bone-forming cell, 
and regulating energy metabolism. While osteocalcin can exist in two 
forms, γ-carboxylated and undercarboxylated, only the undercarboxylated 
form of this molecule functions as a hormone favouring glucose handling 
and increasing energy expenditure. As a result, the absence of osteocalcin 
leads to glucose intolerance in mice, and infusions of uncarboxylated 
osteocalcin in wild type mice protect them from type 2 diabetes and obesity. 
More recently, we have shown that it is the osteoclast, the bone-resorbing 
cell, that decarboxylates and activates the osteocalcin trapped in the 
extracellular matrix (ECM). Surprisingly, it is the low pH generated during 
bone resorption that allows the osteocalcin to be decarboxylated. Thus, the 
results obtained so far suggest that γ-carboxylation of osteocalcin have an 
inhibitory effect on the bioavailability of this hormone and, indirectly, on 
whole body glucose homeostasis. To formally test this contention we 
generated osteoblast-specific γ-glutamyl carboxylase (Ggcx)-deficient mice 
(Ggcxosb-/-). In contrast to the Ggcx null mice, which died shortly after birth 
from hemorrhage, the Ggcxosb-/- mice were viable and obtained at the 
expected Mendelian ratio. These mutant mice however, displayed a 5-fold 
increase in their serum levels of uncarboxylated osteocalcin. In agreement 
with our working hypothesis glucose handling was significantly improved 
in Ggcxosb-/- as measured by a glucose tolerance test (GTT). We also 
observed an increase in insulin sensitivity in these mice when we subjected 
them to an insulin tolerance test (ITT). Fasting insulin was increased in 
Ggcxosb-/- mice, suggesting that pancreatic β-cell function was improved in 
these animals. Lastly, Ggcxosb-/- mice presented a 50% decrease in their fat 
mass, which results in a lower body weight at 5 month of age. Importantly, 
when fed a high fat diet (HFD), the Ggcxosb-/- mice gained significantly less 
weight than control mice and were protected against the glucose intolerance 
induced by HFD. Taken together, these results establish that γ-glutamyl 
carboxylase through it expression in osteoblasts negatively regulates 
glucose homeostasis. Thus they further support the hypothesis that it is the 
undercarboxylated form of osteocalcin that acts as a hormone. This work 
also suggests that Vitamin K, an essential cofactor of γ-glutamyl 
carboxylase, may play a role in the control of energy metabolism by bone. 
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COOPERATIVE ACTION OF WNT4 AND GERM CELLS IN 
MAINTAINING OVARIAN CELL FATE DURING MOUSE 
EMBRYOGENESIS. 
 
Danielle Maatouk, Blanche Capel  
 
Duke University, Department of Cell Biology, Durham, NC, 27713 
 
Primary sex determination in mammals occurs during embryogenesis with 
the formation of the gonads. In XY embryos, Sry shifts the bipotential 
gonad towards a testicular fate, establishing the expression of Sox9, which 
carries out all known downstream functions of Sry. To date, no single gene 
has been identified that drives female sex determination. However, in 
humans, the existence of XX males lacking Sry predicts that the mutation of 
female genes could disrupt the female pathway and derepress the male 
pathway. We are interested in understanding the pathways that divert the 
bipotential gonad towards an ovarian fate. Two female-specific genes 
involved in canonical Wnt signaling have been identified that antagonize 
the male pathway (Wnt4 and R-spondin) and result in XX masculinization 
in mice and humans when disrupted. We previously showed that activation 
of β-catenin is sufficient to disrupt the expression of SOX9 and male sex 
determination, leading to sex reversal. We now show that loss of β-catenin 
in XX gonads (using a ubiquitously expressed tamoxifen inducible Cre) 
results in only a partial female-to-male sex reversal, suggesting that other 
pathways are necessary for ovarian development. We have investigated the 
role of germ cells in ovarian development and found that a loss of germ 
cells does not alter the fate of ovarian somatic cells. However, when germ 
cells are depleted from XX gonads lacking Wnt4, a more severe sex-reversal 
phenotype is observed, including derepression of SOX9 and morphological 
changes resembling testis cords. This supports previous work from our lab 
that found an anti-testis role for XX germ cells in vitro and suggests that 
multiple pathways promote ovarian development. 
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ANTAGONISM BETWEEN WNT/β-CATENIN SIGNALING AND SIX2 
IN THE CELL FATE DECISION OF NEPHRON PROGENITORS 
 
Joo-Seop Park1, Wenxiu Ma2, Wing H Wong2, Andrew P McMahon1  
 
1Harvard University, Department of Stem Cell and Regenerative Biology, 
Cambridge, MA, 02138, 2Stanford University, Department of Statistics, 
Stanford, CA, 94305 
 
Nephron progenitor cells act as stem cells during kidney development. They 
are replenished by self-renewal and differentiate into epithelial cells, which 
eventually form the entire epithelial structure of a nephron. As the 
neighboring cells called the collecting duct provide signals for the 
differentiation of nephron progenitors, the fate decision of nephron 
progenitors is coordinated with the branching of the collecting duct. 
Nephron progenitors located at the ventral side of the tips of the collecting 
duct become differentiated by undergoing mesenchymal-to-epithelial 
transition while nephron progenitors located at the dorsal side of the 
collecting duct remain undifferentiated. It is critical to maintain a 
population of these undifferentiated cells and to allow their self-renewal in 
order to ensure nephrogenesis at each round of branching. Previous genetic 
studies have shown that Six2, a transcription factor expressed in 
undifferentiated nephron progenitors, is required for their self-renewal and 
that Wnt/β-catenin signaling provided by the collecting duct is responsible 
for their differentiation. In order to better understand how these two 
pathways regulate nephron progenitors in opposing ways, We performed 
genomic mapping of Six2 binding sites in freshly FAC-sorted nephron 
progenitor cells and mapping of β-catenin binding sites in Wnt/β-catenin 
signal-activated cells by chromatin immunoprecipitation and deep 
sequencing (ChIP-seq). Interestingly, Six2 and β-catenin share 129 common 
binding sites. Combining genomic mapping data with gene expression 
profiles allowed prediction of putative common target genes of Six2 and β-
catenin in nephron progenitors. Transgenic analysis of a subset of the 
common target sites of Six2 and β-catenin revealed that Wnt/β-catenin 
signaling activates multiple signaling pathways by inducing expression of 
Wnt4, Fgf8, and Bmp7 and that Six2 represses expression of these Wnt 
target genes by forming a complex with Tcf. In addition, we show that both 
β-catenin and Six2 bind to an enhancer of Six2 where Six2 acts as an 
activator and β-catenin most likely acts as a repressor. Our findings suggest 
that Six2 and β-catenin antagonize each other in regulating expression of 
key genes during nephrogenesis. 
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SIX1 INITIATES BRANCHING MORPHOGENESIS BY REGULATING 
GREMLIN-BMP4 SIGNALING  
 
Pin-Xian Xu2  
 
1Mount Sinai School of Medicine, Genetics and Genomic Sciences, New 
York, NY, 10029, 2Mount Sinai School of Medicine, Developmental and 
Regenerative Biology, New York, NY, 10029 
 
Urinary tract morphogenesis requires subdivision of the ureteric bud (UB) 
into tip- and trunk-specific domains, which will differentiate into intra-renal 
collecting system and the extra-renal ureter, respectively, by responding to 
signals in their surrounding mesenchyme. The homeodomain transcription 
factor SIX1 is transiently expressed in the metanephric mesenchyme (MM) 
surrounding the UB tip at E10.5 and its expression disappears from E11.5. 
In Six1-/- mouse embryos, the collecting duct system fails to form but the 
ureter is present. We investigated the molecular and cellular basis of the 
phenotype displayed by Six1-/- embryos and report here that the tip domain 
of the UB is initially formed in the mutant but the tip cells fail to form an 
ampulla for branching morphogenesis. Instead, the mutant UB elongates 
within Tbx18- and Bmp4-expressing mesenchyme for its differentiation into 
the ureter. We find that the expression of the extra-cellular BMP antagonist 
gremlin 1 (Grem1) in the MM is Six1-dependent and that SIX1 directly 
binds to the Grem1 promoter in the MM and can upregulate its expression 
in transient transfection studies. Treatment of mutant kidney rudiments with 
recombinant GREM1 protein restores ampulla formation and its subsequent 
branching morphogenesis. Since GREM1 acts as an antagonist of BMP4 to 
induce UB branching morphogenesis, we tested whether genetically 
lowering BMP4 activity could restore kidney organogenesis. Indeed, 
genetic reduction of BMP4 levels in Six1-/- (Six1-/-;Bmp4+/-) embryos 
restores urinary tract morphogenesis and kidney formation. This study 
provides the first evidence that Six1 acts by directly upregulating Grem1 in 
the MM to locally antagonizing BMP4 activity to ensure that the UB tip 
cells are induced for ampulla formation and its subsequent branching. This 
finding uncovers an essential function for SIX1 as a critical upstream 
regulator of Gremlin-mediated BMP4 signaling during urinary tract 
morphogenesis. 
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THE ROLE OF HETEROCHROMATIN PROTEIN 1 (HP1) Γ IN 
PRIMORDIAL GERM CELLS 
 
Kanae Abe1, Chie Naruse1, Tomoaki Kato2, Takumi Nishiuchi2, Mitinori 
Saitou3, Masahide Asano1  
 
1Kanazawa Univ., Div. of Transgenic Animal Sci., Adv. Sci. Res. Ctr., 
Kanazawa, 920-8640, Japan, 2Kanazawa Univ., Div. of Functional 
Genomics, Adv. Sci. Res. Ctr., Kanazawa, 920-0934, Japan, 3Kyoto Univ., 
Dep. Anatomy and Cell Biol., Glad. Sch. Med., Kyoto, 606-8501, Japan 
 
Germ cell fate is determined among proximal epiblast cells by the signal 
from extraembryonic tissues in mice. After specification of germ cell fate, 
approximately 40 primordial germ cells (PGCs) appear at the base of 
allantoic bud, proliferate and migrate to genital ridges, reaching around 
25,000 cells until E13.5. Heterochromatin protein 1 (HP1) family members, 
HP1α, β, Γ, are thought to repress gene expression epigenetically by 
binding the methylated histone H3 lysine 9 and to induce the formation of 
heterochromatin structure. We generated HP1Γ mutant mice and found that 
the number of HP1Γ-/- germ cells was dramatically reduced before meiosis. 
HP1Γ was expressed strongly in PGCs among HP1 family members, while 
all HP1s were expressed in somatic cells. The number of HP1Γ-/- PGCs 
was reduced from early bud (EB) stage (E7.25). The ratio of HP1Γ-/- PGCs 
in S-phase decreased and that in G1-phase increased conversely. Moreover, 
the ratio of p21 (Cip1)-positive HP1Γ-/- PGCs increased, suggesting G1/S-
phase transition was inhibited. On the other hand, we could not detect any 
difference in apoptosis, PGC differentiation and histone modification 
between control PGCs and HP1Γ-/- PGCs. These results suggest that 
reduced number of PGCs was caused by impaired cell cycle and HP1Γ 
plays a key role in proliferation of PGCs during early embryogenesis. 
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ENDOTHELIAL OVEREXPRESSION OF LOX-1 INCREASES AORTIC 
LDL UPTAKE, INDUCES ENDOTHELIAL DYSFUNCTION AND 
PLAQUE FORMATION IN VIVO. ROLE OF TRANSCRIPTION 
FACTORS NFΚB AND OCT-1 
 
Alexander Akhmedov, Izabela Rozenberg, Yi Shi, Carola Doerries, Pavani 
Mocharla, Alexander Breitenstein, Christine Lohmann, Sokrates Stein 
 
University of Zurich, Switzerland.  
 
Background- The hallmark of the initiation of atherosclerotic lesion is foam 
cell formation, and oxidized LDL (OxLDL) is believed to play a key role in 
the initiation of the atherosclerotic process. OxLDL is internalized by 
several receptors, such as SR-AI/II, SR-BI, CD36, and CD68. OxLDL is 
also internalized by endothelial cells, but this uptake depends on receptors 
other than the classic scavenger receptors. In 1997, a lectin-like oxidized 
LDL receptor-1 (LOX-1, OLR1) was identified in bovine aortic endothelial 
cells. LOX-1 is a type II membrane glycoprotein with an apparent 
molecular weight of 50 kDa. It has a C-terminal extracellular C-type lectin-
like domain. This lectin-like domain is essential for binding to OxLDL. 
Binding of OxLDL to LOX-1 induces several cellular events in endothelial 
cells, such as activation of transcription factor NF-κB, upregulation of 
MCP-1, and reduction in intracellular NO, which may trigger the onset of 
cardiovascular events or accelerate the development of atherosclerosis. 
Methods and Results- We generated endothelial-specific LOX-1 transgenic 
mice using the Tie2 promoter (LOX-1TG). In endothelial cells, but not 
macrophages, LOX-1TG mice exhibited enhanced oxLDL uptake. 6-week-
old male LOX-1TG and wild-type (WT) mice were fed a high cholesterol 
diet for 30 weeks. In LOX-1TG vascular cell adhesion molecule-1 (VCAM-
1) and E-selectin expression, macrophage accumulation and aortic fatty 
streaks were increased, while eNOS phosphorylation and endothelial 
function were reduced. In endothelial cells of LOX-1TG mice, reactive 
oxygen species were increased and the transcription factors NF-κB and Oct-
1 activated. In atherosclerotic LOX-1TG/ApoE-/- mice, high cholesterol diet 
increased VCAM-1 expression, number of macrophages, T-cells as well as 
plaque size. Conclusions-Thus, our data suggest that LOX-1 plays a critical 
role in the development of atherosclerosis when expressed at 
unphysiological levels. Therefore, LOX-1 might represent a novel 
therapeutic target for atherosclerosis. 
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ROLE OF KERATIN14 IN THE DEVELOPMENT OF STRATIFIED 
EPITHELIA: A PROSPECT FOR IN VIVO STUDIES. 
 
Hunain Alam, Samrat Kundu, Sorab N Dalal, Milind M Vaidya  
 
ACTREC, Vaidya Lab, Navi Mumbai, 410210, India 
 
Keratins are cytoplasmic intermediate filament proteins preferentially 
expressed by epithelial tissues in a site-specific and differentiation 
dependent manner. The complex network of keratin filaments in stratified 
epithelia is tightly regulated during squamous cell differentiation. Keratin14 
(K14) is expressed in mitotically active basal layer cells along with its 
partner Keratin5 (K5) and their expression is downregulated as cells 
differentiate. Apart from cytoprotective functions of K14, very little is 
known about K14 regulatory functions as the K14 knockout mice show 
embryonic lethality. This suggests that it performs unique tissue specific 
functions. K14 expression was inhibited using RNA interference in cell 
lines derived from stratified epithelia, to study the K14 functions in cell 
proliferation and differentiation. The K14 knockdown clones demonstrated 
significant reduction in cell proliferation and concomitant reduction in 
phosphorylated Akt levels. K14 knockdown cells also exhibit enhanced 
activated Notch1 levels, which were accompanied by increased involucrin 
and K1 levels. Our in vitro results suggest that K14 maintains proliferation 
potential in the basal layer of stratified epithelia by modulating PI-3K/Akt 
dependent cell proliferation and Notch1 dependent cell differentiation 
processes. The future studies using in vivo system will give us insights into 
the exact function of K14 in differentiation program and development of 
stratified epithelia. 
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FGF3 IS REQUIRED IN THE NORMAL TERMINATION OF 
EMBRYONIC AXIS EXTENSION 
 
Matthew J Anderson1, Thomas Schimmang2, Mark Lewandoski1  
 
1NCI , Cancer and Developmental Biology Laboratory, Frederick, MD, 
21702, 2University of Valladolid, Institute For Biology and Molecular 
Genetics, Valladolid, 47002, Spain 
 
Elucidating mechanisms that control segmentation, a common motif by 
which embryos generate pattern, is essential to understand embryological 
development. In vertebrates, segmentation of the anterior-posterior (AP) 
axis is evident in the repeated pattern of the adult vertebrae, which are 
derived from embryonic segments called somites. Somites also give rise to 
skeletal muscle, tendons, and dorsal dermis of the torso. Somitogenesis 
occurs in a progressive AP fashion as new somites reiteratively segment 
from a posterior region termed the presomitic mesoderm (PSM). Relative to 
our knowledge on how somitogenesis and axis extension are initiated and 
maintained little is known about how these processes cease. 
 
Fibroblast growth factors (FGFs) are key players in the regulation of axis 
extension. Previously we’ve shown that several Fgfs appear to play partially 
redundant roles during somitogenesis. However, Fgf3 plays a non-
redundant role in the cessation of axis extension as mice lacking this gene 
have a variably kinked and shortened tail. Consistent with this role for Fgf3, 
its expression in the PSM is downregulated as normal axis extension ceases. 
 
Loss of Fgf3 leads to an increase in cell death in the distal PSM during early 
midgestation, diminishing the PSM such that it is depleted prematurely at 
embryonic day 12.5 instead of 13.5, resulting in fewer somites and AP axis 
truncation. Normally, molecular signals that determine somite size are 
modulated during the gradual loss of PSM so that smaller somites form. In 
mutants, this occurs ahead of schedule causing abnormally shaped somites 
and a tail that tapers faster than normal. 
 
Our data suggests a mechanism by which somite formation and cessation of 
the AP axis is directly influenced by the amount of PSM. In Fgf3 mutants, 
premature PSM loss leads to an adjustment in timing of somitogenesis 
cessation, causing abnormal somite and notochord morphogenesis, leading 
to the kinked and shortened tails in the adult Fgf3 mutant. This work sheds 
light on the mechanisms that control the final stages of axis extension and 
illuminates the role of Fgf3 in this process. 
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A MOUSE MODEL FOR JUVENILE HYDROCEPHALUS 
 
Oliver K Appelbe, Elena A Glick, Jenniffer R Ramalie, Ekaterina Y 
Steshina, Jennifer V Schmidt  
 
University of Illinois at Chicago, Biological Sciences, Chicago, IL, 60607 
 
Juvenile hydrocephalus, the accumulation of cerebrospinal fluid (CSF) in 
the ventricles of the brain, causes significant morbidity among human 
children affecting roughly 1 in 500 newborns. The disease manifests due to 
overproduction, decreased absorption, or restricted flow of CSF. Few 
genetic causes of this disease are known, and therefore animal models can 
prove beneficial in identifying candidate genes. 
The Juvenile hydrocephalus (Jh) mouse line contains a transgenic 
integration on mouse chromosome 9. Homozygous Jh mice exhibit 
hydrocephalus by two weeks of age and few survive beyond eight weeks. 
This phenotype represents a novel cause of the disease since no known 
hydrocephalus mutations map to the region. Analysis of the integration site 
showed disruption of an uncharacterized gene, I11. Preliminary data 
suggests that a transgene carrying a functional copy of I11 can rescue the Jh 
phenotype. However, the predicted protein product of I11 has no 
recognizable functional domains and its role in CSF maintenance is 
unknown. Future research will focus on definitively establishing the role of 
I11 in hydrocephalus and dissecting its function.  
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FIBRONECTIN AND INTEGRIN ALPHA 5 PLAY ESSENTIAL ROLES 
IN DEVELOPMENT OF LEFT-RIGHT ASYMMETRY IN MICE. 
 
Maria Pulina1, Ashok Mittal2, Shuan-Yu Hou3, Dorthe Julich4, Scott 
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Early studies in Xenopus laevis suggested that cell-extracellular matrix 
(ECM) interactions regulate the development of the left-right axis of 
asymmetry; however, the identity of ECM components and their 
receptors important for this process have remained unknown. We have 
analyzed left-right patterning in mouse embryos lacking fibronectin (FN) 
and discovered that FN is required for the establishment and 
maintenance of asymmetric gene expression by regulating morphogenesis 
of the node, expression of Lefty1 at the embryonic midline and signaling by 
TGF beta family of proteins. Furthermore, our experiments indicate that a 
major cell surface receptor for FN, integrin α5, is also required for the 
development of left-right asymmetry and that this requirement is 
evolutionarily conserved in vertebrates. Taken together, our studies 
demonstrate the requisite role for a structural ECM protein and its integrin 
receptor in the development of the left-right axis of asymmetry in 
vertebrates.  
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THE CRE PORTAL - A NEW INFORMATION RESOURCE FOR 
CONDITIONAL MUTAGENESIS IN THE MOUSE 
(WWW.CREPORTAL.ORG) 
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Conditional mutagenesis is a powerful tool for examining effects of stage-
specific gene function or for use in cases where gene deletion results in 
developmental lethality in knockout mice. Large-scale efforts are underway 
to produce ‘conditional-ready’ (floxed) ES cells for most mouse genes. 
Mice produced from these ES cells will have great value for examining 
gene function and regulation in different tissues or at different 
developmental ages. However, to achieve this potential, it will be critical to 
know which recombinase (cre) allele/driver combination will provide 
correct activity and specificity to fulfill the research aims. A significant 
number of mouse strains expressing cre recombinase, including inducible 
cre alleles driven by different drivers, have been generated. To maximize 
the utility of these cre strains in generation of conditionally-deleted 
mutations, tissue specificity of cre activity (or sites of ectopic function) 
must be known. 
 
The cre portal is a new, comprehensive web resource (www.creportal.org) 
for researchers using conditional mutagenesis in mice. Querying by a 
specific driver or anatomical system can retrieve curated annotations of cre 
expression/activity and specificity data. Each allele in the cre portal has a 
link for phenotypic information at Mouse Genome Informatics (MGI, 
www.informatics.jax.org). Phenotypes can be found here for progeny of 
many of the cre-bearing strains that have been crossed to conditional-ready 
mice. This integration of cre specificity data with phenotypic information is 
a powerful tool that can assist researchers in designing experiments or 
identifying important reagents. For some cre alleles, specificity or 
phenotype data may not currently be available, but molecular details of the 
cre construct, inducibility (and inducing agent) if applicable, publications in 
which a particular cre has been used, and the availability of strains carrying 
cre alleles in public repositories can be accessed for all of the cre alleles. 
 
At the present time, >1200 cre transgenic or knock-in alleles and >500 
unique drivers are represented. In addition to cre, data for other 
recombinases such as Flp, dre, and phiC31 are available.  
 
The Recombinase (cre) portal project is supported by NIH grants HG000330 and 
HD033745, and by the EU grant HEALTH-F4-2009-223487. 
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SONIC HEDGEHOG’S ROLE AS A REGULATOR OF THIRD 
PHARYNGEAL POUCH FATE. 
 
Virginia Bain, Nancy Manley  
 
University of Georgia, Genetics, Athens, GA, 30602 
 
The thymus, an organ essential for T-cell development, originates from 
third pouch endoderm. Thymus fate is ascertained by the presence of 
transcription factor Foxn1 which is first expressed at E11.25 in mice. 
Previous work from the Manley lab has shown that in the absence of Sonic 
hedgehog (Shh), Foxn1 is expressed throughout the third pharyngeal pouch 
and in neighboring pharynx while the parathyroid marker Gcm2 is absent 
from the Shh null pouch. Collaboration from the Richie lab and Manley lab 
has shown that in the absence of neural crest mesenchyme (Splotch mice) 
the third pouch has an increased Foxn1 positive thymus domain and a 
decreased Gcm2 positive parathyroid domain at E11.5. However, initial 
pouch patterning is normal at E10.5. Previous work from our lab has shown 
evidence for Shh signaling both within the dorsal-anterior 3rd pouch 
endoderm and in the adjacent NCC mesenchyme. Similarities between the 
Splotch mutant and the Shh mutant led us to ask where is Shh signaling 
required to negatively regulate thymus fate and positively regulate 
parathyroid fate.  
We generated tissue specific knockouts of the Shh signal transducer 
Smoothened in neural crest mesenchyme or pouch endoderm to determine 
where and how Shh signaling regulates the fates of the thymus and 
parathyroid. In the absence of Shh signaling in NCC mesenchyme, the 
phenotype at least partially mimics the neural crest mesenchyme deletion in 
that the Foxn1 and Gcm2 domains are altered within the pouch at E11.5 
while initial Gcm2 expression at E10.5 is normal. This result suggests that 
Shh from NCC mesenchyme is upstream of a signal that negatively 
regulates thymus fate while Shh from pouch endoderm positively regulates 
parathyroid fate.  
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THE RACK1-EIF6 AXIS IN DEVELOPMENT AND CANCER 
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Studies on cellular models have shown that RACK1 is an intracellular 
receptor for PKC and a ribosomal protein (1). We have shown that RACK1 
can lead to translational activation by dissociating eIF6 from ribosomal 
subunits (2), and that eIF6 itself is rate-limiting in translational control (3). 
The physiological relevance of RACK1 in vivo, and whether it acts 
primarily as a ribosomal protein or a PKC receptor is unknown. We 
therefore produced RACK1 mutant mice. Here we show that RACK1 
depletion results in embryonic lethality. At heterozygosity RACK1 
hypomorphic mice show defects in neural crest migration and postnatal 
growth. The molecular mechanism by which RACK1 causes lethality is 
under investigation. 
 
 
1. Nilsson J. et al. Regulation of eukaryotic translation by the RACK1 
protein: a platform for signalling molecules on the ribosome. EMBO Rep. 
2004 5:1137 
2. Ceci M,et al.Release of eIF6 (p27BBP) from the 60S subunit allows 80S 
ribosome assembly. Nature. 2003 426:579 
3. Gandin et al. Eukaryotic initiation factor 6 is rate-limiting in translation, 
growth and 
transformation. Nature. 2008 455:684 
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Severity of craniofacial defects may vary widely even when the underlying 
cause is the same, but the sources of this variation are poorly understood. 
Mice with disruption of Twisted gastrulation (Twsg1) develop craniofacial 
malformations with a wide range of severity despite being an isogenic 
C57/BL6 background. The goal of this study was to understand the basis of 
craniofacial defects and their variability in Twsg1-/- mice. We used 
expression arrays to analyze the transcriptome of the mandibular component 
of the first branchial arch at E10.5 from three classes of Twsg1-/- embryos: 
phenotypically normal, mildly affected, and severely affected and compared 
to wild type (WT) mice. Transcriptional alterations correlated with 
phenotypic severity. Remarkably, unaffected mutants also differed 
transcriptionally from WT embryos. Additional effectors of the Twsg1 
mutant phenotype included Alx1, Dkk1, Isl1, Pitx2 and Sox2. Giving insight 
into compensatory mechanisms that may support normal development, 
several genes that regulate craniofacial development (Eya4, Lhx8, Prrx2, 
Satb2, Tbx22) showed opposing expression changes with up-regulation in 
unaffected mutants but down-regulation in affected mutants. Since the 
expression levels of genes may be influenced by nearby repetitive DNA 
elements, we attempted to associate repetitive sequence environment with 
the phenotype. Partial least squares discrimination analysis was performed 
using either gene expression values alone, or when taking into account both 
gene expression and repetitive sequence data.  This analysis clearly 
separated all four groups of mouse embryos from each other into tight 
clusters when B2, B4, LINE-1, and ERV elements were taken into account.  
Severely affected Twsg1-/- samples were classified with 95% accuracy when 
only LINE-1 was taken into account.  Gene expression alone delivered only 
63% accuracy.   Our study suggests repetitive sequence environment can 
affect the expression of neighboring genes involved in craniofacial 
development and account for some of the observed phenotypic variability 
and disease susceptibility. 
-- 
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The assembly and folding of secreted proteins in the ER is regulated by ER 
stress signaling (ERSS) which responds to the load of folded and unfolded 
protein to maintain an equilibrium. Perturbation of this homeostasis induces 
ER stress and may seriously affect the viability of cells, which if not 
alleviated, triggers apoptosis. In humans, mutations in COL10A1 trigger ER 
stress and result in metaphyseal chondrodysplasia type Schmid (MCDS). 
Through studying the impact of expressing a mouse equivalent of a MCDS 
mutation, a 13bp deletion in Col10a1 (13del), in transgenic mice we had 
previously identified a new mechanism of adaptation to ER stress. In 
hypertrophic chondrocytes (HCs) expressing mutant collagen X 13del 
proteins which cannot fold properly in the endoplasmic reticulum (ER), 
ERSS is triggered. These 13del HCs successfully adapt to ER stress and 
survive by reverting to an earlier differentiation state. We compared the 
transcriptomes of 13del HCs in different phases of adaptation to ER stress 
with those of wild type HCs undergoing terminal differentiation. 
Bioinformatics analyses were applied to identify the factors and regulatory 
circuitries that underlie the adaptive response of 13del HCs. We found 
major perturbation of metabolic pathways, especially affecting amino acid 
biosynthesis and mitochondria function. Our results also implicate the 
oxidative stress and hypoxic stress pathways in the adaptation of 13del HCs 
providing insight into the integration and cross-talk of these stress pathways 
in vivo. We also probed genetically the relationship between ERSS and the 
mechanisms of adaptation by 13del HCs. Up-regulation of CHOP and its 
downstream target GADD34 mark activation of the PERK pathway upon 
ER stress. CHOP is a transcription factor involved in ER stress-induced 
apoptosis and translational control. Up-regulation or recovery of protein 
synthesis upon alleviation of ER stress requires GADD34, which is also a 
downstream target of CHOP. We found that the degree of altered 
differentiation of 13del HCs and adaptation to ER stress is controlled by 
both CHOP and GADD34. This is the first evidence for a direct link 
between the ERSS and the changed differentiation programme of 13del 
HCs. Our findings have broad implications for adaptive mechanisms to ER 
stress in vivo and pathophysiology underlying chondrodysplasias caused by 
mutations that impact on protein assembly and secretion.  
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Transcription is silenced in the fully grown oocyte and newly formed 
embryo, consequently they depend on the regulated translation of mRNAs 
that have been transcribed and stabilized during oocyte growth to complete 
meiosis and activate embryonic genome. SPINDLIN is an abundant 
cytoplasmic protein, which also localizes to the meiotic spindle, and is 
translated from stored maternal mRNA.  
 
SPINDLIN-interacting proteins were isolated from a mouse ovary 
expression library by the yeast two-hybrid method and the 
hyarulonan/mRNA-binding protein family members, SERPINE1 RNA 
Binding Protein (SERBP1) and Hyarulonan Binding Protein 4 (HABP4), 
were identified. SERBP1 has previously been implicated in regulating 
mRNA stability.  
 
We find ectopically expressed SPINDLIN binds to SERBP1 in HEK293T 
cells and that an endogenous protein complex is also co-
immunoprecipitated from mouse embryonic fibroblasts. SPINDLIN 
contains three TUDOR-like domains which have been suggested to bind 
methylated protein. Indeed, a point-mutation in one of the three TUDOR 
decreases SPINDLIN binding to SERBP1. Both Spindlin and Serbp1 
transcripts and proteins are found in full-grown and mature oocytes 
suggesting a role in the oocyte-to-embryo transition. Furthermore, both 
proteins localize to the cytoplasm in full-grown oocytes and also to the 
meiotic spindle in mature oocytes. We suggest that SPINDLIN modulates 
SERBP1 activity to regulate mRNA stability during the oocyte-to-embryo 
transition.  
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The zinc finger and BTB domain containing 16 Zbtb16 (also called Plzf, 
Zfp145 or Green's luxoid) belongs to the POZ/zinc-finger family of 
transcription factors. It contains a BTB/POZ domain that mediates 
epigenetic transcriptional repression. ZBTB16 is essential for proper 
skeleton patterning and male germ cell renewal. Two alleles have been 
reported that display similar phenotypes: a targeted knock-out, and the 
spontaneous nonsense mutation luxoid. We describe a new ENU induced 
mis-sense allele of Zbtb16 called seven toes (Zbtb16 7t). Homozygous 
animals exhibit hindlimb and axial skeleton abnormalities. Whereas the 
skeletal abnormalities are similar to those of the other alleles, Zbtb16 7t 
differs in that it does not cause spermatogonial depletion and male 
infertility. Positional cloning revealed a point mutation changing the 
evolutionarily conserved amino acid Glu44 to Gly, possibly altering the 
BTB domain's activity. Therefore, Zbtb16 7t is a separation-of-function 
allele that reveals differential requirements for domains of ZBTB16 in 
different developmental milieus. 
 26 
EXPRESSION OF NA+-K+-2CL- COTRANSPORTER 1 IS 
EPIGENETICALLY REGULATED DURING POSTNATAL 
DEVELOPMENT OF HYPERTENSION. 
 
Hyun-Min Cho, In Kyeom Kim  
 
Kyungpook National University School of Medicine, Pharmacology, 
Daegu, 700-422, South Korea, 2Brain Korea 21, , Daegu, 700-422, South 
Korea 
 
The expression of Na+-K+-2Cl- cotransporter 1 (NKCC1) is upregulated in 
various models of hypertension such as spontaneously hypertensive rat 
(SHR) and rats with coarcted aorta. We tested the hypothesis that 
expression of NKCC1 is epigenetically regulated during postnatal 
development of hypertension. The mesenteric arteries from 5, 10, and 18 
week-old Wistar Kyoto (WKY) and SHR were excised and subjected to 
vascular contraction. The expression levels of Nkcc1 mRNA and protein in 
aorta, heart, and kidney from 5, 10, and 18 week-old WKY and SHR were 
measured by real-time PCR and western blot, respectively. The methylation 
status and histone modification of Nkcc1 promoter region was analyzed by 
bisulfite sequencing and chromatin immunoprecipitation (ChIP) assay, 
respectively.  
The inhibition of dose-response curves by bumetanide as well as the 
expression levels of Nkcc1 mRNA and of NKCC1 protein in aorta, heart, 
and kidney were comparable between 5 week-old SHR and age-matched 
WKY, but much greater in 18 week-old SHR than in age-matched WKY. 
CpG dinucleotides of Nkcc1 promoter region in WKY were getting 
methylated with age whereas those in SHR mostly remained unmethylated 
after development of hypertension. DNA methyltransferase 3B (DNMT3B) 
highly associated to the promoter in WKY, whereas CXXC finger protein 1 
(Cfp1) highly bound to the promoter in SHR. Suppressive histone code dm-
H3K9 was greater in WKY than SHR. Activating histone code Ac-H3 as 
well as mRNA levels of histone acetyltransferases were higher in SHR than 
WKY. In conclusion, expression of NKCC1 is epigenetically regulated 
during postnatal development of hypertension.  
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DDX11 is a member of the highly conserved DEAD2 sub-family of 
DEAD/H-box helicases that also includes ERCC2 (Excision Repair Cross-
Complementation Group 2), FANCJ (Fanconi Anemia Group J) and RTEL1 
(Regulator of Telomere Length 1). Studies with yeast and human Ddx11 
have demonstrated an involvement of these helicases in sister chromatid 
cohesion, cell cycle progression and genome stability. Recently, mutations 
in DDX11 have been shown to be the causative genetic defect in Warsaw 
Breakage Syndrome, a human disorder characterized by hypersensitivity to 
DNA damaging agents and defects in sister chromatid cohesion. In mouse, 
loss of DDX11 has been previously shown to result in embryonic lethality. 
However, the developmental defects that lead to embryonic death in mouse 
Ddx11 mutants are still poorly understood. 
 
Here we describe the phenotypic characterization and positional cloning of 
Cetus, a mouse ENU-induced mutation that disrupts Ddx11. Homozygous 
Cetus mutant embryos are small, show a reduction in mesodermal cell 
populations and fail to thrive beyond E8.5. Positional cloning of Cetus 
revealed a non-synonymous point mutation in helicase domain motif V of 
DDX11. Cetus failed to complement a null allele of Ddx11, indicating that 
the point mutation in motif V completely disrupts the activity of Ddx11. 
Our results have revealed that Ddx11Cetus and Ddx11-/- embryos contain a 
significant number of cells with misaligned chromosomes at metaphase and 
a corresponding disruption of cell cycle progression. These observations are 
consistent with a conserved role for DDX11 in proper sister chromatid 
cohesion in mouse and demonstrate a specific requirement of the DDX11 
motif V for helicase function and early mouse morphogenesis. 
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Two distinct Polycomb complexes, PRC1 and PRC2, have been shown to 
repress many common developmental genes in embryonic stem cells 
(ESCs). Previous studies suggested that local binding of PRC1 depends on 
PRC2. While this model is widely assumed, it is still unclear to what extent 
PRC1 functions are dependent on PRC2. This is partly because the genome-
wide location of the PRC1-catalyzed histone modification, mono-
ubiquitinated H2A (uH2A), is still not available except for that in MEF cells 
(Kallin et al. 2009). 
 
In this study, using a ChIP on chip approach, we present genome-wide 
maps of uH2A deposition in ESCs, and comparative analysis to key PRC1 
subunits, Ring1B and Cbx2, and the PRC2-catalyzed histone modification, 
trimethylated H3 lysine 27 (H3K27me3). uH2A deposition is evident at a 
distinct subset of H3K27me3 targets gene that show striking enrichment for 
PRC1 and are particularly dependent on PRC1 components for continued 
repression. Compared to other H3K27me3 targets, uH2A target genes show 
de-repression in much more extent by developmental cues or PRC1 loss, 
higher overrepresentation of gene ontology (GO) terms involved in 
transcription and/or development, and also correspond to longer 
hypomethylated CpG islands. Based on these observations, we concluded 
the genes enriched for uH2A along with H3K27me3 as core targets for 
Polycomb repression to maintain ES cells in an undifferentiated state. 
 
In this process, we found that the degree of de-repression of the uH2A 
targets is not so prominent in ESCs deficient for Eed (a PRC2 component) 
as that in PRC1-deficient ESCs. We also found that these gene promoters 
retain a considerable level of uH2A in the absence of Eed. Furthermore, 
using a complementation approach, we demonstrate the presence of PRC2-
dependent and -independent mechanisms for uH2A deposition at 
developmental gene promoters. 
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Identification of molecular mechanisms that control stem cells is 
fundamentally important to understanding tissue development and the 
progression of various tissue disorders, including cancer. Skin, the 
outermost barrier between body and environment, is an excellent model 
system to uncover these mechanisms. A single layer of embryonic skin stem 
cells gives rise to all skin lineages, including the epidermis, the hair 
follicles, and the sebaceous glands. Postnatally, separate pools of adult stem 
cells located in the interfollicular epidermis and in the bulge region of the 
hair follicle maintain skin lineages during normal homeostasis and upon 
wounding.  
 
In vitro studies of embryonic stem cells have identified Polycomb-
dependent trimethylation on H3K27 (triMeK27-H3) as a key regulator of 
stem cell identity however its role in control of tissue-specific stem cells in 
vivo is largely unknown. The Polycomb complex is a transcriptional 
repressor that is targeted to gene promoters and prevents recruitment of 
transcriptional machinery. EZH2, the catalytic subunit of the Polycomb 
complex, has been previously reported as the sole histone methyltransferase 
of K27-H3. Recently, EZH1, a homolog of EZH2, has been shown to be 
physically present in a Polycomb complex and is capable of establishing 
triMeK27-H3 histone modification and Polycomb-dependent gene 
repression.  
 
Here we conditionally ablated both Ezh1 and Ezh2 to address the role of 
Polycomb repression in the control of skin development and regulation of 
skin stem cells. We have shown that loss of Polycomb repression has a 
dramatic effect on skin development leading to defective formation of hair 
follicles and sebaceous glands. Moreover Ezh1/2 2KO skin stem cells loose 
their self-renewal ability and are unable to sustain skin appendages. These 
data underscore the importance of the Polycomb complex in control of 
tissue development and maintenance of stem cells. 
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Mice of the genus Peromyscus (deer mice) are among the most abundant 
mammals of North America occurring in the wild from Alaska to Central 
America. They occur in diverse natural habitats. A major advantage of 
research with Peromyscus is their ready adaptability to colony conditions. 
Research on this genus has been widespread across disciplines. To enhance 
Peromyscus as a research organism genetic, reproductive, and genomic 
resources are being developed including: (1) a medium density genetic map 
of nearly 400 loci, (2) ESTs that are sequenced and analyzed from various 
tissues of P. maniculatus (BW stock) and P. polionotus (PO stock), (3) 
whole genome sequencing of 4 Peromyscus species is approved by NIHGR 
and underway, and (4) embryo manipulation and cryopreservation.  
Variation in microsatellites and RFLPs in protein encoding genes have been 
used as markers for development of a genetic map. A backcross progeny 
panel was used to follow meiotic events in F1 hybrids produced from 
crossing BW females with PO males. The backcross panel consisting of 88 
members representing 4 families was genotyped for approximately 400 
marker loci and almost all families were informative. The End-Join program 
was used to construct and analyze the map. All linkage groups are 
associated with specific chromosomes. Comparison of the linkage maps of 
Peromyscus with mouse and rat suggests a closer relationship between 
Peromyscus and rat than mouse.  
Approximately 50,000 ESTs have been sequenced and analyzed 
representing 8 tissues (brain, testes, liver, kidney, skin, newborn, fetus and 
spleen). Between 5,500 and 6,700 unique EST sequences are represented. 
The EST clones are available from the Clemson University Genomics 
Center. 
Development of genetics, genomics, and reproductive resources will be 
useful for studies in Peromyscus. The Peromyscus Stock Center maintains 
numerous species and mutant stocks with single gene inheritance such as 
epilepsy, juvenile ataxia and adult ataxia. There are also numerous 
behavioral differences between the BW and PO interfertile species making 
genetic analysis feasible. Several phenotypes under the control of single 
genes will be briefly described. 
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Development and differentiation of mammalian epithelial tissues is 
regulated by transcriptional programs in which the transcription factor p63, 
a member of the p53 gene family, has a key role. The constitutive p63-null 
mouse shows a complete lack of stratified squamous epithelium and is 
deficient in mammary glands, pointing to a critical role for p63 in these 
tissues. In humans, p63 is overexpressed in several types of cancer, and 
germline mutations in p63 result in a variety of epithelial malformation 
syndromes, including limb mammary syndrome. The mammary gland is 
mainly composed of luminal and basal epithelial cells. In the mature 
mammary gland, p63 is expressed only within basal cells, which are 
interposed between luminal cells and the basement membrane to mediate 
their interactions. During pregnancy the postnatal mammary gland 
undergoes development including proliferation, differentiation, and cell 
death. Although p63 expression seems to be temporally regulated during 
pregnancy, its function and regulated signals during pregnancy and lactation 
are poorly understood. Since p63 expression is associated with breast cancer 
and early pregnancy protects women from breast cancer, the analysis of 
pregnancy-induced p63-dependent development may give insights for 
targeting breast cancer. 
To address this we are using a conditional mouse model to delete p63 in the 
adult murine mammary gland prior to pregnancy. Subsequently, this 
induces a dramatic failure of pregnancy-associated lobuloalveolar cell 
proliferation and differentiation which is associated with a complete 
absence of lactation and consequently death of all pups. Based on these 
findings, we hypothesize that p63 regulates non cell-autonomous signals in 
basal cells that are required for survival, proliferation and/or differentiation 
of alveolar cells. Since aberrant cell-cell signaling is associated with many 
diseases including cancer, we plan to identify the signals targeted by p63 
that are required for pregnancy-induced mammary gland development. 
These studies will likely uncover new pathways in p63-dependent cell-cell 
signaling, and may provide novel therapeutic strategies for treatment of 
human malformation syndromes and/or cancer. To complement these 
studies, we have developed biochemical means to identify proteins 
interacting with p63 and thereby regulating p63-dependent transcription, 
which might play roles in mammary glands. Furthermore, these proteins 
may ultimately serve as therapeutic targets for treatment of cancer subtypes 
which overexpress p63. 
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High Mobility Group N (HMGN) is a family of non-histone chromosomal 
proteins that specifically bind to nucleosome, the building block of the 
chromatin fiber, and alter chromatin structure. Mouse HMGN5 is a unique 
member of HMGN family which is specifically localized to euchromatin, 
transcriptionally active region. Cell culture studies revealed that altered 
expression of mouse HMGN5 significantly affected cellular transcription 
profile by modulating global chromatin architecture. To test the role of 
HMGN5-dependent chromatin reorganization in vivo, we have generated 
conditional transgenic mice in which overexpression of HMGN5 is induced 
by cre-mediated excision of LacZ sequence. Since proper cardiac 
differentiation and function are known to be impacted by disruption of 
chromatin structure, we have generated heart specific HMGN5 
overexpressing mouse by utilizing α-myosin heavy chain (α-MHC) 
promoter-driven cre recombinase. The transgenic mice were smaller than 
non-transgenic siblings, and mice with highest level of HMGN5 
overexpression died around 6 weeks old. Histological analysis revealed that 
transgenic mice exhibit signs of heart hypertrophy. RT-PCR showed 
elevated expression of β-MHC mRNA, a marker of cardiac hypertrophy, 
which is normally expressed in embryonic cardiomyocyte. 
Immunofluorescece revealed that HMGN5 overexpressing cardiomyocytes 
in transgenic mice exhibited enlarged nuclei with gross abnormalities in 
chromatin architecture, including decreased number and redistribution of 
heterochromatic foci. Several histone modifications such as H3K14-ac and 
H3K4-me3 were also affected by HMGN5 overexpression. MRI analysis 
demonstrated increased myocardiac mass accompanied by cardiac 
malfunction, namely reduced right and left ventricle ejection fractions. 
Overall, our results demonstrate that HMGN5-induced alterations of 
chromatin organization in cardiomyocytes cause morphological 
abnormalities in heart and lead to cardiac malfunction. Our results provide 
the direct link between structural integrity of chromatin fiber, non-histone 
chromosomal proteins, and functional properties of the entire organ. 
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Neuronal migration is a developmental process essential to the formation of 
functional neural networks in the central nervous system. In the vertebrate 
hindbrain, facial branchiomotor neurons (FBMNs), which control jaw and 
facial movements, undergo a characteristic caudal migration during 
development through several hindbrain segments, or rhombomeres (r). In 
zebrafish, components of the non-canonical wnt/planar cell polarity (PCP) 
pathway, including the atypical cadherins celsr1a, celsr1b, and celsr2, 
regulate migration in a non-cell autonomous manner. To examine the extent 
of the molecular and cellular conservation of these mechanisms, we 
examined the role of Celsr1 in mice. In Celsr1Crash missense mutants and 
Celsr1KO mutants, a subset of FBMNs exhibited direction reversal, 
migrating rostrally instead of caudally, and was not due to defects in 
hindbrain patterning, axon guidance, or misspecification of FBMNs into 
non-migratory neuron types. 
 
Celsr1 is expressed broadly in the developing hindbrain, including the floor 
plate and ventricular zones, but not in differentiated FBMNs. To investigate 
the tissue-specific requirement for Celsr1 in regulating FBMN migration, 
we used the Cre-Lox system to conditionally inactivate Celsr1 in the floor 
plate, r4, and r3/r5. FBMNs fail to migrate caudally in Gli2 mutants, which 
lack floor plate cells, indicating a role for the floor plate in this process. 
However, Celsr1 function is not required in the floor plate. On the other 
hand, inactivation of Celsr1 in r3/r5 phenocopied the Celsr1KO migration 
defect, with inactivation in r4 showing a less severe phenotype. Together, 
these data suggest that Celsr1 expression in the ventricular zone of multiple 
rhombomeres non-autonomously regulates the directionality of FBMN 
migration. We are currently testing whether Celsr1 regulates the expression 
of neuronal guidance molecules (Wnt5a, Sema3a, VEGF-A, Plxna1, Cdh8) 
which may control FBMN migration. 
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A fundamental process in brain development involves the migration of 
facial branchiomotor neurons (FBMNs) in the embryonic brain stem across 
several rhombomeres (r) to their final locations. Several components of the 
Wnt/planar cell polarity (PCP) pathway, including the transmembrane 
protein vangl2, have been shown to regulate FBMN migration in zebrafish. 
Therefore, we analyzed FBMN migration in the Vangl2 mouse mutant, 
Looptail (Lp). In Vangl2Lp/+ embryos, FBMNs failed to undergo their 
characteristic caudal migration from r4 into r6 and instead formed elongated 
facial motor nuclei spanning r4 and r5. FBMNs in Vangl2Lp/Lp embryos 
were arrested in r4 and showed a delayed radial migration to the pial surface 
of the neural tube. However, hindbrain patterning and FBMN progenitor 
specification were intact, and FBMNs did not transfate into other non-
migratory neuron types, indicating a specific effect on migration. While a 
number of Wnt/PCP genes were expressed normally in Vangl2Lp mutants, 
the domain of Wnt5a expression was shifted anteriorly. 
 
Studies in zebrafish suggest that FBMN migration is regulated independent 
of the Wnt/PCP pathway, since some, but not all, Wnt/PCP genes regulate 
FBMN migration. We tested whether this was also the case in mammals. In 
embryos null for Ptk7, a PCP component, FBMN migration was partially 
blocked. In contrast, FBMNs migrated normally in Dishevelled (Dvl) 1/2 
double mutants, and in zebrafish embryos with disrupted dvl signaling, 
indicating Dvl function is largely dispensable for FBMN migration. 
Consistent with this, loss of Dvl2 function in Vangl2Lp/+ embryos did not 
exacerbate the Vangl2Lp/+ FBMN migration phenotype.  
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PDCD2 (Programmed cell death domain 2) is a zinc finger MYND domain-
containing protein which is highly conserved from yeast to humans. 
Currently, PDCD2 function is unknown. Recent findings in Drosophila 
(Minakhina et al. 2007, 2010) and zebrafish (Kramer et al. in preparation) 
suggest that PDCD2 is a regulator of hematopoiesis and PDCD2 has been 
shown to be down-regulated by the B-cell lymphoma associated repressor 
protein Bcl-6 and may play a role in lymphomagenesis (Baron et al., 2007). 
We are employing the mouse model system to study the in vivo function of 
PDCD2. In silico promoter analyses of vertebrate PDCD2 homologues 
demonstrated multiple binding sites for transcription factors controlling 
early embryogenesis and hematopoiesis. We were therefore interested in 
examining PDCD2 expression during embryogenesis and hematopoiesis. 
We detected PDCD2 mRNAs and protein widely in the post-implantation 
mouse embryo, which were particularly prominent in sites of hematopoiesis 
and in the developing nervous system. With the progress of ontogenic 
development, PDCD2 protein continued to be expressed in several tissues 
but was strongly expressed in a subset of hematopoietic cells in the fetal 
liver and the bone marrow. Moreover, PDCD2 protein was enriched in the 
subcapsular zone of the newborn thymus, containing CD4-/CD8- 
thymocytes. We also detected PDCD2 as early as the preimplantation 
embryo and in mouse embryonic stem cells, identifying this gene as an 
early marker of embryogenesis. Thus, our data describe a pattern of PDCD2 
expression that commences in the preimplantation embryo, is highly 
enriched in ESCs and continues to be expressed in a subset of 
hematopoietic cells during progression of ontogenic development. These 
initial analyses encourage us to investigate the effect of PDCD2 loss of 
expression during embryogenesis and hematopoiesis. 
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The characterization of genes through loss-of-function studies provides a 
powerful method to understand biological mechanisms. For this reason we 
are developing a tool, which allows inducible silencing of a specific 
endogenous promoter in a drug-controllable manner. We use promoter-less 
lentiviral-based gene traps, which only exhibit YFP reporter expression, if 
adjacent cellular promoters are “trapped”. By adding Tet operator (TetO) 
repeats to our gene trap, we additionally have the means to recruit an 
ectopic repressor, which induces heterochromatin, in a reversible way. More 
specifically, the tTRKRAB repressor contains the KRAB domain of the 
human KOX1 zinc finger protein fused to the E. coli tetracycline repressor 
(tTR), and binds to TetO in a doxycycline (dox)-controllable fashion. In 
proof-of-principle experiments we make use of lentiviral-mediated 
transgenesis to engineer mice with trapped promoters. We then cross these 
mice to a line expressing tTRKRAB and characterize YFP expression in 
different tissues of the offspring. Preliminary results on lymphocytes show 
that YFP expression, which is a direct read-out of promoter activity, can be 
reduced in the presence of tTRKRAB. This reduction is reversible through 
the addition of dox, which is consistent with reversible silencing of the 
cellular promoter. We are currently screening more mouse lines with 
differentially trapped promoters, in addition, to improving our 
methodological setup. These results will be presented here. 
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Melanocyte stem cells (MSCs) originate from the melanoblast lineage of the 
neural crest. During melanoblast development the transcription factor SOX10 
functions to define the melanoblast lineage by upregulating genes critical to 
melanogenesis. However, the role of SOX10 in the adult organism is unknown. 
We have found that an increased level of SOX10 affects MSC behavior in adult 
mice and results in premature hair graying. We have also correlated mutations 
in human SOX10 with melanoma. The fact that both normal stem cells and 
tumor cells share the ability to self renew suggests that understanding the role of 
SOX10 in MSC establishment or maintenance will provide insight into how 
SOX10 might participate in cancer. 
 
In order to ascertain the temporal and functional requirement for SOX10 in the 
melanocyte system of the hair follicle, we propose to assess the presence and 
position of MSCs and melanocyte progenitors in two transgenic mouse lines--
one driving the overexpression of Sox10 from a melanocyte-specific promoter 
(Tg(DctSox10)) and another that will allow us to conditionally induce the 
knockout of Sox10 in the melanocyte lineage during different timepoints. 
During hair follicle morphogenesis, SOX10 is downregulated in MSCs and 
regained by melanocyte progenitors during hair cycling. Preliminary evidence 
suggests that low/absent levels of SOX10 are required to maintain MSC fate, as 
Sox10 overexpression in Tg(DctSox10)/+ mice results in ectopic pigmentation 
in cells residing in the stem cell compartment of the hair (hair bulge). 
Furthermore, during the first adult hair cycle, Tg(DctSox10)) homozygotes 
exhibit a reduction or loss of both melanocytes in the hair bulb and 
pigmentation in the hair that is correlated with an absence of MSCs. 
Interestingly, this loss of MSCs in Tg(DctSox10))/Tg mice is not associated 
with an increase in apoptotic cells in the hair bulge. 
 
Complete loss of SOX10 is embryonic lethal due to the requirement of SOX10 
for neural crest development, thus our inducible/conditional knockout approach 
will elucidate the stages of the hair cycle where SOX10 is needed. Once we 
better understand the biological mechanisms by which SOX10 affects MSC 
establishment and maintenance, we will determine whether these same 
processes are disrupted or coopted in human melanomas in which SOX10 is 
expressed. In addition, MSCs and hair graying may prove to be a highly 
relevant, in vivo biological system to identify novel pathways involved in 
cellular self-renewal. 
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The mouse embryo has a remarkable ability to compensate for a substantial 
increase or decrease in cell number, and the resulting offspring are normal 
in size.  
This indicates that there are growth control mechanisms during mouse 
embryo development, but details, including whether or not size is regulated 
by the embryos or by the maternal environment, are still poorly understood. 
To determine whether or not the size regulation mechanisms are intrinsic to 
the embryo, we produced a culture system that enables us to analyze 
embryos at the post-implantation stage. 
We produced embryos having half the normal number of cells (1/2 
embryos), which were produced from a blastomere during the two-cell 
stage, and embryos that were doubly and triply increased in cell number 
(X2 and X3 embryos) by aggregating two or three eight-cell embryos. To 
explore whether or not differences in growth exist between differently sized 
embryos under the culturing condition, we examined the cell number and 
area of outgrowth during the culture period (3.5 - 8.5 dpc). The rates of 
increase in both cell number and outgrowth area of the 1/2 embryos were 
higher than those of the control, which indicated what exactly is causing the 
difference in growth speed. 
Downward size control was not seen in our study of aggregated embryos, 
while upward size control happened under in vitro condition. Furthur 
exploration of the embryos under the culturing system could be helpful to 
determine whether the embryos or the maternal environment plays a main 
roll in regulating the size of mouse embryos. 
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System A amino acid transport is one of the major neutral amino acid 
transporters and has been hypothesised to play an essential role in providing 
the growing fetus with nutrients. It directly mediates the uptake of small 
neutral amino acids and indirectly contributes to uptake of a wide variety of 
other amino acids through establishing a cellular amino acid gradient. In 
order to address the long standing question of the role of System A transport 
in placental and fetal development and whether altered placental amino acid 
transport is a cause or a response to altered fetal growth, we have created a 
novel conditional mouse model by using chromosome engineering. We 
employed MICER vectors to target System A genes Slc38a1 (SNAT1) and 
Slc38a2 (SNAT2) on mouse chromosome 15 and are using a combination 
of ubiquitous, embryo and placenta specific Cre-expressing strains to 
investigate the role of Slc38a1 and Slc38a2 in placental supply and fetal 
demand. We have shown that deletion of Slc38a1/Slc38a2 results in severe 
growth restriction in both placenta (76%N) and embryo (58%N) at day 18.5 
of gestation and that homozygous null embryos suffer from severe anemia 
due to a reduction in the number of red blood cells (25%N). In addition, in a 
subset (~20%) of homozygous null embryos we also observe neural tube 
defects. 
Ongoing work is currently focussing on investigating a potential 
impairment in definitive haematopoiesis in the null embryos, the origins of 
the neural tube defect and whether placental or embryonal deletion of 
Slc38a1/Slc38a2 have independent or additive effects on the growth of the 
developing fetus.  
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Pregnancies complicated by diabetes have a higher risk for congenital 
defects, such as heart and neural tube defects. Diabetes in pregnancy also 
predisposes mothers and children to disease later in life, such as metabolic 
syndrome and hypertension.  
 
In a mouse model of diabetic pregnancy, we have previously shown that 
diabetes-exposed embryos exhibit altered gene expression, with enrichment 
of transcription factors, chromatin-modifying proteins, and Wnt-pathway 
genes. Approximately a third of the currently known neural tube defect 
genes are also misregulated, implicating known pathways as well as 
epigenetic mechanisms in birth defect risk in diabetic pregnancies. 
 
In this study, we hypothesized that placental abnormalities contribute to 
adverse outcomes from diabetic pregnancies. By gene expression profiling, 
we detected significantly altered gene expression in diabetic placenta. This 
involved genes in the maternal as well as the embryonic compartments, 
such as Sfrp5 and Ascl2, respectively. We also found several genes for 
which expression in placenta was previously unknown, such as Ankyrin 
repeat domain 2, Slc6a4 (Serotonin transporter), Calcitonin related peptide 
B and Cholecystokinin. 
 
The cellular composition of the decidual compartment was altered and the 
junctional and labyrinth layers were reduced in diabetic placenta at later 
stages. This was accompanied by ectopic differentiation of 
spongiotrophoblast-like cells within the labyrinth. The molecular changes 
and abnormal differentiation of multiple cell types precede impaired growth 
of junctional zone and labyrinth, and placenta overall. These alterations are 
likely to play a role in pregnancy complications, and may have implications 
for developmental origins of adult disease. 
 
 
 41 
ROLE OF DISCOIDIN DOMAIN RECEPTOR 2 (DDR2) IN MOUSE 
GROWTH 
 
Ikuma Kawai, Hirokazu Matsumura, Tomoka Hisaki, Sakiko Kobayashi, 
Kunihiko Naito, Kiyoshi Kano  
 
University of Tokyo, Graduate school of Agricultural and Life Sciences, 
Bunkyoku, 1138657, Japan 
 
Discoidin domain receptor 2 (DDR2) is a receptor tyrosine kinase. We 
recently identified homozygous smallie mutant mice (BKS.HRS. Ddr2slie/slie 
/J, Ddr2slie/slie mutants), which lack a functional DDR2. Ddr2slie/slie mutant 
mice are dwarfed; they are also infertile due to peripheral dysregulation of 
the endocrine system.  
To understand the role of DDR2 in growth, we produce transgenic mice that 
ubiquitously overexpress Ddr2 cDNA harboring a CAG promoter. Ddr2 
transgenic mice gain weight slowly after weaning and do not undergo the 
growth spurt observed in control littermates, most noticeably in females. 
Almost all tissues examined, including cartilage and skeleton, appear 
histologically normal. In contrast to control mice, Ddr2 transgenic mice do 
not develop increased adiposity in subcutaneous or visceral fat with aging. 
Ddr2 transgenic mice eat in similar amounts per body weight to wild-type 
mice, which suggests that DDR2 might have an important role in lipid 
metabolism. 
To evaluate DDR2’s role in endochondral ossification, we analyzed it using 
ATDC5 cells, which are known as a chondrogenic cell line. We produced 
stable Ddr2 knockdown cell lines by the continuous expression of miRNA 
for Ddr2, and analyzed cell growth and differentiation into chondrocytes. 
Interestingly, suppressed Ddr2 caused the activation of cell proliferation 
and accelerated cell differentiation in stable Ddr2 knockdown cells. We also 
quantified the expression of FGF2, which activates the proliferation of 
mesenchymal cells including chondrogenic cells, and revealed that FGF2 
mRNA was reduced in the Ddr2 knockdown cell line. 
Characterization of the DDR2 gene might provide new insights into growth 
including the control of adiposity and endochondral ossification. 
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Cornelia de Lange Syndrome (CdLS: OMIM#122470), a birth defects 
disorder that affects nearly every tissue and organ system in the body, is 
most often caused by heterozygous mutations in NIPBL, which encodes a 
cohesin-associated protein conserved among all eukaryotes. Recent studies 
suggest that NIPBL regulates gene expression through mechanisms 
independent of cohesin’s established role in chromatid cohesion. Nipbl+/- 
mice reproduce many features of CdLS, including small body size, 
craniofacial anomalies, behavioral disturbances and high perinatal mortality 
[Kawauchi, Calof et al., 2009, PLoS Genetics, 5]. About 34% of individuals 
with CdLS suffer from heart defects, with ventriculoseptal (VSD) and 
atrioseptal (ASD) defects common. Similarly, ASDs are seen in 30-60% of 
late-gestation Nipbl+/- mouse embryos; these likely contribute to the high 
perinatal mortality (~80%) observed in Nipbl+/- mice.  
To understand the etiology of cardiac defects in CdLS, we are performing 
morphological and molecular analyses of heart development in Nipbl+/- 
mice. We find that defects are evident much earlier than observed initially. 
For example, delayed fusion of the ventricular septum with the cardiac 
cushion is seen in ~75% of Nipbl+/- mice at E13.5. Moreover, when we 
quantify expression of genes known to play a role in cardiac patterning, 
especially ones associated with septal defects, we see significant 
upregulation of a subset of these, such as Hand1 and Pitx2, from E10.5-
E13.5. At E10.5, Hand1 is normally restricted to the developing left 
ventricle; this pattern is not altered in Nipbl+/- mice, nor is in situ 
hybridization intensity for Hand1. What is altered, however, is the 
proportion of left-vs-right ventricular tissue, due largely to decreased right 
ventricle size. Interestingly, when Nipbl+/- hearts are examined at E9.5, 
both left and right ventricles are smaller than normal, suggesting a defect in 
cell proliferation. Consistent with this, we find c-myc expression to be 
decreased by ~25% in the hearts of E10 Nipbl+/- mice.  
To pinpoint when and in what cell types heart defects originate in Nipbl+/- 
mice, we have begun using conditional-invertible gene-trap alleles. 
Germline transmission of one such “FLEX” (Flp/Cre) allele has been 
confirmed, and we find that NipblFLEX/+ mice exhibit decreased Nipbl 
mRNA, as well as reduced body size. These data suggest that these animals 
will show other defects observed in Nipbl+/- mice, and will prove useful for 
analyzing cardiac defects in CdLS. Supported by NIH P01-HD052860. 
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The C57BL/6 (B6) mouse strain is the most widely strain used for 
transgenesis and mutagenesis. However, gene targeting in B6 embryonic 
stem (ES) cells is not very efficient and therefore is currently done using 
129 ES cells, which then require extensive backcrosses to B6 mice to 
establish a pure genetic background. Typically, ten backcrosses are needed, 
a process that can take up to two years and is therefore costly and 
inefficient. To make the generation of mouse models more rapid and high 
throughput, we have developed B6 ES cell lines. These B6 ES cell lines 
have a number of advantages over those already available. First, they can be 
used for gene targeting and have a high percentage of germline transmission 
(~50-80%). Second, these ES cell lines can be used for tetraploid 
complementation, producing a high percentage (15-20%) of mice that are 
entirely B6. Third, these ES cells lines can be used to rapidly generate mice 
that are homozygous for the gene of interest. These advantages indicate that 
these B6 ES cells facilitate the rapid generation of mouse models in a cost-
effective and efficient manner.  
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Extensive epigenetic reprogramming occurs during cloning and in the 
induction of pluripotent stem cells (IPS). Similarly, during normal germline 
transmission, the epigenetic state of the genome is known to undergo 
extensive reprogramming both in the gametes and in the early embryo. This 
reprogramming may be essential to re-establish a developmental ground 
state between generations, but the mechanism of these epigenetic 
reprogramming events remains poorly understood. We have previously 
shown that mutants in spr-5, the C. elegans ortholog of the histone 
demethylase LSD1/KDM1 exhibit progressive sterility over many 
generations due to the transgenerational accumulation of the histone 
modification dimethylation of histone H3 on lysine 4 (H3K4me2). This 
suggests that H3K4me2 can serve as a stable epigenetic memory and that 
erasure of H3K4me2 by KDM1 in the germline prevents the inappropriate 
transmission of this epigenetic memory from one generation to the next. To 
pursue this role further, we generated mice with germline mutations in 
KDM1. Progeny from mice that lack maternal KDM1 exhibit significant 
embryonic and perinatal lethality. These progeny are genotypically normal, 
suggesting that the defects are due to the stable transmission of 
inappropriate histone methylation from the parents to the offspring. Based 
on this data, we propose that KDM1 demethylation may be required for 
somatic cell nuclear transfer (SCNT) and for the somatic reprogramming 
that is induced during the generation of IPS cells. 
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Faithful transcriptome regulation is crucial for reproductive and 
regenerative medical applications, because it changes dynamically in each 
cell lineage with the epigenetic/transcription factor regulation cascades 
during the course of development and growth. Intracytoplasmic sperm 
injection (ICSI), one of the human assisted reproductive technologies 
(ART), has long raised concerns about its influence on development. 
Therefore, it is important to determine its pre- and postnatal effects as well 
as possible transmission to the next generation. By conducting 
comprehensive transcriptome and phenotypic analyses in mice under strict 
conditions, we demonstrate that ICSI induces distinct long-lasting 
transcriptome change (epigenetic shift) not only at preimplantation but also 
remains at the neonatal stage. However we observe no remarkable 
differences in the ICSI adults in either the gene expression or phenotypic 
profile, and there was no indication of transmission to the next generation 
via natural mating. Our results suggest there are no lifelong or 
transgenerational effects of ICSI, but there is a need for intense follow-up of 
ICSI children during infancy and early childhood in assisted reproductive 
technologies. 
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The nonreceptor tyrosine phosphatase Shp2 (PTPN11) has been implicated 
in tyrosine kinase, cytokine, and integrin receptor signaling. We have 
recently shown that conditional mutation of Shp2 in neural crest cells and in 
myelinating Schwann cells resulted in deficits in glial development that are 
remarkably similar to those observed in mice mutant for Neuregulin-1 
(Nrg1) or the Nrg1 receptors, ErbB2 and ErbB3. Our genetic and 
biochemical analyses demonstrated that Shp2 is an essential component in 
the transduction of Nrg1/ErbB signals (Grossmann et al., 2009). Here, we 
investigate the importance of two known downstream signaling cascades, 
MAPK and PI3K, both of which can be affected by the loss of Shp2. We 
attempt to rescue the loss of Shp2, Nrg1 or ErbB3 in neural crest and in 
Schwann cells by introducing gain-of-function alleles that express either 
constitutive active form of MEK1 or p110α (catalytic subunit of PI3K). 
Preliminary results indicate that the activation of MAPK pathway in neural 
crest is sufficient to rescue the phenotypes in early Schwann cell 
development observed in Shp2 mutant mice, whereas activating PI3K 
pathway fails to do so. We intend to address the role of both MAPK and 
PI3K also in immature and in myelinating Schwann cells and to elucidate 
by genetic means the mechanism of Nrg1/ErbB signal transduction at 
several distinct stages of Schwann cell lineage development. 
 
Grossmann, K.S., Wende, H., Paul, F.E., Cheret, C., Garratt, A.N., Zurborg, 
S., Feinberg, K., Besser, D., Schulz, H., Peles, E., et al. (2009). The tyrosine 
phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling 
throughout Schwann cell development. Proceedings of the National 
Academy of Sciences of the United States of America 106, 16704-16709. 
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A basic question that has long fascinated developmental biologists is how 
growth is regulated during development to produce organs of specific sizes. 
Cell proliferation is an essential process that mediates organ growth and 
morphogenesis during vertebrate development. Here, the roles of Pbx 
homeoproteins are discussed in the regulation of mammalian growth and 
organ size. We use the spleen as a model system, exploiting mouse models 
deficient for the transcription factors Pbx1, Hox11, Nkx2.5, Nkx3.2, and 
Pod1, which are either asplenic or exhibit hyposplenia. From our previous 
studies, Pbx1 has emerged as a central, hierarchical co-regulator of spleen 
organogenesis. By generating a conditional Pbx1 loss-of-function in the 
splenic anlagen of the mouse, by using Nkx2.5-, as well as Wt1-Cre deleter 
lines, we found that Pbx1 removal in the spleen mesenchyme causes 
dramatic morphological and growth defects of the organ, including marked 
downregulation of Nkx2.5. Also, by RT-PCR profiler array analyses, we 
discovered that p15ink4b is dramatically up-regulated in the hypoplastic 
spleens of Pbx1Δex3/Δex3;Nkx2.5-Cre+ mice. Chromatin 
immunoprecipitations and transcriptional assays indicate that Pbx1 
regulates p15Ink4b expression in the spleen mesenchyme. Crosses of 
p15ink4b-deficient mice with spleen-specific Pbx1-deficient mice 
demonstrate that the impaired spleen expansion in the latter mice is rescued 
by removing p15ink4b function in vivo. Indeed, Pbx1Δex3/Δex3;Nkx2.5-Cre+ 
mice that are also deficient for p15ink4b develop spleens that are 
significantly larger and more compact than those present in spleen-specific 
Pbx1 mutants with intact p15ink4b function. Stereology on spleen size, 
counts of cell density, and in vivo proliferation assays have been conducted 
on spleens from Pbx1Δex3/Δex3;Nkx2.5-Cre+ and Pbx1Δex3/Δex3;Nkx2.5-
Cre+;p15ink4b+/- as well as Pbx1Δex3/Δex3;Nkx2.5-Cre+;p15ink4b-/- embryos. 
“Rescued” spleens from embryos that lack both Pbx1 and p15ink4b exhibit 
rates of cellular proliferation that are higher than those present in spleens 
from embryos lacking Pbx1 alone in the spleen mesenchyme, and are 
similar to those of wild type spleens. These results highlight the essential 
role of Pbx in mammalian organ expansion in vivo, via direct regulation of 
the Cdk inhibitor p15ink4b, a validated biological mediator of cell 
proliferation in the embryonic spleen. 
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Aim: We have been developing the vibratory microinjection system 
(VMS), which is completely different from the Piezo Impact Micro 
Manipulator. The current version of VMS provides a micropipette with 
longitudinal vibration up to 100 kHz, the amplitude of which is controlled 
by voltage applied to a vibrator composed of three multilayer piezoelectric 
actuators and the housing. In this study, we evaluated 35-kHz vibratory 
microinjection (VM), compared with the ordinary microinjection (OM). 
Methods: 1) The voltages controlling the amplitude of vibration ranged 
from 5 to 10 V, which also made lateral vibration of the pipette tip slightly 
visible. 2) Fertilized eggs obtained from BDF1 mice were alternately 
injected with and without vibration using a single micropipette in M2 
medium at 26ºC and at an injection pressure of 30 hPa. The quota for one 
micropipette was 30 eggs (15 eggs for each group). Even when the 
micropipette pulled materials from pronucleus, it was being used until the 
quota was fulfilled. Each procedure of microinjection was taken on a CCD 
video camera for subsequent image analysis. 3) After microinjection, all the 
eggs (210 eggs for each group) were cultured in M16 medium in a CO2 
incubator. Embryonic development was assessed for 4 days. 
Results: 1) VM shortened the injection time by 25%: 3.39 ± 1.87 sec 
(average ± standard deviation) in VM group and 4.55 ± 2.78 sec in OM 
group (P < 0.0001, Student’s t test). 2) Degrees of pronuclear swelling and 
times spent swelling the pronucleus were measured. The pronuclei were 
swollen identically: 114.8 ± 7.68% and 114.9 ± 7.04% in VM and OM 
groups, respectively. However, VM shortened the time spent swelling the 
pronucleus, or DNA injection time, by 30%: 1.87 ± 0.94 sec in VM group 
and 2.65 ± 1.17 in OM group (P < 0.0001), indicating that VM increased 
the injection speed of DNA by 42%. 3) A total of 420 eggs were 
manipulated with 14 micropipettes. Materials inside pronucleus were pulled 
out in 11 of 210 eggs in VM group whereas the "pulling-out" event was 
observed in 24 of 210 eggs in OM group (P = 0.02, χ2 test). 4) After 4-day 
culture, 98 eggs (46.7%) in VM and 92 eggs (43.8%) in OM group 
developed to blastocyst stage. Seventy-nine eggs (37.6%) in VM and 82 
eggs (39.1%) in OM group were dead.  
Conclusions: These results indicate that the VMS is an efficient option in 
gene transfer. In addition, the higher speed of DNA injection suggests that 
the VMS is capable of injecting larger DNA fragments and/or more viscous 
DNA solutions. Much less frequent “pulling-out” events suggest that 
ultrasonic-vibration may remove materials already stuck to a micropipette.  
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In pre and early gastrulation mouse embryos reciprocal interactions between 
the visceral endoderm (VE), epiblast, and extraembryonic ectoderm direct 
anterior-posterior axis formation and allocation of progenitors to the three 
primary germ layers. It is unknown whether the VE contributes additional 
organizing functions as gastrulation proceeds. Through the generation and 
analysis of tissue-specific Bmp2 mutants we find that VE-expressed BMP2 
plays a central role in ventral folding morphogenesis, a fundamental but 
poorly understood developmental process, which when impaired, can result 
in human birth defects affecting the heart and body wall. Our studies show 
that Bmp2 exhibits a dynamic pattern of transcription in the VE during pre-
streak and gastrulation stages. Contrary to previous studies, Bmp2 
expression localizes to a discrete region of the anterior VE in mid-to-late 
streak embryos. While loss of BMP2 in epiblast-derivatives perturbs 
amnion formation, absence of BMP2 in VE blocks foregut invagination, an 
integral step in ventral morphogenesis, leading to abnormal positioning of 
head and heart. Embryos lacking VE-expressed BMP2 display phenotypic 
defects strikingly similar to those observed in an epiblast-specific knockout 
of Bmpr1a. Thus these findings potentially identify a signaling cascade in 
which BMP2 supplied by the anterior VE signals to its receptor on epiblast 
cells to direct anterior morphogenesis during mouse gastrulation. 
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Although conditional mutagenesis in mice using gene targeting and site 
specific recombination technology has revolutionized our ability to study 
the in vivo function of genes, there remain a number of severe limitations to 
the existing techniques. We have developed a new genetic approach for 
mosaic mutant analysis in mouse that simultaneously conditionally 
inactivates a gene and permanently marks the cell and its descendents with 
GFP. In this technique termed Genetic Inducible Mosaic Analysis (GIMA) 
inducible Flp based transgenes (FlpeER or FLPoER) are combined with a 
new targeted allele (R26FNGC) that expresses an eGFPcre fusion protein 
from the ROSA26 locus following Flp-mediated recombination of an frt 
flanked STOP sequence. Within 48 hr of administering tamoxifen to mice 
carrying a FlpER transgene, R26FNGC, and a floxed endogenous allele, up 
to 97% of the GFP marked cells also carry a mutant allele, with eventual 
100% concordance of GFP and a mutant allele. GIMA was used to study 
the fate of small cohorts of β-Catenin mutant cells in the developing spinal 
cord with single cell resolution, and to provide further evidence that Wnt 
signaling can dorsalize cells in the ventral spinal cord. The GIMA approach 
is a broadly applicable tool for conditional mosaic mutant analysis in mouse 
using the growing number of engineered floxed alleles, including 
developmental studies, tumor analysis, and studies of gene function in adult 
mice. Furthermore, R26FNGC can be used to convert cell type specific Flp-
expressing strains into effective Cre deleter mice in which mutant cells are 
labeled with GFP. 
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The human condition known as Premature Ovarian Failure (POF) is 
characterized by loss of ovarian function before the age of 40. Most cases of 
POF are idiopathic, but 10-15% of POF cases are familial, underlying a 
genetic origin of the disease. The homeobox transcription factors Dlx5 and 
Dlx6 are involved in the control of steroidogenesis and of male genital 
development. We show that allelic reduction of Dlx5 and Dlx6 in the mouse 
is associated with a POF-like phenotype, characterized by reduced fertility 
and premature follicular depletion. We also provide evidence supporting the 
notion of a reciprocal regulation between Dlx5;Dlx6 and Foxl2, another 
POF-associated transcription factor. Furthermore, we report the linkage and 
homozygosity analysis of a large POF family presenting a recessive pattern 
of inheritance. We identify a region of high LOD score on chromosome 
7q21.3 which includes DLX5 and DLX6. 
Our findings suggest that the DLX5;DLX6 locus is a new POF candidate 
which might be part of a steroidogenic regulatory pathway including 
FOXL2. 
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Mouse spermatogenesis is a complex process through which diploid 
spermatogonia develop into haploid spermatozoa. Extensive chromatin 
remodeling takes place during this process, transforming the mouse genome 
into a highly compacted form with unique features. Chromatin remodeling 
proteins are expected to play critical roles in epigenetic reprogramming 
during spermatogenesis. Indeed, targeted disruption of several chromatin 
remodelers in mice causes defects in spermatogenesis and impaired fertility. 
However, it remains poorly understood that which chromatin remodelers 
are essential for spermatogenesis and how they function during the process. 
Here, we discovered that chromodomain helicase DNA binding protein 5 
(Chd5), a member of the CHD chromatin remodeling protein family, plays 
important roles during mouse spermatogenesis. We found Chd5 is highly 
expressed in mouse testis and is especially enriched in spermatids where the 
most dramatic chromatin remodeling occurs. We developed a mouse model 
with Chd5 specifically disrupted by gene targeting and found that disruption 
of Chd5 results in impaired fertility in male mice. Detailed analyses 
revealed reduced sperm number, impaired sperm motility and increased 
sperm morphologic abnormality in Chd5 mutant mice. Out data suggest for 
the first time that Chd5, which we previously identified as a novel tumor 
suppressor, also plays essential roles in spermatogenesis. 
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Heparan sulfate proteoglycans comprising heparan sulfate 
glycosaminoglycan chains (HS chains) and core proteins have been 
functionally implicated as co-receptors for multiple growth factors in the 
cell surface and extracellular matrix. However, the precise mechanisms by 
which HS chains regulate the activity of growth factors in complex 
mammalian morphogenetic processes remain to be elucidated. Here, we 
identified the transgene insertion allele of Ext2, a gene causative of multiple 
hereditary exostoses that catalyzes the elongation of HS chains. Marker 
expression analyses of Ext2-deficient embryos revealed that HS chains are 
essential for the response to Fibroblast growth factor (FGF) signaling and, 
in particular, for the local distribution of FGF ligands in the extraembryonic 
ectoderm. Moreover, the expression of HS chains attached to the cell 
surface is specific to those areas in which FGF signaling is potentially 
active. Additional fine mosaic studies with single-cell resolution involving 
chimeras suggested that the expression of cell surface-attached HS chains is 
crucial for early embryonic development. Given that 22 FGF ligands, 4 FGF 
receptors, and 12 membrane-associated core proteins are redundantly 
expressed, we propose that the spatially and temporally localized expression 
of HS chains attached to cell surfaces also contributes to FGF signaling 
distribution during mammalian morphogenesis. 
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The first lineage segregation in the pre-implantation mouse embryo gives 
rise to cells of the inner cell mass and the trophectoderm. Segregation into 
these two lineages during the 8-cell to 32-cell stages is accompanied by a 
significant amount of cell movement, and as such it has been difficult to 
accurately track cellular behavior while maintaining embryo viability using 
conventional imaging techniques. Consequently, it is unclear whether 
dividing cells that give rise to the same (symmetric division) or different 
(asymmetric division) cell fates exhibit different behaviors. To achieve the 
high spatial and temporal resolution necessary for tracking individual cell 
lineages, we utilized two-photon light-scanning microcopy (TPLSM) to 
visualize and follow every cell in the embryo using fluorescent markers. We 
found that cells undergoing asymmetric cell fate divisions originate from a 
distinct population of cells that have been previously classified ambiguously 
as outer or inner cells. This imaging technique, coupled with a tracking 
algorithm we developed, allows us to show that these cells exhibit different 
dynamic behaviors and occupy a unique position in the mouse embryo 
between the fourth and fifth cleavages. We also provide an accurate 
description of the correlation between cell division order and cell fate, as 
well as demonstrating the lack of a strong correlation between cell division 
angle and cell fate.  Our studies demonstrate the utility of two-photon 
imaging in answering questions in the pre-implantation field that have 
previously been 
difficult or impossible to address. This system and tracking ability further 
provides a framework for the use of specific markers to track live cell fate 
molecularly and with high accuracy. 
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The insertional mouse mutation Acrodysplasia (Adp) confers a parent-of-
origin developmental phenotype, with animals inheriting the mutation from 
their father showing skeletal abnormalities, while those inheriting the 
mutation from their mother are normal. This parental-specific phenotype, 
along with mapping of the insertion to a region of chromosome 12 proposed 
to contain imprinted genes, suggested that disruption of genomic imprinting 
might underlie the Adp phenotype. Genomic imprinting is the process by 
which autosomal genes are epigenetically silenced on one of the two 
parental alleles; imprinting mutation phenotypes manifest after inheritance 
from one parent but not the other. Imprinted genes typically occur in dense 
clusters that contain few nonimprinted genes, and therefore assaying 
representative genes from the Adp critical region might identify any 
imprinted domains. Fourteen genes spaced across the Adp region were 
analyzed for imprinting, but all were found to be biallelically expressed. 
Other explanations must therefore be considered for the parent-of-origin 
Adp phenotype. 
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We describe a transgenic reporter mouse model in which luciferase 
expression is dependent upon activation of cAMP Response Element 
Binding protein (CREB), a well characterized transcription factor 
downstream of multiple signaling pathways. CREB binding sites (CREs) 
are found in the promoter region of many genes involved in a wide variety 
of cellular functions. CREB is activated by phosphorylation of a conserved 
serine (Ser 133) in response to, among other things, cellular cAMP levels. 
In addition to its phosphorylation state, transcriptional induction by CREB 
is regulated by its binding to accessory proteins and the methylation state of 
the CREs, thus providing cellular context and tissue specificity.  
In vivo bioluminescent imaging (BLI) in small animals is an important 
technology enabling the evaluation of potential drug candidates, delivery 
systems, cell migration, tumor progression and metastases, and a variety of 
other pharmaceutically relevant biological events. BLI has the advantage of 
being noninvasive and highly sensitive. In addition, the ability to monitor 
cellular processes in living animals allows for longitudinal studies that both 
reduce the number of animals needed and provide insights not achievable 
from conventional endpoint studies.  
We have begun to characterize this model for its utility in monitoring 
phosphodiesterase (PDE) activity in the brain. PDEs hydrolyze cyclic 
nucleotides in cells, and inhibition results in the accumulation of cyclic 
nucleotides, activation of Protein Kinase A and CREB mediated 
transcription, resulting in light production in our model. Current protocols 
to monitor cAMP levels in rodent brain are labor intensive and terminal, 
requiring large animal numbers while providing only a one time snapshot of 
the cellular signaling environment. This model provides noninvasive 
imaging of CRE-mediated transcription downstream of cAMP accumulation 
and is useful for evaluating potential drug candidate efficacy, specificity, 
blood brain barrier penetration, and PK characteristics.  
Given the ubiquity of CREB transcriptional activation, we have also begun 
to evaluate the utility of this model as a readout for other physiological 
processes. Data will be presented in which the model was used to monitor 
gluconeogenic gene upregulation, as well as signaling in brown adipose 
tissue.  
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Aim: Some cellular damages are inevitable in pronuclear microinjection, many 
factors of which are considered to relate to the damages. We focused on some 
ingredients of DNA solution.  
Methods: 1) The DNA solution used in this study was made of GFP gene (1.67 
kb), Tris/EDTA (TE) buffer containing 0.1 mM EDTA and ultrapure water. 
Then, we tested three liquids as injection liquid: TE buffer alone (TE group), 
ultrapure water alone (Water group) and a 2.0 ng/μl GFP gene solution (GFP 
group). In addition, 150 mM KCl solution was tested for the sake of interest 
(KCl group). 2) Fertilized eggs were collected from 13 BDF1 mice, and divided 
into the 4 groups. Pronuclear injection was performed in M2 medium at 26ºC 
and at an injection pressure of 30 hPa. The volume of liquid injected was 
controlled so that pronuclei swelled equally. Eggs that had undergone improper 
microinjection were excluded from assessment. Each injection procedure was 
taken on a CCD video camera for subsequent image analysis. 3) After injection, 
all the eggs were cultured in M16 medium in a CO2 incubator. Embryonic 
development was assessed for 4 days. 
Results: 1) The rates of pronuclear swelling were almost identical among 4 
groups: 114.0 ± 12.5% (average ± standard deviation) in GFP group (N = 40), 
117.4 ± 11.6% in TE group (N = 28), 116.6 ± 11.5% in Water group (N = 30) 
and 115.1 ± 10.2% in KCl group (N =30). 2) One day after injection, 90% of 
eggs in GFP group reached 2-cell stage, 92.9% in TE group, 93.3% in Water 
group and 60.0% in KCl group. On 4th day, 57.5% in GFP group developed to 
blastocyst stage, 67.9% in TE group, 50% in Water group and 16.7% in KCl 
group. Cumulative death rates after 4 days were 7.5% in GFP group, 10.7% in 
TE group, 6.7% in Water group and 33.3% in KCl group. Both embryonic 
development and survival curve in KCl group were significantly worse than 
those in the other three groups, wheres those in the other three groups were 
similar (Not significant).  
Conclusions: Because the GFP solution and TE buffer are isotonic and have 
almost the same pH, only difference may be presence of GFP gene, suggesting 
that its concentration of 2.0 ng/μl is not so influential. Because the main 
differences between the TE buffer and ultrapure water are presence of 0.1 mM 
EDTA, pH and osmolarity, the detrimental effect of 0.1 mM EDTA may be 
equal to the combined harmful effects of lower pH and zero osmolarity in pure 
water. The results in KCl group suggest that increase in intracellular chloride 
concentration may be significantly detrimental to cell survival and 
development. 
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In vertebrates, skeletal myogenesis is controlled by four myogenic 
regulatory factors: Myf5, Mrf4, Myogenin and MyoD. Myf5 is the first to 
be expressed and initiates the myogenic cascade. Our group and others 
identified several Myf5 and Mrf4 enhancers responsible for the expression 
of both genes during development.  
Myf5 expression in the branchial arches (BA) is controlled by at least five 
separate elements. An element located in the intergenic region between 
Myf5 and Mrf4, the proximal arch element (PAE), is able to drive early 
expression in the second BA and later on maintain the expression of Myf5 
until 12.5 dpc in both BAs. Using a bioinformatic approach we identified an 
evolutionary conserved peak in the PAE. We have cloned this region, 
referred to as small proximal arch element (sPAE), in our standard Myf5-
promoter-nlacZ reporter construct and analyzed its ability to drive 
expression during embryogenesis. Further sequence analysis revealed two 
highly conserved E-boxes located in the middle of the sPAE. Using site-
directed mutagenesis we tested the relevance of these binding sites to drive 
LacZ expression in vivo. Previous studies shown that the bHLH factors, 
MyoR and Capsulin are expressed in the BA and mice lacking these factors 
were missing some craniofacial muscles. In this context, using chromatin 
immunoprecipitation we confirmed the binding of MyoR to this highly 
conserved element in vivo.  
These findings suggest that MyoR is the main transcription factor 
controlling the expression of Myf5 through binding to this specific 
enhancer. Further identification of conserved transcriptional binding sites 
on other BA enhancers will reveal the complex regulatory scenario 
controlling the myogenic program during craniofacial muscle development. 
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Extensive epigenetic reprogramming occurs during cloning and in the 
induction of pluripotent stem cells (IPS). Similarly, during normal germline 
transmission, the epigenetic state of the genome is known to undergo 
extensive reprogramming both in the gametes and in the early embryo. This 
reprogramming may be essential to re-establish a developmental ground 
state between generations, but the mechanism of these epigenetic 
reprogramming events remains poorly understood. We have previously 
shown that mutants in spr-5, the C. elegans ortholog of the histone 
demethylase LSD1/KDM1 exhibit progressive sterility over many 
generations due to the transgenerational accumulation of the histone 
modification dimethylation of histone H3 on lysine 4 (H3K4me2). This 
suggests that H3K4me2 can serve as a stable epigenetic memory and that 
erasure of H3K4me2 by KDM1 in the germline prevents the inappropriate 
transmission of this epigenetic memory from one generation to the next. To 
pursue this role further, we generated mice with germline mutations in 
KDM1. Progeny from mice that lack maternal KDM1 exhibit significant 
embryonic lethality, suggesting that KDM1 is also required to reprogram 
epigenetic memory between generations in the mouse. Furthermore, 
deletion of KDM1 in the mouse testis results in sterility, with a complete 
failure to maintain the testis stem cell population. Consistent with this, 
Wang et al. previously demonstrated that ES cells can be derived from 
KDM1 mutant embryos, but undergo massive cell death when induced to 
differentiate. Based on these data, we propose that KDM1 could be required 
to reprogram epigenetic transcriptional memory during the specification of 
new cell fates. We are currently testing this model by conditionally deleting 
KDM1 in neural crest cells and in neural stem cells. 
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Many recent findings underline the critical role of sequences located far 
from protein-coding genes in regulating their transcriptional activities. 
However, our understanding of the mechanisms governing the range and 
specificity of action of such remote regulatory elements is still rather 
limited. 
To get insight into these mechanisms and explore the regulatory 
organization of the genome, we have developed GROMIT (Genome 
Regulatory Organisation Mapping with Inserted Transposons). GROMIT is 
based on an in vivo transposition system that distributes a regulatory sensor 
gene and a loxP site throughout the mouse genome. We used GROMIT to 
generate and characterize about 150 mouse lines, each with an insertion of 
the reporter transposon at a different genomic position. Strikingly, most of 
these insertions - close to or several hundreds of kilobases away from genes, 
linked or not to developmental genes - showed highly tissue-specific 
expression of the reporter gene, contrasting with the rather widespread 
expression of most genes. This pervasive presence of regulatory potentials 
throughout the genome reveals the complex and modular organization of 
the genome in distinct but interlaced regulatory domains with restricted 
tissue-specific activities. 
Importantly, each insertion can be remobilised to produce new mice with 
insertions around the selected starting point. With GROMIT, the 
remobilisation rate of single copy transposon is very high (from 20% to 
50%), and due to the local hopping bias of Sleeping Beauty, a large 
proportion of the new insertions lands within 1 to 2 Mb of their initial 
position. This property facilitates the fine mapping of the regulatory 
organization of specific loci, and reveals the range of action of enhancers, 
the presence of silencers and regulatory boundaries, complementing other 
genome-wide approaches. Thus, by the virtue of its simplicity and 
efficiency, requiring only breeding and genotyping, GROMIT opens an 
unprecedented level of access to functional investigations of the mouse 
genome. Furthermore, combined with in vivo CRE-mediated recombination, 
this dynamic and versatile resource enables to generate series of 
overlapping deletions and duplications over regions of interests, notably to 
model human aneuploidies and copy-number/structural variants. I will 
illustrate the general use of our approach and resource and discuss the new 
insights it provides into the regulatory organization of mammalian 
chromosomes.  
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Gene targeting by homologous recombination (HR) in mouse embryonic 
stem (ES) cells represents a powerful tool for tailored manipulation of the 
mouse genome. However, the efficiency of this technology is limited by 
great variation in targeting frequencies among different loci. In light of the 
increasing need to re-engineer more subtle mutations at the same locus, 
Recombinase-Mediated Cassette Exchange (RMCE) was developed. RMCE 
takes advantage of pairs of heterotypic, non-interacting recombination sites 
for a particular site-specific recombinase (usually Cre or Flp) that need to be 
first introduced into the locus of interest by conventional HR and only few 
compatible alleles are currently available. Anticipating the release of 
thousands of conditional mouse alleles by the International Knockout 
Mouse Consortium, we developed an approach to efficiently re-engineer 
these alleles with the aim to extend the long-term value and use of these 
vast ES cell resources. This novel approach, called dual RMCE (dRMCE) 
takes advantage of the wild-type loxP and FRT sites already present in the 
majority of all conventional conditional alleles and many gene traps and 
permits re-engineering of the corresponding loci with frequencies of up to 
~70% correct replacement. Minimally, this represents a 5- to 65-fold 
increase in efficiency in comparison to HR. For example, dRMCE can be 
used to express mutant cDNAs, epitope or fluorescent tags and heterologous 
genes under control of any endogenous locus of choice. Due to its 
efficiency and simplicity, the dRMCE technology is well suited for high-
throughput approaches such as functional screening of disease-causing 
mutations in particular pathways and/or genes of interest directly in mouse 
ES cells (e.g. upon induced differentiation into specific cell-types) or in 
mice generated from engineered clones. Finally, the dRMCE technology 
provides non-specialist researchers with access to advanced genetic 
engineering of a large fraction of the mouse genome and enhances the long-
term value of the existing large collections of mutant mouse ES cell lines. 
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We have developed a modular, inducible expression system that targets 
with very high efficiency to the Rosa26 locus of mouse embryonic stem 
cells (ESCs). Our system combines Gateway modularity with the Tet-On 
expression system in a highly efficient Rosa26 targeting vector (pGATOR). 
This technology enables the rapid generation of inducible RNAi and cDNA 
expression alleles at the Rosa26 locus in ESCs, either clonally or as a 
pooled library. To illustrate the utility of our system, we generated ESCs 
harboring a tetracycline-inducible library of 94 shRNAs, and used 
massively parallel sequencing to identify “dropouts” during a long-term 
screen for self-renewal phenotypes. Of 12 shRNAs targeting Oct4, 9 were 
depleted from the library by more than 8-fold after 4 weeks. Hits from the 
screen were then validated by targeting individual tetracycline-inducible 
pGATOR-shRNA clones to the Rosa26 locus. The pGATOR system thus 
provides a simple and scalable platform for conducting functional studies in 
ESCs. 
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Conditional mutagenesis is rapidly becoming the method of choice for the 
study of gene function, but the types of alleles that can be engineered are 
limited both by vector design and target gene structure. We therefore 
developed a new technology — Conditional-by-Inversion (COIN) — that 
utilizes an optimized invertible gene trap-like cassette, the COIN module. 
The COIN module is placed in the antisense strand of the target gene, where 
it is effectively inert until activated by a recombinase-mediated inversion 
event that flips the COIN module into the sense strand, thereby disrupting 
transcription of downstream exons while simultaneously providing a 
reporter for tracking the mutation. The COIN module can either be inserted 
into one of the target gene’s natural introns (an intronic COIN) or directly 
into a coding exon as part of an artificial intron (an exonic COIN), greatly 
increasing allele design flexibility over existing conditional knockout 
approaches. The unique artificial intron feature enables the introduction of 
the COIN module (or other elements) in nearly any location within the 
target gene, freeing up design choices and increasing the types of alleles 
that can be designed.  
 
We have constructed COIN alleles for a large number of genes and 
performed detailed phenotypic analysis on ES cells and mice before and 
after activation of the COIN modules. Beyond establishing the robustness, 
reliability, and broad applicability irrespective of exon-intron structure of 
this method, our study uncovered rare cases of post-inversion hypomorphic 
alleles, observed only with intronic COINs, that were caused by ‘skipping’ 
of the inverted COIN module, resulting in expression of a mixture of both 
wild type and COIN-encoding mRNA. We showed that re-engineering the 
intronic COIN allele as an exonic COIN by placing the COIN module into 
the immediate neighboring exon could rectify this problem. These results 
not only inform future design decisions, but may explain the hypomorphism 
occasionally observed with traditional gene trap alleles, which are by nature 
intronic. Finally, the exon-splitting and reporter features of COINs open up 
new engineering modalities for the generation of multifunctional alleles that 
go beyond conditional-nulls, ranging from simple splitting of exons to 
introduce novel intronic elements to complex multifunctional alleles with 
more than two functionalities. Examples of these allele designs will be 
presented. 
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We are developing new options for genome engineering with particular 
emphasis on engineering stem cell genomes. Recent progress with site 
specific recombinases includes further applications with Cre, FLPo and Dre 
recombinases. Using recombineering, we have developed a variety of allele 
designs for gene targeting and BAC transgenes, including high throughput 
methods for protein tagging. We have applied these methods to explore 
several issues relevant to the epigenetic status of ES cells, including the 
molecular basis of bivalency. Bivalency refers to the dual presence of 
histone 3 lysine 4 trimethylation (H3K4me3) and H3K27me3 over the same 
promoter region. Genes displaying bivalency in ES cells are typically 
expressed in specific lineages and not, or very lowly, expressed in ES cells, 
presumably due to repression by H3K27me3 and polycomb-group action. 
We are examining these issues in mouse ES cells cultured in normal 
conditions (serum + LIF) or in 2i conditions (GSK3β and MEK inhibitors + 
LIF) using tamoxifen-inducible conditional mutagenesis and tagged protein 
expression from BAC transgenes. As a further point, we have developed a 
robust method for BAC transgenesis in human ES cells based on assisted 
integration using piggyBac transposase. These methods extend the utility of 
ES cells to serve as experimental models for the study of pluripotency and 
regenerative therapy.  
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Eph-ephrin signaling regulates multiple processes during development and 
in adult physiology and disease, and can function both by forward signaling 
to the Eph receptor or by reverse signaling into the cell which expresses the 
ephrin. We have taken an approach integrating genetic analysis, proteomic, 
and transcription profiling methods to identify how ephrin-B1 controls 
craniofacial, skeletal, and neural development. By generating mice 
harboring point mutations that specifically ablate reverse signaling while 
maintaining forward signaling, we find that reverse signaling is critical for 
axon guidance whereas forward signaling controls skeletal and craniofacial 
development. I will discuss the mechanisms by which Eph-ephrin signaling 
regulates these diverse processes. 
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During early mouse embryogenesis, temporal and spatial regulation of gene 
expression and cell signaling influences lineage specification and 
embryonic polarity. The visceral endoderm, plays a central role not only in 
nutrient uptake and delivery, but also in embryonic patterning. Two groups 
of visceral endoderm cells, located on the opposite sides of the 
anteroposterior axis, the anterior visceral endoderm (AVE) cells and 
posterior visceral endoderm (PVE) cells, are thought to establish this 
primary body axis.  
Wnt3 is expressed in the PVE opposite to the AVE, suggesting that AVE 
cells block Wnt3 expression in the anterior side of the embryo. To address 
this question, we analyzed the expression of Wnt3 in Cripto mutants, in 
which, the AVE fails to move to the anterior side of the embryo. Our results 
show that the removal of AVE cells from the anterior side of the embryo 
allows Wnt3 expression to expand to the AVE.  
Previous data showed that several primitive streak markers, are radialy 
expressed in the proximal epiblast region of Cripto mutant embryos. To test 
the hypothesis that the expansion of Wnt3 expression in these mutants is 
responsible for this ectopic expression, we inactivated Wnt3 in Cripto 
mutants through the generation of double Cripto/Wnt3 mutant embros. Our 
results show that the ablation of Wnt3 signaling in Cripto mutants 
completely abolishes the expression of primitive streak markers such as 
Brachyury. These results support a model in which the AVE restricts the 
expression of Wnt3 to the PVE, preventing it from expanding to the anterior 
region of the embryo and leading to the formation of the primitive streak 
opposite to the AVE. It also suggests that the radialized Wnt3 signaling in 
Cripto mutants is responsible for radialization of primitive streak markers in 
a non-cell antonomous manner.  
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Using a combination of live imaging and genetic labeling we have 
previously shown that the gut endoderm tissue layer forms by a coordinated 
multifocal egression of epiblast-derived definitive endoderm (DE) cells into 
the preexisting visceral endoderm (VE) epithelial layer. VE cells are 
dispersed by egressing DE cells, and even though the resulting gut 
endoderm tissue exhibits an apparent molecular homogeneity, it comprises 
cells of two different (extraembryonic and embryonic) origins. 
Various studies have implicated the Sry-related HMG-box transcription 
factor 17 (Sox17) in the formation of endoderm in vertebrates. Using live 
imaging reporter strains we note that Sox17 mutants fail to fully disperse 
the VE, resulting in a series of endoderm-specific defects including failure 
in: the emergence of the node onto the surface of the embryo, left-right 
asymmetry establishment, and gut tube formation. 
Furthermore, tissue-specific (VE vs. DE) ablation of Sox17 reveals that the 
requirement for this transcription factor is non-cell autonomous within the 
gut endoderm, suggesting that a novel mechanism of cellular cross-talk may 
operate in the acquisition of molecular equivalence in cells of the gut 
endoderm tissue. Sox17 is required in both embryonic (DE) and 
extraembryonic (VE) tissues during their intercalation, where it appears to 
non-cell autonomously regulate its own expression, which may be critical 
for achieving molecular equivalence between DE and VE derivatives. 
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Somites form along the embryonic axis by progressive segmentation from 
the anterior border of the presomitic mesoderm (PSM) and later 
differentiate into segmented body structures, such as vertebrate and ribs, as 
well as unsegmented skeletal muscle, tendons, and dermis. Somites are 
thought to form via the intersection of two signaling activities, known as the 
clock and the wavefront. Previous work in cultured embryos has suggested 
that Fibroblast Growth Factor (FGF) activity encodes the wavefront signal, 
which maintains the PSM in its undifferentiated state. However, it is unclear 
which (if any) of the six FGFs expressed in the PSM encode this activity, as 
removal of any one ligand is insufficient to disrupt early somitogenesis.  
 
Here we show that when both Fgf4 and Fgf8 are deleted in the PSM, we 
observe a highly unusual phenotype whereby the entire PSM apparently 
engages in a single, simultaneous round of somitogenesis. In these mutants, 
expression of FGF signaling targets are lost despite ongoing expression of 
other FGF ligands. This loss of FGF signaling results in early failure of 
somitogenesis and truncation of the embryonic axis at approximately the 3-
somite stage. Expression of most PSM genes is absent in mutants, including 
cycling genes, markers of undifferentiated PSM, and WNT pathway genes. 
Instead, at the stage when the anterior PSM would normally start to segment 
off somites, we observe that somite markers are prematurely expanded 
throughout the PSM of mutant embryos, demonstrating premature 
differentiation of the entire PSM into somitic tissue. These data demonstrate 
that FGF signaling prevents somitic differentiation of the PSM and can 
therefore be considered the wavefront activity.  
 
We have further investigated the separate requirements for FGF and WNT 
signaling by restoring WNT activity to the FGF mutant PSM using a gain-
of-function β-catenin allele. When WNT signaling is restored, PSM 
progenitor markers such as Brachyury are partially restored, but premature 
differentiation of the PSM still occurs, demonstrating that FGF wavefront 
signaling operates independently of the WNT pathway.  
 
This study provides the first genetic evidence that FGF signaling is the 
source of the Wavefront and identifies the FGF ligands that encode this 
activity. Furthermore, these data show that FGF activity maintains WNT 
signaling, and that both signaling pathways are required in parallel to 
maintain PSM progenitor tissue. 
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In vertebrate embryogenesis, mesp family genes encoding bHLH 
transcription factors show cyclic expression in the anterior presomitic 
mesoderm (PSM) as narrow bands just before somite formation. Mouse 
Mesp2 expression is initiated by encountering with the Notch signal 
oscillation, an output of a segmentation clock, in a Tbx6 (a T-box 
transcription factor)-dependent manner. Mesp2 then degrades Tbx6 directly 
or indirectly, forming a sharp anterior boundary of Tbx6. This anterior 
border of Tbx6 likely defines the anterior limit of Mesp2 expression 
domain. However, it is still to be elucidated why Mesp2 expression is 
repressed in the posterior PSM, despite Tbx6 expression and oscillating 
Notch signal are both active in the posterior region. Previously FGF 
signaling has been implicated as a negative regulator of Mesp2 
transcription. Here we show that another T-box transcription factor 
Brachyury (Bra) could repress Mesp2 in the posterior PSM and tailbud. Bra 
mRNA expression is stronger at the tailbud and the protein expression 
domain extends to the anterior PSM just like Tbx6. However, unlike Tbx6, 
Bra did not activate Mesp2 in synergy with Notch signal. In vitro reporter 
assay indicated that the induction of Mesp2 expression by Tbx6 and Notch 
was suppressed when Bra is included in the assay. T-box deleted mutant of 
Bra failed to repress Mesp2 activation. Bra can bind weakly to Tbx6 
binding sites in Mesp2 cis regulatory sequence, and we've not identified any 
independent cis-element in Mesp2 promoter required for the repression by 
Bra. Taking together, it is plausible that Bra contributes to maintain Mesp2 
expression silence in the posterior PSM by competing with Tbx6. 
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Limb bud development is controlled by complex regulatory networks. 
These networks instruct coordinated patterning and proliferation of 
mesenchymal progenitors along the dorso-ventral (DV), antero-posterior 
(AP) and proximo-distal (PD) limb axes. In particular, sonic hedgehog 
(SHH) is known to specify the AP limb bud axis and regulate its expansion 
as part of a larger self-regulatory signalling system. Transcriptome analysis 
now uncovers an unexpected function of SHH in PD limb axis development 
as Shh-deficient mouse limb buds are proximalized. Expression of proximal 
genes and retinoic acid (RA) pathway activity is up-regulated and distally 
expanded Shh-deficient limb buds. In parallel, the expression of the RA 
inactivating enzyme Cyp26b1 is decreased in the distal mesenchyme. We 
have investigated the possible SHH-RA interactions using a combination of 
experimental manipulation, genetics and mathematical simulations. Our 
findings reveal a SHH-dependent signalling module that normally enhances 
RA clearance by increasing FGF signalling in the apical ectodermal ridge 
(AER), which in turn up-regulates Cyp26b1 expression. Disruption or 
reduction of CYP26b1-mediated RA clearance interferes with distal limb 
bud development leading to molecular proximalization of Shh, AER-Fgf and 
Cyp26b1 deficient limb buds. In addition we provide molecular evidence 
for early specification of the PD axis by a mutually inhibitory interaction of 
RA with AER-FGFs. Subsequently AP and PD limb bud patterning 
becomes interlinked via SHH mediated regulation of the AER-
FGF/CYP26b1/RA signalling module, which enables spatially coordinated 
progression of limb bud development. 
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The basic functional unit of the kidney is the nephron. In man, the kidney is 
comprised of many hundreds of thousands of nephrons through which the 
plasma is filtered several times per hour. In so doing, nitrogenous waste-
products and other toxic small molecules are removed and the osmotic 
balance of interstitial fluids kept within physiological bounds.  
 
We are interested in the mechanisms by which progenitor cell maintenance 
and commitment are balanced in the process of nephrogenenesis ensuring 
the formation of a full complement of epithelial nephron precursors and the 
subsequent mechanisms governing patterning and morphogenesis of the 
complex tubular network of the functional nephron. The ability to form new 
nephrons is lost with exhaustion of the nephron progenitor pool. This leaves 
repair of the existing structures as the only normal option for maintaining 
kidney function. I will discuss our findings on generation, patterning and 
repair of the mammalian nephron. 
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 Developmental angiogenesis proceeds through multiple morphogenetic 
events including sprouting, intussusception, and pruning. Mice lacking the 
membrane-anchored metalloproteinase regulator Reck [1] die in utero 
around embryonic day 10.5 with halted vascular development [2] and 
precocious neuronal differentiation [3]; however, the mechanisms by which 
the vascular phenotype arises remained unclear.  
 We found that Reck is abundantly expressed in the cells associated with 
blood vessels undergoing angiogenesis or remodeling in the uteri of 
pregnant female mice. Some of the Reck-positive vessels show 
morphological features consistent with non-sprouting angiogenesis. 
Treatment with a vector expressing a small hairpin RNA targeting Reck 
severely disrupts the formation of blood vessels with a compact, round 
lumen. Similar defects were found in the vasculature of Reck-deficient or 
Reck conditional knockout embryos.  
 Our findings implicate Reck in vascular remodeling, probably through 
non-sprouting mechanisms (i.e., intussusception and pruning), in both 
maternal and embryonic tissues. 
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 73 
THE IKMC MOUSE KNOCKOUT PORTAL - SHARING AND 
INTEGRATING RELATED DATA 
 
Darren Oakley1, Vivek Iyer1, Sébastien Briois1, Damian Smedley2, Martin 
Ringwald3, Jim Kadin3, Jeremy Mason3, Bill Skarnes1  
 
1The Sanger Institute, High Throughput Gene Targeting, Hinxton, 
Cambridge, CB10 1HH, United Kingdom, 2European Bioinformatics 
Institute, Mouse Informatics, Hinxton, Cambridge, CB10 1SA, United 
Kingdom, 3The Jackson Laboratory, Mouse Genome Informatics, Bar 
Harbor, ME, 04609 
 
The International Knockout Mouse Consortium (IKMC) aims to mutate all 
genes in the mouse using a combination of gene trapping and high-
throughput gene targeting technology[1]. The IKMC has established a 
website (http://www.knockoutmouse.org) that serves as a single point of 
entry to these extensive mutant resources, providing standardized 
information about alleles generated by the international programs 
(EUCOMM, KOMP, NorCOMM, TIGM, MirKO). 
 
Here we focus on the 'MartSearch' component of the portal 
(http://www.knockoutmouse.org/martsearch) that uses BioMart[2] and 
search engine technology to integrate IKMC mouse knockout resources 
with other relevant biological data. Currently, this portal combines 
information on mouse knockouts with numerous other datasets, including 
gene information from MGI and Ensembl, gene expression data from 
EurExpress, phenotype data from Europhenome, mouse distribution 
information from EMMA, and human disease associations from MGI and 
OMIM. Work is underway to develop and integrate BioMarts of GXD gene 
expression data and biochemical pathways. Data representation, integration, 
and querying capabilities via the BioMart interface will be refined and data 
from other resources will be added. 
 
The MartSearch portal showcases a novel use of both a search engine and 
data warehouses, allowing users to make both simple and expert queries and 
to provide bulk data downloads. In addition, this approach allows other 
groups to re-present IKMC data through other web interfaces: indeed both 
the WTSI Mouse Portal (http://www.sanger.ac.uk/mouseportal) and the 
EUMMCR Repository (http://www.eummcr.org) use these technologies to 
show different subsets of the same IKMC data with different emphases. 
 
[1] A Mouse for All Reasons, Collins et. al, Cell, Volume 128, Issue 1, 9-
13, 12 January 2007 
[2] Damian Smedley, Syed Haider, Benoit Ballester, Richard Holland, 
Darin London, Gudmundur Thorisson and Arek Kasprzyk BioMart - 
biological queries made easy. BMC Genomics. 2009 Jan 14;10:22. 
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Eps8 is the prototype of a family of proteins involved in Actin remodeling. 
Eps8 is a modular protein that interacts with a number of proteins themselves 
involved in Actin remodeling, e.g. Abi and Irsp53. In addition, Eps8 binds 
directly to Actin and acts both as an barbed end Actin capper as well as a F-
actin bundler. The specific activity of Eps8 appears to be regulated by its 
interaction partner and phosphorylation state. Eps8L2 shares the modular 
organisation of Eps8 and -as far as investigated- the same biochemical 
functions. In vivo the two proteins are co-expressed in the majority of the 
organs (Offenhäuser et al., 2004). In C.elegans and D. melanogaster in which 
only one EPS8 gene exists the loss of Eps8 is lethal. Instead, in the mouse the 
loss of either Eps8 or of Eps8L2 has no effect on viability. Eps8-KO and 
Eps8L2-KO mice are healthy and fertile. A detailed phentoype analysis of 
Eps8-KO mice has shown that these mice show a number of defects due to 
altered actin dynamics: 1) increased NMDA currents in neurons leads to 
increased resistance to ethanol (Offenhäuser et. al, 2006), 2) shortend microvilli 
lead to reduced bodyweight, improved metabolism and increased lifespan 
(Tocchetti et al., 2010). Eps8L2-KO mice instead show normal resistance to 
ethanol consistent with its lack of expression in the CNS. In addition, Eps8L2-
KO show normal insulin sensitivity despite a slight reduction in bodyweight, 
indicating that also the metabolic phenotype is specific for Eps8. Thus the 
phenotypes identified in Eps8-KO appear to be specific for Eps8. To unmask 
redundant roles of the two proteins, we generated Eps8Eps8L2-DKO. Only a 
fraction of Eps8Eps8L2-DKO mice arrive to weaning with evident growth 
retardation and survive beyond weaning only if provided with soft food in the 
cage. Thus, the combined loss of Eps8 and Eps8L2 is incompatible with life 
also in mammals. Current studies are directed towards understanding the precise 
defects in Eps8Eps8L2-DKO animals. 
 
Offenhäuser N, Borgonovo A, Disanza A, Romano P, Ponzanelli I, Iannolo G, Di 
Fiore PP, Scita G. The eps8 family of proteins links growth factor stimulation to 
actin reorganization generating functional redundancy in the Ras/Rac pathway. Mol 
Biol Cell. 2004 Jan;15(1):91-8. Epub 2003 Oct 17. 
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D'Angelo E, Frassoni C, Amadeo A, Tocchetti A, Pozzi B, Disanza A, Guarnieri D, 
Betsholtz C, Scita G, Heberlein U, Di Fiore PP. Increased ethanol resistance and 
consumption in Eps8 knockout mice correlates with altered actin dynamics. Cell. 
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Pronuclear injection (PI) is the most common method used to generate 
transgenic mice, despite wide variability in the level and pattern of 
transgene expression because of its dependence on gene copy number, 
configuration, and integration site. Targeted integration of a single-copy 
transgene has become recently possible through homologous recombination 
or site-specific recombination in embryonic stem (ES) cells. Such targeted 
transgenesis is advantageous for achieving predictable and reproducible 
transgene expression. However, the targeted system is more technically 
demanding and time-consuming than PI-based transgenesis. 
This study established a PI-based targeted transgenesis (PITT) system based 
on Cre-loxP site-specific recombination in fertilized eggs, but not in ES 
cells. Seed mice were initially generated through ES cell targeting to 
contain loxP-site derivatives at a predetermined locus (e.g. Rosa26). A 
transgene, flanked by two mutant loxP sites, was then integrated into target 
loci in the seed mice by recombinase-mediated cassette exchange (RMCE) 
in fertilized eggs. By applying this method, we have established a total of 
25 transgenic lines so far, including fluorescent gene transgenic mice 
showing ubiquitous, strong, and reproducible transgene expression. We also 
demonstrated that knockdown mice can be readily generated by PITT by 
taking advantage of our reproducible and highly efficient expression 
system. The PITT method could therefore provide a strong basis for 
systematically generating a variety of targeted transgenic lines, without 
going thorough ES cells, for reliable transgene expression and for gene 
knockdown. 
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Glial cell line-derived neurotrophic factor (GDNF) is implementary to 
ureteric budding and branching. If applied exogenously, GDNF promotes 
ectopic ureteric buds from the Wolffian duct. Microarray screening of 
GDNF-regulated genes in the Wolffian duct revealed several early response 
genes to GDNF. Among them was Visinin like 1 (Vsnl1) encoding for a 
neuronal calcium sensor protein. We now show that Vsnl1 is expressed 
exclusively in the ureteric epithelium and is lacking in Gdnf-null kidneys. 
In tissue culture, its expression was restored by exogenous GDNF and by 
the alternative bud inducers, FGF7/Follistatin. Hence, Vsnl1 characterizes 
the tip of the ureteric bud epithelium regardless of the inducer, also in the 
absence of Ret. Vsnl1 shows a mosaic expression pattern in the tips. This 
pattern of Vsnl1 was mutually exclusive with that of Xgal labeling in the 
Batgal reporter mice for Wnt activity. In accordance, Vsnl1 was 
downregulated in β-catenin stabilized kidneys, but also in β-catenin 
deficient kidneys. Moreover, in mouse collecting duct cells, Vsnl1 
compromised β-catenin stability, suggesting that Vsnl1 and β-catenin are 
counteracting in the ureteric epithelium. 
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The cellular behaviors underlying the morphogenesis of the gut endoderm, 
the tissue that will give rise to the respiratory and digestive tracts and 
associated organs, are complex and not well understood. We are combining 
live imaging and genetic labeling, to visualize the dynamic cell behaviors 
during endoderm formation in the mouse gastrula.  
Our data reveal that the gut endoderm arises by widespread intercalation of 
embryonic (definitive endoderm) and extraembryonic (visceral endoderm) 
tissues. We propose that this morphogenetic event facilitates an increase in 
the surface area of the embryo to accommodate its rapid growth at this 
stage, and leads to extensive cell mixing which results in the gut endoderm 
comprising cells of two distinct origins.  
Epithelial-to-mesenchymal transition (EMT) and cell delamination at the 
primitive streak provide both the appropriate morphology and trajectory for 
definitive endoderm cells. We therefore suggest that definitive endoderm 
cells egress (i.e. insert) into the pre-existing visceral endoderm epithelium, 
and in doing so undergo a process of mesenchymal-to-epithelial transition 
(MET). Acquisition of endoderm-specific marker expression could reveal a 
commitment for primitive streak-derived cells to egress and subsequently 
undergo MET to epithelialize. Elevated rates of cell proliferation in the 
epiblast and its derivatives as compared to the overlying visceral endoderm 
could provide a driving force for remodeling of visceral endoderm cell 
junctions, and promote egression of epiblast-derived cells onto the surface 
of the embryo. Furthermore, active remodeling of the extracellular matrix 
may initially facilitate cell egression but later on enforce lineage 
segregation.  
To gain mechanistic insight into the process of gut endoderm formation, we 
have begun to characterize the sequential events driving this event in both 
wild type embryos and mutants in which different steps are affected.  
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The mouse Teashirt1 (Tshz1) gene is one of three homologues of the 
Drosophila gene Teashirt, which encodes a zinc-finger protein that 
functions both in the Wnt signaling pathway and as a homeotic determinant 
of trunk identity. All vertebrate Teashirt genes encode zinc-finger 
homeodomain factors, which are expressed throughout the developing and 
adult nervous system.  
We present here a detailed characterisation of the cell populations within 
the granule cell layer of the embryonic mouse olfactory bulb, and assign to 
Tshz1 an essential role in both the radial migration and the molecular 
specification of early born, distally generated granule cell neurons. Early-
born granule cell neurons arrived within the bulbs of Tshz1-/- mutant mice, 
but distributed aberrantly within the radial dimension, forming closely- 
packed cell aggregates. Within these clusters, cells of the Tshz1 lineage 
failed to express the zinc-finger transcription factors Sp8 and Sall3 and 
remained in an immature state as defined by the loss of expression of the 
markers neuN, glutamic acid decarboxylase (GAD)-67, γ-amino butyric 
acid (GABA), tyrosine hydroxylase and guanine deaminase (cypin). 
Currently, we are using FACSorting to isolate GFP-positive cells from 
control and mutant olfactory bulbs in order to compare changes in gene 
expression. 
Tshz1 is the first molecule to be characterised, which functionally 
distinguishes between the differentiation programs of olfactory bulb granule 
cell and periglomerular cell neurons. Furthermore, our analyses indicate that 
soluble and/or cell surface factors produced by the Tshz1+ outer granule cell 
lineage regulate the spatial distribution of other neuronal populations within 
the olfactory bulb.  
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The Sanger Institute Mouse Genetics Programme (MGP) capitalizes on the 
availability of the mutant ES cell resources generated by the EUCOMM and 
KOMP projects by generating and phenotyping mutant mouse lines at a 
large scale. The mutant strains and the phenotypic data are freely available 
to the scientific community to promote deeper analysis aimed at uncovering 
the molecular mechanisms involved in the phenotypic alterations resulting 
from the mutant alleles. 
The MGP has produced over 400 mutant strains, of which more than 200 
have finished the phenotypic screen. The phenotypic data can be obtained 
by visiting the Sanger Mouse Portal 
(http://www.sanger.ac.uk/mouseportal/). The website offers the opportunity 
to download a weekly updated summary heat map that includes all the 
strains being examined. Scientists are also encouraged to sign up for a 
regular phenotypic alert email to receive early warnings on interesting 
phenotypes. When two (2) heterozygote mice are genotyped for a particular 
allele, the strain is advertised to the community at the International 
Knockout Mouse Consortium (IKMC) website 
(http://www.knockoutmouse.org/about). Although the specific mice to be 
distributed may not be available immediately, the MGP seeks to receive 
notifications of interest, and while the mice are on the shelf, a reasonable 
effort is made to distribute them to interested parties with minimum delay. 
Although a majority of strains is currently selected because of prior interest 
on the gene, we expect that increasingly strains will be selected because of 
the phenotypic data generated from the MGP. The selection of phenotypic 
tests included in the program is strongly influenced by an active interaction 
with experts from the community and is aimed at exploring a biological 
space of medical relevance. We will present an update on the program 
activities and highlight some interesting and novel phenotypic findings. 
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Glycosylation of proteins is postulated to be important for protein stability, 
protein folding and quality control, ligand recognition and binding. The 
importance of glycosylation in development is apparent from the vast 
number of congenital disorders caused by altered glycosylation of proteins. 
Through an ENU induced screen to identify genes important in mouse 
embryonic development, we identified wsnp (wing shaped neural plate) as 
an allele of Ktelc1, which encodes a protein glucosyltransferase. The wsnp 
allele harbors a point mutation in a splice donor site resulting in multiple 
improperly spliced products that are likely to be non-functional. These 
mutants die before e9.0 and have severe defects in epithelial-to-
mesenchymal transition at the primitive streak, and the embryos are 
deficient for mesoderm-derived structures, as visualized by Meox1 
expression. Additionally, the mutants have an abnormally shaped neural 
plate that fails to close and form the neural tube. O-glucosylation is a very 
rare modification found in only a handful of proteins and the functional 
importance of this modification on proteins remains to be elucidated. The 
Drosophila homologue of KTELC1, Rumi, was shown to O-glucosylate 
Notch, a cell surface receptor involved in multiple cell fate decisions. 
Absence of this O-glucosylation leads to an inability to cleave the Notch 
intracellular domain therefore altering the Notch signalling. Consistent with 
the fly data, we find that wsnp mutants have defects in processing Notch 
and therefore are unable to produce the activated form of Notch upon ligand 
binding. Furthermore, the expression of Notch target genes is decreased in 
these mutants. However, the phenotype of wsnp mutant is more severe than 
all known mutations that affect the Notch pathway indicating a Notch-
independent function of KTELC1. We are currently investigating the 
importance of glucosylation in the Notch pathway and aiming to identify 
other potential targets of KTELC1 that play important roles in embryonic 
development. 
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Spina bifida aperta is a common and disabling neural tube defect in 
humans; it occurs when the caudal progression of neural tube closure from 
the hindbrain/cervical boundary is interrupted. Spinal neural tube closure 
requires the formation of ‘hinge points’, which are localised regions of 
bending in the neuroepithelium. At upper spinal levels, a single median 
hinge point (MHP) is formed, which is dispensible for closure. At lower 
spinal levels, dorsolateral hinge points (DLHPs) become apparent, and are 
essential for closure between the 16- and 30-somite stages. Mice 
homozygous for the Zic2 loss-of-function allele, Kumba (Zic2Ku/Ku) have a 
fully penetrant spina bifida that is characterised by the absence of (DLHPs) 
in the neuroepithelium. Although DLHP formation is known to be regulated 
by varying inhibition from the Shh and Bmp signalling pathways, little is 
known about the genetic and molecular targets of Zic2 that preclude normal 
neuroepithelial morphogenesis. Using a microarray screen of Kumba 
posterior neuropore regions, we have identified and validated differentially 
expressed genes that may contribute to the Zic2Ku/Ku spina bifida. Our 
analysis confirmed that canonical Wnt signalling is down-regulated via 
Wnt3a in the Zic2Ku/Ku posterior neuropore at the time DLHPs are expected 
to form. We have also identified an orphan nuclear receptor, GCNF/Nr6a1, 
that is downregulated in the Zic2Ku/Ku neuroepithelium, and is linked to Bmp 
pathway activation. These findings suggest that an alteration of dorsal Wnt 
or Bmp signalling may be linked to failure of DLHP formation. Although 
an overactivation of Shh signalling is expected to inhibit DLHP formation, 
markers of Shh signalling activity, such as dorso-ventral patterning of the 
neural tube, and expression of the downstream effectors Ptc and Gli2, are 
unaltered in Zic2Ku/Ku mutants. This suggests that Shh is not responsible for 
the neurulation defect in these embryos. In fact, in parallel with our 
microarray analysis, we have characterised a defect in the Zic2Ku/Ku 
notochord, which is narrow and discontinuous compared to wild-type 
controls. This might be expected to cause defects in ventral neural plate 
development in Zic2Ku/Ku embryos and, indeed, preliminary findings 
indicate enhanced mitotic activity in the ventral neural plate, ‘blunting’ the 
dorso-ventral proliferation gradient. These findings highlight the need for 
precise regulation of dorsal and ventral signals for neural plate 
morphogenesis, prior to the onset of neurogenesis. 
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TaconicArtemis together with Taconic Cranbury represents the highly 
innovative site of Taconic. Together we are able to offer full range services 
from mouse model generation to phenotyping and compound profiling.  
Speed, Quality and Innovation have been the driving forces for 
TaconicArtemis to develop custom-tailored genetically engineered mouse 
(GEM) models for fast and efficient in vivo drug target validation. We are 
offering a wide range of mouse models that include constitutive / 
conditional Knock Out, constitutive / conditional Knock In, humanizations, 
targeted Transgenesis, and inducible gene Knock Down by RNA 
interference within competitive timelines and retaining high quality design 
and production.  
We further enlarged our biological platform in order to position our models 
from the target validation to the pre-clinical phase of the drug discovery 
pipeline. In order to reduce drug attrition rates we generated innovative 
transADMET (absorption, distribution, metabolism, excretion, toxicology) 
mouse models for drug discovery and development. Key murine ADMET 
genes such as nuclear receptors (e.g. PXR and CAR), Phase I enzymes (e.g. 
Cyp3A) and drug transporters have either been exchanged for their human 
counterparts or knocked out for use as controls. 
To improve to the drug discovery process further we developed the 
inducible KinaseSwitch System which permits the selective inhibition of 
only the desired target kinase. Proven technologies (ASKA) are used to 
create mutations that allow binding of the inhibitor only by the kinase of 
interest.  
Our major goal is the development and constant improvement of in vivo 
systems that allow on the one hand a better understanding of the molecular 
basis of human pathology and fundamental biological processes and on the 
other hand the fast and predictive discovery of novel and more efficient 
drugs.  
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The Gene Expression Database (GXD) collects and integrates different 
types of mouse developmental expression data from wild-type and mutant 
mice, including data from RNA in situ, immunohistochemistry, in-situ 
reporter (knock-in), Northern blot, Western blot, and RT-PCR experiments. 
The GXD staff reads the scientific literature and enters the expression data 
from those papers into the database on a daily basis. GXD also acquires 
expression data directly from researchers, including laboratories performing 
large-scale expression studies. GXD records expression information in 
detail using standardized text annotations, and data entries are accompanied 
by images of the original data whenever possible. GXD currently includes 
data from more than 38,000 experiments containing over 430,000 
expression results, and data from almost 1,500 mouse mutants. In addition, 
the database holds over 72,000 images of original expression data. These 
images have been carefully indexed with respect to the genes analyzed, the 
probes used, the strain and genotype of the specimen, the developmental 
stages and anatomical structures in which expression was reported to be 
present or absent, and other parameters. Furthermore, by being an integral 
part of the larger Mouse Genome Informatics (MGI) resource, GXD 
combines its expression data with other genetic, functional, phenotypic, and 
disease-oriented data. Therefore, users can search for expression data and 
images in many different ways, using a wide variety of biologically and 
biomedically relevant parameters. 
 
We welcome direct submissions of expression data to GXD. Data 
submissions receive accession numbers that can be cited in publications and 
grant applications. Inclusion of expression data in GXD provides 
integration with all the other data in GXD and MGI and makes it widely 
accessible to database queries, thus increasing its utility and exposure. 
Guidelines and tools for electronic data submission are accessible at our 
web site.  
 
GXD is freely available through the MGI web site 
(http://www.informatics.jax.org), or directly at 
http://www.informatics.jax.org/expression.shtml. GXD is supported by NIH 
grant HD033745.  
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The locus Idd6 is involved in type 1 diabetes development in the nonobese 
diabetic (NOD) mouse through its effect on the immune system and in 
particular T cell activities. Analysis of congenic strains for Idd6 revealed 
the Aryl hydrocarbon receptor nuclear translocator-like 2 (Arntl2) as 
candidate. Arntl2 belongs to the basic helix-loop-helix/Per-Arnt-Sim 
(bHLH/PAS) family of transcription factors controlling the circadian 
rhythm. Our results show that diabetes incidence is increased by Arntl2 
mRNA interference in Idd6 congenic mice concomittent with an increase in 
CD4+ T cells and a decrease in regulatory T cells in the peripheral immune 
system. Our results show further that upregulation of cellular Arntl2 levels 
correlates with inhibited CD4+ T cell proliferation and their decreased 
diabetogenic activity. These data suggest that Arntl2 in the Idd6 interval 
may act on CD4+ T cell proliferation and the balance between effector and 
regulatory T cells to protect against autoimmune type 1 diabetes in the 
NOD mice. They also reinforce the current findings on key functions of 
circadian rhythm related genes in controlling metabolic pathways. These 
genes include the Arntl2 homologues Aryl-hydrocarbon receptor (AhR), 
which controls key regulatory immune functions, ARNT and ARNTL1, 
which both have been associated with diabetes in human and in mouse. 
 
Funding acknowledgement: this work was supported by grants from the 
ANR (ANR-06-PHYSIO-016-01) the ARD, and the EFSD/JDRF/Novo 
Nordisk Programme and by recurrent funding from the CNRS, INSERM 
and Institut Pasteur. 
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Folate is vitamin of the B complex, and constitutes an essential 
micronutrient. It serves as an enzymatic cofactor in single-carbon transfer 
reactions in the processes of nucleotide, amino acid and lipid synthesis, and 
is thought to contribute to the development and maintenance of the 
epigenome through its role in histone and DNA methylation. Folate 
deficiency has been linked to risk for birth defects, cardiovascular disease, 
reduced immune function, and certain types of cancer. 
 
Mammalian cells have developed an elaborate mechanism to harvest folate, 
involving extracellular folate receptors, several transmembrane carriers, and 
an intracellular enzymatic ‘trapping’ strategy to prevent folate from leaving 
the cell. Despite the essential nature of folate, which would suggest 
ubiquitous expression, genes for folate receptors show distinct tissue-
specific expression patterns. 
 
To gain insights into the biological functions of Folate receptor 4, we have 
generated mice with a ‘floxed’ allele of the Folr4 gene, where the first two 
coding exons of the gene are flanked by loxP sites. For a germline deletion 
of Folr4, we crossed Folr4fl/fl homozygous mice with mice carrying a Cre 
recombinase transgene under the control of the MMTV promoter. These 
mice show high expression of Cre in the oocyte; introduction of a paternal 
floxed allele lead to recombination at loxP sites before the first cell division, 
which created a germline deletion in the resulting mouse. Based on FACS 
analyses of splenocytes, this Cre-mediated deletion resulted in a null allele 
for the Folr4 gene. 
 
We report that mice homozygous for the Folr4 null mutation are viable, as 
crosses of heterozygous animals yield all three genotypes in Mendelian 
fashion. However, while Folr4 homozygous mutant males are fertile, Folr4 
homozygous mutant females appear infertile despite seemingly normal 
ovulation. We find the Folr4 gene expressed in several locations in the 
female reproductive tract, most notably the ovary and the developing 
oocyte, but also the uterine endometrium. Lack of Folr4 affects gene 
expression in the uterus at the time of implantation, whereas periconceptual 
supplementation with folate can reverse such gene expression changes. We 
conclude that the Folr4 gene represents an important checkpoint for fertility 
and reproduction. 
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The ability to prepare genetically modified mice from mouse embryonic 
stem (ES) cells with defined mutations has accelerated the discovery of 
gene function in whole animal models. The international consortium to 
knock out every gene in the mouse (KOMP) has generated thousands of 
gene-targeted ES cell clones that can be used to prepare ES cell-mouse 
chimeras and gene-targeted mouse strains. This methodology simplifies 
access to mouse models for investigators, obviating the need to design 
gene-targeting vectors, to manipulate totipotent ES cells in culture and to 
screen ES cell clones for desired genetic changes. Gene-targeted and gene-
trapped ES cell clones were imported from participating members of 
KOMP (EUCOMM, NorCOMM, SIGTR, BayGenomics, FHCRC, GGTC, 
CMHD, Regeneron, and TIGM). ES cell clones were analyzed with respect 
to euploid chromosome numbers, Mycoplasma contamination, verification 
of gene targeting event, generation of ES cell-mouse chimeras, and 
germline transmission of gene trapped alleles. More than 100 clones were 
characterized. The majority (73%) formed germline chimeras. Rarely, 
clones were incorrectly targeted or required subcloning to isolate gene-
targeted subclones. The most common reason that ES cells did not go 
germline was because of aneuploid chromosome makeup. Additional clones 
failed to form germline chimeras for unspecified reasons. The data 
presented suggest that in order for an investigator to be assured of obtaining 
a knockout mouse model at least two ES cell clones with mutations in the 
gene of interest will need to be procured. When it is necessary to achieve 
germline transmission from two independent ES cell clones so that 
confounding phenotypes arising from spurious spontaneous mutations 
during ES cell culture can be eliminated then at least three ES cell clones 
should be imported for chimera production and germline breeding.  
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Transgenic animals are unique mutants to study genes, their function, 
regulatory mechanisms, or (human) diseases. Cryopreservation of pre-
implantation embryos or spermatozoa is a common approach to save those 
lines against loss or to keep them in a repository. Only following the 
cryopreservation of a sufficient number of samples and a successful quality 
assessment a mutant line can be taken out of a breeding nucleus.  
The quality of spermatozoa of different donors within a mouse line is 
heterogeneous. Technical problems during the cryopreservation procedure 
might happen, too. Subsequently, a significant quality assessment of the 
cryopreserved samples of each donor-animal is mandatory.  
To replace the common, but animal consuming in vitro-fertilization and the 
subsequently needed embryo transfer for quality assessment purposes of 
cryopreserved spermatozoa, an animal free procedure was developed: A 
fluorescence microscopy based technique was established and validated. 
Viability, density, motility, and morphology of spermatozoa were analyzed 
as parameters of major interest.  
Spermatozoa are treated with two dyes staining all or only dead cells, 
respectively. Several fields of view are acquired fluorescence-
microscopically and analyzed with the appropriate software. The data 
received cover the three parameters viability, density, and morphology to 
assess the quality of the spermatozoa: In addition to the fluorescence 
microscopy a video sequence of 200 frames is recorded to analyse the 
motility.  
To determine the reproducibility of viability, density and motility 
cryopreserved spermatozoa of wildtype and transgenic mice with a different 
genetic background were investigated. Therefore different samples of the 
same animal and repeated measurements within the same sample were 
investigated. The data received indicate that the parameter “viability” is 
statistically significant most important to assess cryopreserved spermatozoa.  
Under the prerequisite that each transgenic spermatozoa donor mouse can 
be re-genotyped and a single IVF is performed to determine the fertilization 
capacity of a line, this approach facilitates a reliable quality assessment of 
cryopreserved spermatozoa without additional animal consuming 
experiments for quality assessment purposes. This contributes to the animal 
welfare and the 3R principles postulated by Russell and Burch, too.  
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Due to their major scientific potential the number of GM mice is rapidly 
increasing. Several limitations when working with these animals are to be 
considered resulting in the need for an effective storage system to keep and 
store also those lines which are out of current use. Therefore cryopreservation 
of pre-implantation embryos or spermatozoa is a valuable tool.  
To gather quickly relevant information about all GM mouse lines available in-
house, a database was developed enabling optimum knowledge management 
and easy access to the resources available.  
Originally, the database was developed for a repository of cryopreserved GM 
mice. To offer a complete information, all active GM lines were introduced into 
this database, too. This is also a support for the Technology Transfer 
Department handling frequent requests about possibly available animal models 
and having the duty to find out a possible exploitation.  
In a further step a cross link to the institutional publication database was 
performed, offering the direct link between a publication and a mouse described 
or mentioned there. In addition, legal restraints ask to gather further 
information, especially about the mutation itself.  
To achieve an easy access the data base is available as a web-based application, 
no software must be installed locally.  
 
Data organization  
Detailed information is provided for each mouse line:  
- Description:  
Name of the mouse line (short, long, and international version), 
characterization/description, usage of an animal model, genotype, genetic 
background, backcross generation, possible phenotype, genetic modification 
and the generation technique used, origin of the mutation (gene-ID and donor 
organism), the origin of regulatory elements with their donor and vectors; 
housing conditions, a possible need of rederivation, or a movement into another 
facility.  
- Possible publications, keywords, use as an animal model:  
A registered GM mouse line is linked with key publications and vice versa.  
- Legal status:  
Techniques used when generating the mouse line, material transfer agreements, 
or patents. The investigator keeping the rights of the GM line might declare 
whether and under which conditions she/he wishes to make this line accessible 
for others.  
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Mesenchymal-to-epithelial signaling plays a key role in the development of 
many organs. For example, secretion of Fgf10 from the pancreatic 
mesenchyme stimulates proliferation of progenitor cells in the neighboring 
pancreatic epithelium. Although Fgf10 signaling is crucial for expansion of 
the pancreatic epithelium, few of the downstream genes are known. In an 
effort to identify cell-intrinsic factors regulated by Fgf10 signaling in the 
pancreatic epithelium, we found that two members of the ETS-family 
transcription factors, Etv4 and Etv5, were upregulated by Fgf10 
overexpression. In wild type embryos, both factors are expressed almost 
exclusively within the pancreatic epithelial progenitors. We also observed 
expression of Etv4 in pancreatic progenitor cells active in MAPK signaling. 
Moreover, inhibition of the MAPK pathway suppressed the FGF-dependent 
transcriptional activation of Etv4 and Etv5 in vitro. We examined the 
pancreas of Etv4-/- and Etv5-/- embryos to ascertain if the effects of Fgf10 
signaling are mediated through these two factors in vivo. The pancreas of 
Etv4-/- embryos appeared normal, which suggests that Etv5 may compensate 
for Etv4 function as the DNA binding domains of these factors are almost 
identical. We used an outbreeding strategy to circumvent the embryonic 
lethality of Etv5 null embryos. This approach was successful, and we found 
that Etv5-/- embryos displayed a profound reduction in the pancreatic 
progenitor population. In addition, mature endocrine and exocrine cell types 
were diminished in the Etv5 null embryos, which is suggestive of pancreatic 
epithelial hypoplasia. Thus, Etv4 and Etv5 are key components of Fgf10 
signaling that drive pancreatic progenitor cell proliferation. 
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Background: Nuclear receptor 2e1 gene (Nr2e1) encode for an orphan 
nuclear receptor acting as a transcription factor that functions in progenitors 
and neural stem cells to regulate proliferation and cell fate decisions. We 
evaluated the transcriptome of Nr2e1-/- (fierce) animals to identify genes 
directly regulated by Nr2e1.  
Method: LongSAGE libraries from laser microdissected dorsal 
ventricular/subventricular zones of the telencephalon of wild-type (Wt) and 
Nr2e1-/- embryos at E13.5, E15.5 and E17.5 were analyzed using the 
DiscoverySpace system. Sequence tags exhibiting differential expression 
patterns between Wt vs Nr2e1-/- were mapped to the corresponding gene. 
The list of differentially regulated genes was assessed with the oPOSSUM 
promoter analysis system. Genes containing predicted Nr2e1 binding sites 
were subjected to a gene ontology (GO) term enrichment analysis using the 
DAVID service. Expression levels of genes annotated with the most 
relevant enriched GO terms were studied by quantitative reverse 
transcriptase PCR (Q-RT-PCR) in Embryonic Stem Cells (ESCs) 
differentiated using a method of adherent-monoculture neurogenesis (Wt vs 
Nr2e1-/- ESCs). Wt and Nr2e1-/- ESCs targeted with specific luciferase 
constructs will be tested in the cell differentiation procedure to assess the 
function of specific Nr2e1-binding-site predictions.  
Results: 572 genes at E13.5, 647 genes at E15.5, and 380 genes at E17.5 
displayed significant differences in expression (p≤0.05). These correspond 
to 1,275 genes for the three time points, of which 774 contain putative 
Nr2e1-binding sites. 570 of those genes are annotated with enriched GO 
terms (p≤0.05 after correction). The most relevant enriched terms for Nr2e1 
function are “Cell division” (33 genes, p≤0.000), “Cell cycle” (59 genes, 
p≤0.003), “Nervous system development” (55 genes, p≤0.004), and 
“Neurogenesis” (35 genes, p≤0.031). Consistent with the literature, nestin 
tag counts were found to be lower by 7 fold in the Nr2e1-/- library in 
comparison to the Wt library at E13.5. Amongst the potential new targets 
discovered, Cntn2 and Hes6 were expressed consistently in both the SAGE 
data and the Q-RT-PCR of differentiating ESCs.  
Conclusion: Bioinformatic analysis of SAGE data may identify novel 
genes involved in fate specification of neural stem cells. 
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The generation of genetically modified mice is a laborious and lengthy 
process. We have recently developed a new technique to generate 
transgenic mice with a very high rate of success as compared to 
conventional transgenic technology. Spermatogonial stem cells (SSCs) in 
pre-pubescent animals were infected in vivo with recombinant lentiviruses 
expressing EGFP. Once the mice attained adulthood, they were mated with 
normal females and the progeny of this cross analyzed for the presence of 
the EGFP transgene. 60% of the first generation pups showed the presence 
of the transgene and EGFP was expressed in most tissues tested. The 
transgene was heritable as shown by mating experiments between two 
transgenic animals as well as between a normal animal and a transgenic 
animal. This technique has eliminated several of the low efficiency steps 
that are involved in the generation of transgenic mice such as implantation 
of the modified embryo and germline transmission. Further, we have 
developed vectors to generate knockdown animals as well as inducible 
constructs for overexpression and knockdown experiments. These results 
will be presented at the meeting. 
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Fetal growth during pregnancy is controlled by maternal nutrient 
availability and in turn, by placental capacity to deliver these nutrients to 
the fetus. Recently, the placenta has been shown to adapt morphologically 
and functionally during maternal undernutrition in the mouse to maintain 
fetal growth until close to term, despite its small size (Coan et al., 2009). 
The mechanism by which placental phenotype may be modulated in 
response to nutrient restriction is unknown. However, in part, these 
adaptations may involve the placental-specific isoform of the paternally 
expressed Igf2 gene (Igf2P0), a key regulator of placental growth and 
nutrient transfer capacity (Constancia et al., 2002, 2005). Thus, this study 
aimed to determine the role of the Igf2P0 isoform in the placental adaptive 
response to maternal calorie-restriction. Mice bearing wildtype (WT) or 
Igf2P0 deficient litters were fed either ad libitium (CT) or 80% of the CT 
intake (undernourished, UN) during pregnancy. In WT litters, UN reduced 
placental weight from D16 but fetal weight only on D19. It also increased 
amino acid transfer to the fetus per gram of WT placenta. This functional 
adaptation to UN failed to occur in the small, Igf2P0 deficient placenta 
which resulted in earlier onset of fetal growth restriction, evident on D16. 
The Igf2P0 fetuses were also more growth restricted by UN on D19 than 
WT pups. Thus, the imprinted placental-specific Igf2 isoform is required for 
placental adaptation to UN in mice, possibly via regulation of amino acid 
transporter genes. 
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DNA (5-cytosine) methylation functions as a major epigenetic mechanism 
that has essential roles for development, regulation of transcription, 
silencing of retroelements and reprogramming of the genome. Aberrations 
in DNA methylation are frequently associated with diseases such as cancer. 
Despite the immense importance of DNA methylation in mammalian cells, 
at present detection and quantification of this epigenetic mark in a 
genomewide scale remains difficult and time consuming. To address this 
problem, here, we have developed a convenient method to examine 
genomewide DNA methylation by enriching methyl DNA with a 
recombinant MBD domain (from murine Mbd1 protein), followed by 
comprehensive tiling array analysis of more than 16,000 CpG islands in the 
mouse genome (UCSC mm8, 2008). The recombinant MBD domain has 
high affinity for methylated CpG sites and captures robust amount of DNA 
that can be directly labeled with fluorescence dyes (Cy5) and applied to the 
microarray, without requiring laborious LM-PCR or IVT-mediated 
amplification steps, which could also contribute to reduction of 
amplification-related bias in the data. In addition, to interpret the raw data, 
we have developed a novel bioinformatics-based platform that is suitable 
for analyzing DNA methylation microarrays. Our method can successfully 
detect and quantify genomewide DNA methylation profiles for different 
types of cells such as stem (ES), stem-like (iPS: induced pluripotent), germ 
(sperm) and somatic (MEF, B cell, thymocytes) cells, exhibiting the 
sensitivity and dynamic range of this technique. Furthermore, our 
methylation studies are highly compatible with previously reported 
genomewide bisulfite-sequencing (RRBS) analyses, which demonstrate the 
reliability of this method. Taken together, we report that MBD domain 
mediated enrichment of methyl DNA followed by CpG island microarray 
could be a useful tool to analyze genomewide DNA methylation profiles, 
with possible future applications for screening and evaluation of genome 
reprogramming, such as, in iPS cells. 
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Given the importance in several cellular processes, including cell migration 
and proliferation, focal adhesion kinase (FAK) has attracted much interest 
on its role in physical and pathological relevance. The biological role of 
FAK is emerging to be elucidated due to the availability of genetic 
engineered mice, in particular the FAK floxed mice, by combining with and 
varied Cre mice, it allows us to examine the functionality of FAK in 
physiopathologic conditions which are precluded due to the embryonic 
lethality of the conventional FAK knockout. Taking advantage of the 
Cre/loxP driven FAK conditional knockout approach, we generated the 
K12-rtTA/tetO-Cre/ FAK f/Δ triple transgenic mice to specifically delete 
FAK in corneal epithelial cells (CE-FAK), which consequently resulted in 
an impairment of corneal epithelial wound healing compared with the 
control mice. The impaired wound healing in corneal epithelial cells 
predominantly occurred in the earlier stage of the healing process in 
contrast to the prominent delay of wound healing in the late stage in AKT1-
/- mice. Furthermore, the defect in the corneal epithelial wound healing of 
CE-FAK mice was reversed by infection/overexpression with adenovirus-
bearing wild type FAK but not Y397F or FRNK mutant. In agreement with 
the above in vivo result, we also demonstrated several analogous in vitro 
results using human corneal epithelial cells (HCECs), highlighting that 
increased FAK expression and activation are concurrently associated with 
the promotion of cell adhesion and migration toward collagen IV and EGF. 
These results indicate a pivotal role for FAK and its mediated signaling in 
response to corneal epithelial wound stimuli to promote its healing. In 
addition, via applying several pharmacological inhibitors, such as PP2 (an 
Src inhibitor), SP600125, and SB203580, we also found that Src and p38 
are potential downstream effectors of FAK-mediated wound healing in 
corneal epithelial cells in mice. Taken together, this study provides 
comprehensive data for an important role of FAK in corneal epithelial 
wound healing and underscores the need for FAK in physiopathological 
maintenance. 
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Stressors or stimulants induce epigenetic and genetic changes in unicellular 
and multicellular organisms. Some of these changes are inheritable by 
subsequent generation(s) via germ cells. It has been thought that such 
transmission is a copying of germline epigenetic and genetic codes to 
somatic cells during ontogeny, termed linear inheritance here. If so, the 
linear inheritance should be established in an early stage of ontogeny. To 
test this, we injected two stressors, CrCl3 or acidic saline, i.p. into male 
mice and monitored the DNA methylation as well as the homologous 
recombination of the rRNA repeats in sperm and at various developmental 
stages of their offspring. In contrast to the above assumption, we observed a 
nonlinear inheritance, evidenced by dissimilar paternally-mediated 
responses among day-8 embryos and three tissues of 6-week adult 
offspring. The nonlinear inheritance was resulting in part from unequal 
DNA methylation level and gene rearrangement among tissues, integrated 
in normal development and organogenesis. These were demonstrated by 
increased intralitter variances of the rRNA epigenetic and genetic marks 
during maturation as well as differences by direct comparisons among adult 
offspring tissues. This ontogeny-driven nonlinear rRNA epigenetic and 
genetic inheritance signifies that the genome is more dynamic than we 
thought. It may reshape our thinking of organismal evolution and disease 
processes. 
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Aim: Some cellular damages are inevitable in pronuclear microinjection. 
Among many factors causing the damages, we targeted calcium because it 
may enter cytoplasm through a gap which might be created between the 
outer surface of a micropipette piercing the cell membrane and the cell 
membrane surrounding the micropipette. In addition, the ultrasonic-range 
vibratory microinjection (VM) system, which we developed to facilitate 
pronuclear microinjection by providing a micropipette with longitudinal 
vibration, may allow more calcium entry because unintentional lateral 
vibration of the micropipette tip is inevitable. As the voltage applied to the 
vibrator becomes higher, the amplitude of lateral vibration as well as 
longitudinal vibration becomes larger. VM is more effective when the 
lateral vibration is slightly visible than when it is not. Therefore, effective 
VM may create a larger gap than the ordinary microinjection (OM). 
Methods: 1) Two types of 44-kHz VM were compared: higher-voltage 
(High VM) and lower-voltage (Low VM) types. The former had visible 
lateral vibration and the latter did not. 2) Fertilized eggs collected from 27 
BDF1 mice were immersed in 5 μM Fura-2 AM solution for 30 minutes. 
The intensities of fluorescent light (510 nm) emitted by exposing the eggs 
in HBSS to two excitation lights (340 nm and 380 nm) were measured, and 
ratios of the respective intensities were calculated. 3) The eggs were divided 
into 3 groups: OM group (N = 83), Low VM group (N = 59) and High VM 
group (N = 38). GFP gene was injected into a pronucleus in M2 medium, 
which contains 1.17 mM CaCl2, at a pressure of 30 hPa and at 26ºC. 4) 
After injection, the same procedures were repeated again to obtain the 
ratios. 5) In another experiment, 44-kHz VM at higher voltages and OM (N 
= 158 each) were compared in in-vitro embryonic development.  
Results: 1) The ratios of intensities in each group rose significantly after 
microinjection, but the changes in ratio were 1.116 in OM, 1.142 in Low 
VM and 1.133 in High VM. No statistically significant difference was 
observed between the three groups before or after injection. 2) In another 
experiment, VM resulted in slightly better embryonic development and 
quite a lower death rate (24.7% = 39/158 vs. 33.5% = 59/158; P = 0.083, χ2 
test). 
Conclusions: Pronuclear microinjection with or without vibration does not 
allow biologically significant calcium entry. The unintentional lateral 
vibration of the tip of a micropipette produced by the current version of VM 
system may be restricted when the tip pierces the zona pellucida and cell 
membrane. 
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The Pleiades Promoter Project (www.pleiades.org) is an international 
endeavour that integrates genome-wide bioinformatics, large-scale knock-in 
mouse production, and histological examination of expression patterns to 
develop MiniPromoters. These MiniPromoters (≤ 4 kb human regulatory 
sequence), and related tools, are designed to study and treat the brain by 
directed gene expression. Methods: Genes with brain expression patterns of 
interest are subjected to bioinformatic analysis to delineate candidate 
regulatory regions, which are then incorporated into a panel of compact 
human MiniPromoters to drive expression in brain regions and cell-types of 
interest. Using single-copy, homologous-recombination “knock-ins” in 
embryonic stem cells, each MiniPromoter reporter is integrated immediately 
5' of the Hprt locus in the mouse genome. MiniPromoter expression profiles 
are characterized using in vitro differentiation assays of the transgenic 
embryonic stem cells and by in vivo analysis following transgenic mouse 
production. Histological examination of adult brains, eyes, and spinal cords 
for reporter gene activity is coupled to co-staining with cell-type specific 
markers to define expression. Results: The Pleiades Promoter Project uses a 
high-throughput bioinformatically-driven approach to produce brain-
specific MiniPromoters. To date, 27 novel MiniPromoters have 
demonstrated positive brain expression (32% of constructs tested), greatly 
increasing the availability of brain promoters for new research initiatives. 
New promoters for the blood brain barrier (e.g. Ple34), proliferating 
neurons (e.g. Ple131), and glia (e.g. Ple185) may be particularly impactful. 
Conclusion: The publicly available Pleiades MiniPromoters are a key 
resource to facilitate research on brain function, development, and therapies. 
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Using the gene targeting approach, we generated a loxP-floxed-FoxN1 
(termed: fx) mouse model, in which the exons 5&6 (DNA binding domain) 
are flanked by loxPs. Crossing fx mice with ubiquitous- or K14-Cre 
transgenic (Tg) mice, we found that FoxN1 is required not only for prenatal 
(previous knowledge) but also crucially for postnatal epithelial homeostasis, 
because deletion of FoxN1 in prenatal (mediated by Cre from parents) alone 
could not, but deletion in prenatal and postnatal (via offspring-self Cre) 
could induce thymus and skin phenotypes. Crossing fx mice with 
ubiquitous-CreERT2 Tg mice, we found that decline of FoxN1 expression 
mediated by spontaneous leakage of CreERT2 causally speeded up thymic 
aging, and FoxN1 expression has an age-related haploinsufficient feature, 
because deletion of FoxN1 in one copy of FoxN1 gene also caused 
accelerated thymic involution with age. Deleting FoxN1 by different keratin 
promoter-driven Cre/CreERT, we found that the mice developed phenotypes 
in the skin and thymus with different degrees of severity. For example, 
deletion of FoxN1 mediated by K5-CreERT2 in the postnatal thymus 
(tamoxifen-induction) caused severe phenotype mainly in thymic medulla 
but also involving cortex, and deletion via K14-Cre, even in the prenatal 
thymus (at gemeline level) caused only a certain degree of phenotype, such 
as generation of thymic cysts, while the deletion via tamoxifen-induced 
K18-CreERT2 in the postnatal thymus did not cause any obvious defect. The 
results imply that FoxN1 role is associated with epithelial stem/progenitor 
cells because these keratin promoter types, such as K5 and K14, are active 
in epithelial stem/progenitor cells. Together, loxP-Cre/CreERT system lets 
us gain insights into new roles of FoxN1 gene in mouse model. 
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Mouse embryos lacking Wnt3 fail to gastrulate, lack a primitive streak, and 
in consequence, mesoderm and endoderm. Wnt3 is first expressed in the 
posterior visceral endoderm of E5.5 embryos and subsequently in the 
adjacent epiblast at E6.0. These observations led us to hypothesize that 
Wnt3 emanating from the posterior visceral endoderm is responsible for 
primitive streak formation and gastrulation in mouse embryos. To test this 
hypothesis we used TtrCre mice to generate mouse embryos lacking Wnt3 
specifically in the visceral endoderm, but retaining Wnt3 expression in the 
epiblast. Embryos with a visceral endoderm-specific knockout of Wnt3 
phenocopy the Wnt3 null mouse phenotype. They fail to gastrulate or 
express primitive streak markers. These experiments indicate that Wnt3 
function in the posterior visceral endoderm is essential for gastrulation in 
mice. To determine whether visceral endoderm-derived Wnt3 is sufficient to 
drive gastrulation in mouse embryos we generated mouse embryos lacking 
Wnt3 specifically in the epiblast, but retaining the expression of Wnt3 in the 
visceral endoderm. These embryos display delayed expression of primitive 
streak markers, show abnormal gastrulation and are resorbed at around 
E9.5, suggesting that Wnt3 signaling from the visceral endoderm partially 
rescues the absence of Wnt3 in the epiblast. Finally, to investigate whether 
Wnt3 signals through the canonical Wnt pathway we generated Wnt3 null 
embryos carrying a copy of the BatGal transgene, a canonical Wnt pathway 
marker. Wnt3 null/ BatGal heterozygous embryos fail to express β-
galactosidase, indicating that Wnt3 acts through the canonical Wnt cascade. 
Taken together these data support the hypothesis that the posterior visceral 
endoderm acting trough Wnt3 functions as a signaling center for the 
formation of primitive streak in mouse embryos, in a similar manner to the 
Nieuwkoop center of amphibians. 
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Homeobox (Hox) genes encode an evolutionarily conserved family of 
transcription factors involved in numerous developmental pathways. Mouse 
Hoxa3 is expressed in neural crest derived mesenchymal cells of the pharyngeal 
pouches, and in the pharyngeal endoderm. Hoxa3 is required for the 
development of the third and fourth pharyngeal pouch-derived organs, 
formation of the cartilages of the throat and the hyoid bone, formation of the 
ninth and tenth cranial nerves, and in development of the soft palate. 
To determine when Hoxa3 is required in the formation of each of these 
structures, we are using a globally expressed inducible Cre recombinase to 
temporally knock out Hoxa3 during development. Twelve hours after 
recombination was induced, the Hoxa3 gene was efficiently deleted, while the 
mRNA was significantly reduced by 36 hours post-injection. Recombination 
was then induced in embryos at various time points between E9.5 and E11.5, 
and inspection at E13.5 indicated that Hoxa3 is required initially for the 
formation of the third pouch derived organs (E9.5), then for their separation 
from the pharynx (E10.5), and finally for their migration (E11). The thyroid and 
ultimobranchial bodies formed and migrated normally. Skeleton preparations of 
E18.5 embryos in which recombination was induced at time points between 
E8.5 and E12.5 indicated that Hoxa3 plays a very early role in the formation of 
the hyoid bone and thyroid cartilage. 
In mice in which Hoxa3 is knocked out in the neural crest cells using Wnt1-Cre, 
the posterior throat cartilages, cranial nerves, and secondary palate are similar to 
the Hoxa3 null phenotype. These structures are neural crest cell derived, 
indicating that the phenotypes result from a cell-autonomous neural crest cell 
defect. However, the lesser horn of the hyoid is not deleted as in the Hoxa3 null, 
but is reduced, indicating that its formation may also depend on another cell 
type, such as the endoderm. The endoderm-derived thymus and parathyroid 
organs are also affected in the NCC-specific Hoxa3 deleted embryo, indicating 
that the neural crest cells have a specific role in their formation. The thymus 
was ectopic, and remained persistently attached to the pharynx, while the 
parathyroids showed delayed separation from the thymus. 
We also tested whether Hoxa3 is required in the thymus and parathyroid after 
their initial organogenesis. Deletion in the thymus using Foxn1-Cre resulted in 
mild hypoplasia but no other detectable defects. Deletion specifically in the 
parathyroid gland using PTH-Cre revealed a role for Hoxa3 in maintaining 
parathyroid development. 
Together, these experiments show that Hoxa3 function is required in different 
cell types and at multiple times during pharyngeal region development. 
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Retinal ischemia and subsequent neovascularization is a common 
pathogenic process in several leading causes of disabilities including 
diabetic retinopathy, retinopathy of prematurity, vascular occlusive disease, 
macular degeneration, and ocular cancer. Yet, the lack of an animal model 
with proliferative retinal angiogenesis has prevented advances in therapy 
and identification of the underlying molecular mechanisms. Currently 
available retinopathy models including non-human primates do not develop 
preretinal neovascularization and only display mild non-proliferative 
disease within the lifespan of diabetic animals. Hypoxia inducible factor 
(HIF) is a transcription factor and universal sensor for tissue ischemia, but 
over expression of HIF in transgenic models have thus far failed to 
recapitulate human retinal diseases. Using a novel strategy to regulate HIF 
signaling, we reproduced retinal neovascularization in a model with broad 
relevance and translational potential for a number of blinding diseases. 
Methods and Findings. In this study, we identified HIF expression in 
neovascular retinal tissue of humans with mutation of the tumor suppressor 
Von Hippel Lindau (VHL) gene. This suggested that similar regulation of 
HIF in transgenic mice might better reproduce the key features of human 
ischemic retinal disease. A Vhl knockout mouse was created and found to 
stably activate HIF protein, while HIF was not stably expressed in control 
littermates. The Vhl -/- mouse also showed expression of various HIF 
transcriptional targets, such as nitric oxide synthase (NOS). The most 
striking feature of the Vhl-/- mutants was the development of proliferative 
angiogenic disease in a similar sequence to humans with ischemic 
retinopathy. Over the course of a week, there was formation of ischemic 
retinal areas, progressive retinal capillary loss, retinal neovascularization, 
vitreous hemorrhage, iris neovascularization, and retinal detachment. 
Conclusions. We have developed a new mouse model for the study of 
human ischemic retinal diseases by constitutive down regulation of HIF1 
regulator, VHL. Rapid progression of retinopathy in these mutants will 
expedite the evaluation of therapeutic agents for this group of blinding 
disorders. 
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Several large-scale gene targeting and gene trapping projects are 
participating in the International Knockout Mouse Consortium to mutate 
each protein coding gene. Major ongoing pipelines include the EUropean 
COnditional Mouse Mutagenesis program (EUCOMM) and the KnockOut 
Mouse Project (KOMP). The goal of the KOMP project is to generate over 
5000 targeted conditional and over 3500 targeted deletion alleles in ES cells 
or mice. The Genome Center at Washington University in St. Louis is a 
core contributor to KOMP, providing annotation of targeted genes, 
construct design, and validation. We present here project methods, 
interfaces, and progress notes. Genes are manually annotated according to 
HAVANA (Wellcome Trust Sanger Institute) standards using the Otterlace 
software package. Target exons are selected based on exon phase, exon and 
intron size, protein domain structure, distribution of repetitive elements, and 
any overlapping gene structure. Since manual gene annotation is more 
complex and limits the rate of knockout design, an initial process has been 
devised to hasten designs into the pipeline based on detailed examination of 
transcript data supporting target genes via the EnsEMBL and UCSC 
genome browsers. For these loci, final verification via manual annotation is 
prioritized depending on successful pipeline status. Since beginning the 
project, Washington University scientists have annotated 1500 genes, 
completed 600 manual designs, and validated 900 designs, with a further 
2300 annotations, 1500 designs, and 4000 validations remaining. While the 
wet lab phase of KOMP is due to end in late 2011, we anticipate completion 
of the validation process one year later. 
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CHD5 is a predicted chromatin remodeling protein of the SWI/SNF 
superfamily that is robustly expressed in neuronal tissues such as the brain. 
We previously identified CHD5 as a tumor suppressor mapping to human 
1p36, a region of the genome that is frequently deleted in neuroblastoma. 
Although a number of chromatin remodeling proteins have been shown to 
modulate brain function, whether CHD5 performs a similar role is 
unknown. Here we investigate the hypothesis that CHD5 functions in the 
brain. We found that Chd5 is expressed in the nucleus starting at embryonic 
day 13, and maintains its expression postnatally and into adulthood. The 
expression of CHD5 starts during neuronal differentiation and is 
particularly robust in post-mitotic differentiated neurons. Generation of 
Chd5 deficient mice revealed that while homozygotes are viable, they have 
unique behavioral phenotypes such as compulsive-repetitive behavior. We 
are currently looking for altered neuronal pathways in the Chd5 deficient 
brain and to date we have determine that expression of components in 
serotonergic neurons is altered in Chd5 deficient mice. We are currently 
conducting genome-wide gene expression microarray analysis to thoroughly 
examine what other neuronal pathways are altered in the Chd5 deficient 
brain. These findings reveal a role for CHD5 in neuronal function in vivo. 
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The visceral endoderm, an epithelial tissue, appears at a very early stage of 
embryogenesis. This single cell-layered tissue sustains embryonic growth 
through nutrients/gas exchange, and participates in the axis determination of 
pregastrulation embryos by orchestrating various signaling cascades. Both 
nutritional and signaling functions rely upon the endocytosis of various 
molecules from the cell surface through the endocytic pathway. Here, we 
focused on the endocytic dynamics in the visceral endoderm of mouse 
embryos. The apical vacuoles, whose limiting membranes were positive for 
lamp2 and syntaxin-7, accumulated cathepsin B and immunoglobulins, 
indicating that apical vacuoles are equivalent to lysosomes.  
The assembly of this large digestive compartment requires the function of 
phosphoinosityde 3-phosphate signaling, and the small GTP binding protein 
rab7. Loss of these functions resulted in severe alteration in the 
morphology, dysfunction of endocytic pathway and simultaneously, caused 
defective embryogenesis at the peri-gastrulation stages.  
Delivery of endosomes to the apical vacuoles involves unique, 
microautophagy-like process. Fluorescent endocytic markers were 
internalized from the cell surface and delivered to endosomes, which were 
then engulfed by the apical vacuoles. The mixing of endosomal and 
lysosomal contents required lipase activity, indicating that the limiting 
membranes needed to be disintegrated during this process. These results 
revealed a unique membrane dynamics in the visceral endoderm, i. e., 
endosomes are delivered to lysosome-like apical vacuoles through a 
microautophagic process. 
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The mouse prostate gland can undergo serial rounds of regression and 
regeneration in response to deprivation and restoration of testicular 
androgens. Therefore, the prostate epithelium of castrated mice is likely to 
contain a resident pool of castration-resistant stem cells that is responsible 
for driving prostate regeneration. Previous literature has suggested that this 
stem cell pool is likely to reside within the basal epithelial layer, based on 
tissue reconstitution analyses in renal grafts. However, lineage-marking 
studies from our laboratory have identified a luminal stem cell population 
that we identified as castration-resistant Nkx3.1-expressing cells (CARNs) 
(X. Wang et al. (2009) Nature 461: 495-500). Therefore, we have been 
interested in using analogous lineage-marking approaches to explore the 
potential stem cell properties of prostate basal cells. 
 
In our studies, we have utilized CK5-CreERT2 transgenic mice to perform 
lineage analysis by inducible marking of basal cells in the regressed prostate 
epithelium with YFP, followed by analysis of their behaviors during 
androgen-mediated prostate regeneration. Our preliminary results suggests 
that basal cells may not behave as stem cells that drive prostate regeneration 
in vivo, since they are extremely inefficient in generating luminal cells. 
Moreover, basal cells do not proliferate extensively during prostate 
regeneration relative to luminal cells. We will present our ongoing lineage-
marking studies of basal cells in the hormonally-intact and regenerating 
prostate epithelium, and their possible implications for the cell of origin for 
prostate cancer. 
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INTRODUCTION: Specialized retinal cells called the retinal pigment 
epithelium (RPE) maintain vision. Death of these cells lead to degeneration 
of the retina, vision loss, inability to perform daily tasks, and even 
depression in many individuals with retinitis pigmentosa (RP) and macular 
degenerations. Nearly 20% of Americans between the ages of 65 and 75 
years are expected to experience RPE loss due to macular degenerations, 
and its incidence is expected to double by year 2020. A major obstacle to 
restoring vision by cell therapy is the availability of cadaver RPE donors for 
transplantation. Our central hypothesis is that RPE cells derived from 
embryonic stem (ES) cells can be used to successfully replace diseased 
counterparts.  
 
METHODS: The mouse C57BL/6J-Tyrc-2j/J (C2J) ES cells were labeled 
with a yellow fluorescent protein (YFP) and made into the RPE cells of the 
eye in culture. To prove that these were RPE-like cells, specific gene 
markers for the development of RPE were shown to be present in these 
cells. After becoming RPE-like cells, the cells were transplanted into the 
eyes of the retinitis pigmentosa mouse model at 5 days after birth of the 
mouse. Imaging of live mice after transplantation by looking for the yellow 
fluorescence determined that the cells survived the transplantation process. 
Electroretinogram tests that determine visual function were performed on 
the mice to evaluate their vision and see if it had been restored.  
 
RESULTS: The ES cells that have become RPE-like cells expressed the 
correct markers for being RPE cells. After transplantation, the stem cells 
were imaged in the eyes of the mice for as long as 7 months. The mice that 
underwent the transplantation procedure showed a significant gain in vision 
over the 7-month period, while those that were injected with saline and 
other control groups did not show any restoration of visual function.  
 
CONCLUSIONS: For the first time, congenic embryonic stem (ES) cells 
were successfully used to replace diseased retinal cells and restore nervous 
system function in a mouse model of retinitis pigmentosa; a strategy to treat 
millions of humans with age-related macular degeneration and other forms 
of retinal disease, such as retinitis pigmentosa. 
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Rising rates of obesity and the obesity-related conditions that make up 
metabolic syndrome are a major detriment to global health. As more and 
more work is done to better clarify and understand the complex 
combination of factors affecting obesity and metabolic syndrome, proteins 
are characterized, the elucidation of which may lead to the discovery of 
therapies for these conditions. Matrix metalloproteinases (MMPs) make up 
a family of more than 25 enzymes involved in the remodeling of the 
extracellular environment. In an effort to determine the relevance of 
MMP14 on body composition and metabolism as related to the 
development of obesity, we characterized the phenotype of C57BL/6 mice 
with a targeted mutation in Mmp14 (Mmp14+/-) compared with C57BL/6 
wild-type control (Mmp14+/+) mice. Heterozygous mice exhibited resistance 
to diet-induced weight-gain, demonstrated by comparatively lower percent 
body-fat, total tissue mass, and fat mass following a high fat diet. 
Additionally the heterozygous mice simultaneously demonstrated similar 
tissue area and percent lean mass to the wild-type mice, corresponding with 
an overall resistance to increase in body-mass composition. Therefore loss 
of one Mmp14 allele is shown not to affect lean mass or tissue area, and 
thus due to a concurrent increase in fat we demonstrate here that 
heterozygous mice exhibit a change in overall body mass composition when 
fed a high fat diet. 
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Lens development has been an attractive model for studies of cell lineage 
specification and terminal differentiation. Lens fiber cell differentiation is 
characterized by high levels of expression and accumulation of water-
soluble proteins, crystallins. Lens development is controlled by a relatively 
small group of transcription factors including AP-2α, c-Maf, Foxe3, Hsf4, 
Pax6, Prox1, Six3, Sox1 and Sox11. Studies of crystallin gene regulation in 
mouse revealed key roles of Pax6 and c-Maf. In addition, genetic and 
molecular biology data suggest cross-regulation between these genes. 
Herein, ChIP-on-chip studies in lens chromatin identified c-Maf locus as a 
potential direct target of Pax6. We have now identified several evolutionary 
conserved regions in c-Maf locus as potential regulatory regions. A 1.3 kb 
promoter was not sufficient for expression of the EGFP reporter in 
transgenic mouse lens. In contrast, a 1.6 kb 5’-upstream region, CR1 
(conserved regions 1), in combination with the c-Maf promoter was capable 
to elicit expression of EGFP reporter in lens as early as E10.5. Using 
EMSAs, at least five Pax6-binding sites were identified in c-Maf locus. 
Interestingly, two c-Maf BAC transgenic reporter did not support the EGFP 
expression in developing lens, suggesting additional levels of complexity of 
gene regulation of c-Maf locus. The ongoing studies are aimed to identify 
additional enhancers and to determine their properties in regulation of c-
Maf expression in lens development. Finally, we are also testing a 
hypothesis that FGF signaling directly regulates expression of c-Maf during 
the onset of primary lens fiber cell differentiation. 
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The Mouse Genome Informatics Resource 
(http://www.informatics.jax.org/) provides integrated genetic, genomic and 
phenotypic information about the laboratory mouse to facilitate the use of 
mouse models for studying human disease. Users can navigate the web site 
using query and browsing methods or access data using our web services 
and batch querying tools. MGI phenotypic data describe effects of 
spontaneous, induced, and genetically engineered mutations (targeted 
knockouts and conditionals, transgenics, Cre-constructs, targeted reporters, 
gene traps, transposon-induced mutations, etc.) in the context of their strain-
specific genetic background. Over 189,000 phenotype annotations have 
been made using the Mammalian Phenotype Ontology to describe 
genotypes carrying over 36,100 different mutant alleles in nearly 13,000 
genes. More than 3,100 mouse genotypes are annotated as models for over 
1,000 human diseases found in OMIM (Online Mendelian Inheritance in 
Man, http://www.ncbi.nlm.nih.gov/omim). Allele and phenotype data are 
integrated in MGI with data on gene characteristics, expression, function 
(GO), genomic sequences, and strain characteristics, including SNPs and 
trait polymorphisms (QTL). Sophisticated query functions take advantage 
of this high level of integration to permit users to (1) locate mutants in a 
particular gene and identify any associated disease models, (2) find 
mutations in all genes that show a specific phenotype, (3) locate genotypes 
that show multiple phenotypes or multiple diseases, (4) locate relevant 
mouse models for a specific human disease/syndrome, and (5) find mutant 
alleles and phenotypes in a specific genome region of interest.  
 
Supported by NIH grant HG000330.  
 110 
INVOLVEMENT OF THE TUMOR SUPPRESSOR GENE RECK IN 
LIMB PATTERNING 
 
Mako Yamamoto1, Tomoko Matsuzaki1, Rei Takahashi2, Eijirou Adachi3, 
Hiroshi Kiyonari4, Naoko Oshima4, Sachiyo Yamaguchi1, Hitoshi 
Kitayama1, Yoko Morioka1, Shigeyoshi Itohara5, Takashi Nakamura6, 
Haruhiko Akiyama6, Makoto Noda1  
 
1Kyoto University Graduate School of Medicine, Department of Molecular 
Oncology, Kyoto, 606-8501, Japan, 2Faculty of Pharmaceutical Sciences, 
Doshisha Women’s College of Liberal Arts, Department of 
Pharmacotherapeutics, Kyotanabe, Kyoto, 610-0395, Japan, 3Kitasato 
University Graduate School of Medical Science, Department of Matrix 
Biology and Regenerative Medicine, Sagamihara, Kanagawa, 252-0373, 
Japan, 4RIKEN Center for Developmental Biology, Laboratory for Animal 
Resources and Genetic Engineering, Kobe, Hyogo, 650-0047, Japan, 
5RIKEN Brain Science Institute, Laboratory for Behavioral Genetics, 
Wako, Saitama, 351-0198, Japan, 6Kyoto University Graduate School of 
Medicine, Department of Orthopaedic and Musculoskeletal Surgery, Kyoto, 
606-8501, Japan 
 
The membrane-anchored metalloprotease regulator RECK is down-
regulated in various types of human cancers, and forced expression of 
RECK in cancer cells results in suppression of tumor angiogenesis, 
invasion, and metastasis, suggesting its role as a tumor suppressor. On the 
other hand, Reck-deficient (Reck-/-) mice die around mid-gestation with 
multiple defects, including arrested vascular development [1] and 
precocious neuronal differentiation [2], suggesting its importance in 
mammalian development. In the present study, we analyzed the phenotype 
of hypomorphic and conditional Reck mutant mice to gain more insights 
into the mechanisms of its actions during mammalian development. The 
hypomorphic Reck mutant mice (Recklow/-) are largely intact, but they show 
some limb abnormalities including cutaneous horns (i.e., hyperkeratosis) on 
the dorsal side of extremities, round and porous fingertip bones, and the loss 
of skeletal elements on the posterior side of forelimbs. Most of these 
abnormalities could be attributed to the reduced Reck expression in limb 
mesenchyme, since the tissue-specific knockout (Reckflox/-; PrxI-Cre) mice 
recapitulate the phenotype. Whole-mount in situ hybridization indicated the 
initial formation and subsequent attenuation of the Shh-Fgf positive feed-
back loop in the mutant mice, implicating Reck in the maintenance of the 
zone of polarizing activity (ZPA) required for proper anterior-posterior limb 
patterning.  
 
References  
[1] Oh et al. Cell 107, 789-800 (2001)  
[2] Muraguchi et al. Nature Neurosci. 10, 838-845 (2007) 
 111 
AURORA A KINASE (AURA) IS ESSENTIAL FOR EPIBLAST 
GROWTH AND SURVIVAL 
 
Yeonsoo Yoon1, Dale O Cowley2, Terry A Van Dyke3, Jaime A Rivera-
Perez1  
 
1University of Massachusetts, Department of Cell Biology, Worcester, MA, 
01655, 2TransViragen, Inc, Research Triangle Park, NC, 27709, 3National 
Cancer Institute, Mouse Cancer Genetics Program, Frederick, MD, 21702 
 
Aurora A (AurA) is a member of the mitotic serine/threonine kinase family, 
involved in centrosome maturation and spindle assembly during cell 
division cycle. Mutations of AurA are known to result in mitotic arrest due 
to defects in centrosome separation and chromosome segregation. A recent 
report showed that a knockout of AurA leads to embryonic lethality at the 
blastocyst stage with cell proliferation failure, mitotic arrest, and monopolar 
spindle formation. To examine the function of AurA in post-implantation 
mouse embryos, we generated epiblast-specific AurA knockout embryos 
using Sox2Cre-mediated genetic recombination. We observed that an 
epiblast-specific AurA knockout causes epiblast growth inhibition and 
epiblast-specific cellular death through apoptosis in gastrula stage embryos 
and leads to resorption of embryos at around E9.5. We also found that 
despite a reduction in the size of the epiblast at E6.5 an epiblast-specific 
AurA knockout does not affect the axial polarity of mutant embryos, which 
showed normal anterior visceral endoderm (AVE) movement and 
expression of Brachyury, a primitive streak marker in the posterior region. 
The fact that epiblast cells are ablated in epiblast-specific AurA knockout 
embryos demonstrates that AurA is essential for epiblast survival and 
further embryogenesis and provides an alternative way to induce tissue-
specific cellular ablation. 
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Wilms tumor (WT) is one of the most common pediatric solid cancers and 
is believed to arise from the abnormal proliferation and differentiation of 
the metanephric blastema in the developing kidney. We have shown 
previously that activation of STAT1 contributes to the pathogenesis of 
Wilms tumor and induces proliferation while inhibiting differentiation of 
renal progenitor cells. However, the role of STAT1 in maintaining the 
undifferentiated state of metanephric mesenchymal progenitor cells remains 
unclear. Here we present that STAT1 activation through conditional ectopic 
expression of interferon (IFN)-gamma in metanephric mesenchymal 
progenitor cells results in renal hypoplasia in the developing mouse embryo. 
The kidney size of mutant embryos was reduced to about half that of normal 
control embryos despite comparable rates of proliferation and apoptosis. 
Kidney development was retarded showing slower outgrowth of the bud 
and reduced branching in IFN-gamma knock-in embryos. There was no 
great difference in the expression of molecules such as Six1, Eya1, Pax2, 
and Pax8, which are involved in early kidney development,while the 
expression domain for nephron progenitor marker Six2 appeared to be 
reduced. These data are consistent with our explant culture studies and 
suggest that in vivo STAT1 activation also inhibits the differentiation of 
normal renal progenitor cells and thus causes retardation of kidney 
development. 
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The spatial organization of chromatin in the nucleus is critical for the 
regulation of gene expression. Distant regulatory elements have been shown 
to influence gene function via long-range chromatin interactions. However, 
the global genomic architecture directly associated with transcription 
network has not yet been revealed. In this study, we depict the dynamic 
transcription interactomes mediated by RNA polymerase II with the newly 
developed Chromatin Interaction Analysis by Pair End diTag (ChIA-PET) 
to define the chromatin organizations pertinent to transcription regulation 
and epigenetic control in various mouse cells of progressing defined 
developmental lineages. In ChIA-PET analysis, tethered DNA by factor 
specific immunoprecipitated chromatins were joined in together by linker 
ligation. The ligated DNA was analyzed by pair end ditag based sequencing 
to reveal the long range interactions. With nearly saturated PET sequencing, 
thousands of cis- and trans- interactions tethered by RNA Pol II are defined 
and modes of transcription coordinated regulation are revealed. Integrated 
with global transcription expression changes, promoter activities, gene 
activities and major epigenomic features, spatial distribution and temporal 
regulation of transcription networks are defined. Such transcriptional 
inteactomes in the context of cells of differential developmental potential 
offer insights on how genes coordinate function as a cluster and uncover the 
developmental architecture that establishes and maintains the nucleus 
function of mammalian genomes. 
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The molecular mechanisms that govern embryo stem cell pluripotency, self-
renewal, and lineage-specific differentiation have only been partially 
elucidated. Mouse Epiblast Stem Cells (EpiSC) are derived from the early 
post-implantation embryo and share many similarities with human 
embryonic stem cells. In our studies, we are seeking to identify novel 
master regulators of EpiSC pluripotency and self-renewal, which may also 
provide novel insights into induced pluripotency and the reprogramming 
process. For this purpose, we are constructing the first genome-wide 
molecular interaction map (interactome) for mouse EpiSC, to identify the 
regulatory relationships among gene products. 
 
To assemble a mouse EpiSC interactome, we are using novel bioinformatics 
algorithms, applying them to expression profiling data gathered from EpiSC 
undergoing a wide range of differentiation events. Direct interactions 
among gene products, both transcriptional and post-translational, will be 
inferred de novo using experimentally validated reverse-engineering 
algorithms, such as ARACNe and MINDy. This makes the approach 
unbiased, ensuring the fidelity of the interactomes constructed. Master 
regulators will be inferred by interrogating the interactome using the 
MARINa algorithm. Our preliminary data shows that whole-genome gene 
profiling accurately depicts the differential regulatory responses to different 
chemical inducers of differentiation. We will report on our progress towards 
the assembly of a draft EpiSC interactome. 
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The ability to produce coordinated and productive movement is dependent 
on an orderly flow of neural commands through the spinal cord that 
ultimately lead to contractions of specific muscle groups. A key part of this 
circuitry is the connectivity between spinal motor neurons and muscles. 
During embryonic development distinct subclasses of motor neurons are 
specified within the ventral spinal cord. Each motor neuron subclass 
encodes a unique repertoire of receptor systems that are sensitive detectors 
of environmental cues. These signaling systems modulate the assembly and 
disassembly of cytoskeletal components involved in axon growth and 
turning. Motor neurons share guidance receptors such as CXCR4, FgfR, 
EphA, EphB, DCC, Robo, and Npn with many other neuronal types. Thus, 
one challenge in the field of axon guidance has been to understand how the 
vast complexity of brain connections can be established with a relatively 
small number of factors. In the context of motor guidance, we have taken a 
genetic approach to dissect the signaling systems required for axon 
navigation to better understand the temporal and spatial mechanisms used to 
optimize the fidelity of pathfinding and increase the functional diversity of 
the signaling proteins. I will describe our findings that show membrane-
proteases are critical modulators of the output signals from guidance 
receptors. 
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The importance of Hox genes in specifying the diverse neuronal fates in the 
spinal cord has long been recognized. Yet the nature of the transcriptional 
controls that generate the partially overlapping expression domains required 
for these specifications remain largely unknown. Here, we report that the 
correspondence between the physical order of Hoxd genes and their rostral 
limits of expression (spatial colinearity), while respected in the developing 
spinal cord, does not display a fully progressive, staggered distribution. 
Instead, two major anterior-posterior boundaries are detected, coinciding 
with the functional sub-divison of the spinal cord at the positions of the 
brachial and the lumbo-sacral plexii. Interestingly, tiling array-based 
transcriptome analysis reveals that these two domains of Hoxd gene 
expression are regulated as part of two distinct blocks of transcription, 
established independently from one another. Whenever targeted deletions 
abolish the boundary between the two transcriptional blocks in vivo, 
posterior genes are mis-regulated and become expressed ectopically, at the 
expense of anterior, non-coding transcripts. We further evaluated the 
regulatory potential of each gene locus by constructing a series of lacZ-
reporter transgenes covering the entire HoxD complex. The transcriptional 
profile of these transgenes is now being investigated on tiling arrays, by 
crossing them over the respective gene-specific deletions. 
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Autism is a neurocognitive disorder characterized by clinical features 
including repetitive behaviors, restricted interests, language impairment, 
and altered social interactions. Although chromosome rearrangements 
affecting specific genomic intervals have been found in patients with 
autism, the basis for this syndrome is unknown. Here we used chromosome 
engineering to generate a mouse model with deletion of the region of the 
genome corresponding to 16p11.2—a genomic lesion associated with 
autism in humans—as well as a model harboring a duplication of this 
region. Mice with altered dosage of this 34-gene region have unique 
phenotypes, with mice heterozygous for its deletion having 
neuroanatomical, physiological, and behavioral phenotypes reminiscent of 
clinical features of autism. This provides the first functional evidence that 
compromised dosage of 16p11.2 is causal in autism, providing new insight 
into this syndrome.  
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Cancer is a disease of genetic mosaicism. “Mosaicism” as a genetic term 
describes the phenomenon that cells within a multi-cellular organism harbor 
distinct genetic makeups. In the case of cancer, it refers to distinct 
genotypes in cancerous cells from normal ones in the same individual. 
Cancerous mosaicism in human is often initiated by the loss of tumor 
suppressor genes in as few as a single cell, which then evolves through 
further gene mutations and interactions with its stromal niche to develop 
into malignant tumors. 
To study the cancerous process in vivo, a genetic mosaic animal model 
should be ideal. Previously, Drosophila geneticists have developed a 
powerful mosaic system to address these problems. Many elegant and 
otherwise unachievable studies have been carried out with the mosaic 
system, such as mutant-WT cell competition behavior, recessive genetic 
screening for tumor suppressor genes or metastasis-promoting genes. Based 
on a similar design principle to the Drosophila system, we established a 
mouse genetic mosaic system termed MADM (Mosaic Analysis with 
Double Markers) [Zong et al 2005 Cell]. Through Cre-loxP mediated inter-
chromosomal mitotic recombination, the MADM system can generate 
homozygous mutant cells that are unequivocally labeled by green 
fluorescent protein (GFP) and their sibling WT cells labeled by red 
fluorescent protein (RFP) within a heterozygous colorless mouse. Due to 
the low probability of the recombination between chromosomes, mutant 
cells generated by MADM are very sparse (0.1-1% or much lower), closely 
mimicking clonal initiation of human tumors. With the permanent GFP-
labeling, progeny of mutant cells can be studied along each and every 
lineages for their tumorigenic potentials. Last but not least, the RFP-labeled 
WT sibling cells provide an excellent internal control for in vivo phenotypic 
analysis. Here I will present our recent work in glioma modeling with the 
MADM system, which revealed the involvement of a specific glial cell 
lineage in gliomagenesis. Finally, it is important to point out that MADM 
can be applied to study other diseases and normal development for in-depth 
mechanistic studies. 
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Many medulloblastomas, the most frequent malignant brain tumors in 
children, originate from cerebellar granule neuron precursors (GNPs) 
following mutations in genes that normally regulate pathways involved in 
neuronal differentiation. One of these pathways is regulated by sonic 
hedghehog (Shh), a secreted molecule that controls many processes in the 
developing embryos. In the post-natal cerebellum, Shh stimulates the 
proliferation of GNPs and inhibits neuronal differentiation. Gain-of function 
mutations in genes that code for proteins involved in Shh signaling result in 
a dramatic increase in the proliferation of GNPs and can lead to 
medulloblastoma formation both in humans and in mice. Due to its central 
role normal development and in tumorigenesis, it is crucial to understand 
how the Shh signaling is regulated at the molecular level. 
We have recently described that the transcription factor Atonal homolog 1 
(Atoh1) regulates the expression of Gli2, the main transcriptional effector of 
the Shh signaling pathway. Atoh1 is thus required for the transduction of 
the signaling of Shh and its deletion is sufficient to prevent the formation of 
Shh-induced medulloblastomas. We have now extended our studies to 
identify the target genes of Atoh1 in the developing cerebellum. Using a 
combination of transcriptional profiling and in vivo molecular biology, we 
generated an extensive list of genes that are directly regulated by Atoh1. 
Strikingly, we observed that Atoh1 activates the expression of numerous 
genes that are involved in the Shh signaling pathway, suggesting that Atoh1 
plays a role of “master regulator” in the control of GNP proliferation. 
Our data place Atoh1 at the core of cell proliferation regulation in the 
developing cerebellum making it an attractive target for the development of 
therapies aimed at the inhibition of malignant cell proliferation in 
medulloblastomas. 
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The neurons that comprise each neural circuit have a specific spatial, or 
topographical organization that is optimized both for the functioning of 
individual circuits, as well as to allow diverse circuits to interact with 
precision. How neurons become organized in 3D during development is a 
critical unanswered question. The cerebellum, which coordinates fine motor 
control, is an excellent system for studying this question, as neurons that 
carry out related functions project afferent axons into the cerebellum to 
distinct positions along the anterior-posterior (AP) and medial-lateral (ML) 
axes. Furthermore, the distribution of afferents reflects the intrinsic 
organization of the cerebellum along the AP axis into morphological 
lobules and in the ML axis into stripes of gene expression. The Engrailed 
(En) homeobox transcription factors have provided a genetic entry point for 
studying the relationship between intrinsic patterns within the cerebellum 
and afferent organization. By analyzing a series of temporal and cell type 
specific conditional En1/2 mutants we uncovered that the two genes play 
key roles in patterning striped gene expression and foliation, as well as the 
precise targeting of afferents to distinct lobules and their subsequent 
resolution into discrete medial-lateral bands. Moreover, each En gene 
coordinately regulates afferent targeting and patterning of gene expression 
independent of regulating foliation. En1/2 are therefore master regulators of 
3D organization of the cerebellum. Furthermore, construction of complex 
neural circuits involves transcription factors acting at a pivotal point to 
direct both path finding of afferent projections and developmental processes 
that generate the correct numbers of each cell type within the target field.  
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Extensive epigenetic reprogramming occurs during cloning and in the 
induction of pluripotent stem cells (IPS). Similarly, during normal germline 
transmission, the epigenetic state of the genome is known to undergo 
extensive reprogramming both in the gametes and in the early embryo. This 
reprogramming may be essential to re-establish a developmental ground 
state between generations, but the mechanism of these epigenetic 
reprogramming events remains poorly understood. We show that mutants in 
spr-5, the C. elegans ortholog of the histone demethylase LSD1/KDM1 
exhibit progressive sterility over many generations due to the 
transgenerational accumulation of the histone modification dimethylation of 
histone H3 on lysine 4 (H3K4me2). This suggests that H3K4me2 can serve 
as a stable epigenetic memory and that erasure of H3K4me2 by KDM1 in 
the germline prevents the inappropriate transmission of this epigenetic 
memory from one generation to the next. To pursue this role further, we 
generated mice with germline mutations in KDM1. Progeny from mice that 
lack maternal KDM1 exhibit significant embryonic and perinatal lethality. 
These progeny are genotypically normal, suggesting that the defects are due 
to the stable transmission of inappropriate histone methylation in the 
embryo. Furthermore, deletion of KDM1 in the mouse testis results in 
sterility, with loss of the testis stem cell population. These data suggest that 
KDM1 may be required both to maintain stem cell populations, as well as to 
restore totipotency after fertilization. In addition, KDM1 demethylation 
may be required for the somatic reprogramming that is induced during the 
generation of IPS cells. 
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To preserve homeostasis during entire life, stem cells resist premature 
differentiation and senescence, and maintain self-renewing cycle. The 
stemness is regulated by two different mechanisms, cell-intrinsic regulation 
and exogenous signals from microenvironments. In order to gain insights 
into the cell-intrinsic mechanism, we focused on analysis of epigenetic 
properties of adult tissue-specific stem cells in testes. Testicular germ cells 
connect each other after cell division so that the number of chains reflects 
their cell division history. We initially expected the existence of A single 
(As)-spermatogonia specific chromatin modification, since it is widely 
accepted that only As-spermatogonia acts as a stem cell and produces 
progenies called A paired (Apr) and A aligned (Aal) spermatogonia that are 
believed to be no longer capable of self-renewal. In this study, we found 
that spermatogonia from As to Aal-8 showed homogenous epigenetic 
profiles, lacking the expression of de novo DNA methyltransferases with 
global low cytosine methylation levels and the repressive histone 
modification, H3K9me2. These major repressive modifications were 
simultaneously integrated at the stage of Aal-16 spermatogonia when the 
cells started expressing Kit and completely lost stem cell activity. The 
artificial expression of Dnmt3b in Kit-negative spermatogonia induced the 
expression of progenitor marker, Kit, suggesting that premature 
differentiation might initiate. On the contrary, NP95-deficiency testes 
showed sever differentiation defects in testes at the transition from Kit-
negative to Kit-positive spermatogonia, suggesting that de novo DNA 
methylation is crucial for the transition to progenitor cells. 
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Repression of Xist RNA expression is considered a prerequisite to reversing 
X-chromosome inactivation (XCI) in the mouse inner cell mass (ICM), and 
reactivation of X-linked genes is thought to follow loss of Xist RNA 
coating and heterochromatic markers of inactivation, such as H3K27me3. 
We analyzed X-chromosome activity in developing ICMs and show 
reactivation of gene expression from the inactive-X initiates in the presence 
of Xist coating and H3K27me3. Furthermore, forced upregulation of 
NANOG results in depletion of Xist RNA coating, yet extinction of the Xist 
coat does not lead to altered reactivation kinetics. Taken together, our 
observations suggest that X-linked gene transcription and Xist coating are 
uncoupled. These data fundamentally alter our perception of the reactivation 
process and support the existence of silencing mechanisms in the ICM that 
operate independent of Xist and H3K27me3. 
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Crosses between two North American deer mouse species, Peromyscus 
maniculatus (BW), and P. polionotus (PO), produce dramatic parent-of-
origin effects on growth and development. BW females mated to PO males 
(bw x po) results in growth-retarded offspring but apparently healthy 
offspring. In contrast, PO females mated to BW males (PO x BW) produce 
overgrown but severely dysmorphic conceptuses. The rare PO x BW litters 
which reach parturition harbor fatal defects (e.g. hemorrhaging) and/or are 
unable to pass through the birth canal, resulting in maternal lethality. The 
placenta is particularly affected in both cases; ~ 10% of PO x BW 
conceptuses consist only of extra-embryonic tissues. The PO x BW 
conceptuses share similarities with gestational trophoblast disease and other 
developmental disorders. BrdU and TUNEL studies show that both 
proliferation and cell death are altered. Expression of imprinted genes and 
DNA methylation at associated regulatory regions is perturbed in the PO x 
BW hybrids. To understand the developmental etiology of the placental 
phenotypes, we undertook further in situ hybridization and gene expression 
studies. As suggested by morphology, marker assays show a great reduction 
in the spongiotrophoblast of bw x po placentas. In contrast, the hyperplastic 
PO x BW placentas are disorganized: markers such as Tpbp1 and Cdkn1c 
suggest intermingled portions of labyrinth and spongiotrophoblast. Giant 
cells are thought to derive directly from trophoblast stem cells (TSCs); they 
are present in at less than expected numbers in PO x BW placentas. 
However, certain PO x BW cell clusters did not stain with Tpbp1, Cdkn1c, 
or Prl3b1/Pl2, a marker of mature giant cells. These cells were positive for 
Hand1, thought to determine giant cell fate. Despite the presence of Hand1, 
these cells appeared diploid. Expression of Cdx2, a primary TSC marker, 
drops over time in PO x BW placentas (relative to parental strains and bw x 
po hybrids). At the same time, the PO x BW placentas re-express 
Pou5f1/Oct4 at high levels. Thus both differentiation and stem cell numbers 
and/or maintenance appear compromised. As Pou5f1/Oct4 is also regulated 
by DNA methylation, we hypothesize an epigenetic de-differentiation 
occurs in these PO x BW tissues. 
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Hox genes play evolutionarily conserved roles in specifying axial position 
during metazoan development and are widely implicated in the evolution of 
body plans. The Hoxa3 null mutant mouse was among the first made using 
gene targeting, generated nearly 20 years ago. While the Hoxa3 null 
phenotype has been well described, little is known about the mechanisms by 
which Hoxa3 (or any other Hox protein) influences development, including 
the functions of domains outside of the highly conserved homeodomain and 
cofactor-binding hexapeptide. Many studies have emphasized conservation 
of Hox function both between species and among paralogs within species, 
with changes in gene expression being proposed as the major route by 
which Hox genes influence morphological evolution. We performed a 
cross-species Hoxa3 gene swap to test whether the functional equivalence 
of paralogous Hox3 genes extends across vertebrate species, substituting the 
coding sequence of mouse HOXA3 with that of its zebrafish ortholog 
Hoxa3a. Zebrafish hoxa3a (zfhoxa3a) expressed from the mouse Hoxa3 
locus can substitute for mouse Hoxa3 in some tissues, but has novel or null 
phenotypes in others. We further show using an allele encoding a chimeric 
protein that this difference maps primarily to the zfhoxa3a C-terminal 
domain (CTD). Molecular evolutionary analysis also shows that zebrafish 
Hoxa3a has undergone rapid evolution relative to other vertebrates. These 
data are consistent with our functional data, and together suggest that the 
mouse and zebrafish proteins have diverged considerably since their last 
common ancestor, and that the major difference between them resides in the 
CTD. Our data further show that Hox protein function can evolve 
independently in different cell types or for specific functions, suggesting a 
mechanism by which ‘toolkit’ transcription factors can evolve new 
functions. Our results also support the hypothesis that functional differences 
between these Hoxa3 proteins are due to divergence in non-homeodomain 
sequences, specifically in the C-terminal domain. Our data further 
demonstrate that cross-species gene swaps of highly conserved proteins can 
identify protein domains that mediate functional divergence between 
orthologous genes. 
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Uncovering the network that mediates NODAL signaling is critical toward 
understanding both self-renewal and commitment to endoderm. To 
elucidate the NODAL transcriptional network in embryonic stem cells and 
derived endoderm, we elucidated the genomic targets for SMAD2/3, 
SMAD3, SMAD4, and FOXH1. We demonstrate that targets for these 
transcription factors are highly dynamic between the two cell types and are 
concentrated around promoters in ES cells, but not derived endoderm. 
Furthermore, using motif analysis, we find that 30% of all SMAD2/3, 
SMAD4, and FOXH1 binding genome-wide associates with a novel motif 
(CAGCAGG). We find that this motif is an E-box HLH motif known to 
associate with the TCF family of proteins (TCF3, 4 and 12; previously E2A, 
HEB and E2.2). Further, we validate that TCF proteins, SMAD proteins and 
FOXH1 bind to this CAGCAGG consensus sequence and that FoxH1 
interacts with TCF3. Morpholino knock down of TCF3 in Xenopus 
embryos inhibits gastrulation by inhibiting mesendodermal specification. 
Together this suggests a role for TCF as a Nodal co-factor.  
 
To elucidate how the SMAD complex functions together with the chromatin 
state, we performed genome wide mapping of H3K4me3 and H3K27me3 in 
both ES cells and derived endoderm. Interestingly, we find that bivalent 
regions, containing both H3K4me3 and H3K27me3, increase substantially 
during endodermal differentiation, making promoters in endodermal cells 
extensively bivalent. A few ES cell bivalent promoters do indeed become 
monovalent in endoderm, having only H3K4me3. These monovalent 
promoters are both significantly associated with SMAD2/3 binding, are 
highly transcriptionally active, and are enriched for known endodermal 
specification genes, including FOXA2, EOMES, SOX17, GATA4, GATA6 
and GSC The correlation between SMAD2/3 binding, monovalent 
formation and transcriptional activation suggests that SMAD2/3 plays an 
important role in bivalent resolution within regions critical for endodermal 
specification 
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Despite our knowledge of signaling centers and genes controlling patterning 
along the primary axes in the developing limb, there are gaps in our 
understanding of how a limb is built. In an effort to broaden our insight into 
the genetic mechanisms underlying limb formation and patterning, our lab 
is currently focused on identifying new genes required during embryonic 
limb development. Work by multiple labs have verified that forward 
genetics screens are feasible in the mouse and are an excellent, unbiased 
method to uncover factors critical for a wide variety of developmental 
processes. We are currently working with several novel, recessive mouse 
mutants derived from chemical-based mutagenesis screens. One difficulty 
of forward genetics in mice has been the time required to identify the 
affected locus through standard meiotic mapping. However, advances in 
sequencing technology are streamlining mutant identification, making 
forward genetics more tractable. We have utilized a genome reduction 
approach (Sequence Capture; Nimblegen), coupled with massively parallel 
sequencing (Illumina) to identify the affected gene in three of our mutants. 
These mutants have led to insights on 1) the role of cilia in limb patterning, 
2) the Shh-Gre-Fgf feedback loop and 3) the role of proteoglycans in limb 
outgrowth. 
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Breast cancer is the most common malignancy in women. To date, 
inheritance of a mutant BRCA1 or BRCA2 gene is the best-established 
indicator of an increased risk of developing breast cancer, the most 
frequently diagnosed cancer in women. For BRCA1/2 mutation carriers the 
lifetime risk of developing breast cancer is up to 80%. Therefore, it is not 
surprising that individuals with a family history of these cancers are now 
opting to know if they have a mutation in one of these genes. One of the 
inherent drawbacks of sequencing-based approaches is the determination of 
the actual risk associated with any variant identified in the gene. This is 
evident by the fact that more than 800 variants of BRCA1 and 1100 variants 
of BRCA2 are listed as variants of unknown clinical significance in the 
breast cancer information core database. We have recently reported a mouse 
embryonic stem cell based assay to test the functional significance of 
variants of unknown clinical significance identified in BRCA1 and BRCA2. 
The assay is based on the ability of human BRCA1/2 to complement the 
loss of endogenous genes in mouse embryonic stem cells. The procedure 
involves generation of a desired mutation in BRCA1 or BRCA2 present in a 
bacterial artificial chromosome (BAC) and introduction of the BAC into ES 
cells engineered for the assay. Using this assay we have characterized 
R1699Q, a low risk variant of BRCA1. Interestingly this variant affects ES 
cell survival but exhibits no defect in genomic stability or cell cycle 
regulation. We have used this variant to uncover the role of BRCA1 in 
regulation of an oncogenic micro RNA, miR-155. We show that over 
expression of this micro RNA contributes to tumorigenesis.  
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Hepatocytes comprise approximately 70% of the adult liver and carry out 
wide-ranging roles; from lipid homeostasis, hormone production, plasma 
protein secretion to chemical detoxification. Accomplishing such a 
plentitude of critical processes exerts extraordinary demands on 
transcriptional control mechanisms within the liver. Indeed, two decades of 
gene-by-gene promoter analysis in hepatocytes has revealed a prevalence of 
combinatorial transcription factor control over gene expression. Here, we 
explore the dynamic and collaborative behaviour of two well-characterised 
transcription factors during in vivo cell differentiation and organ formation. 
Using ChIP-Seq and RNA-Seq analysis of hepatoblasts isolated from 14.5 
d.p.c embryos and adult livers we have observed over 5000 peaks occurring 
exclusively in each developmental stage. We show that differential temporal 
binding patterns of HNF4a and FOXA2 may regulate distinct transcriptional 
programs during liver development  
To understand the mechanisms underlying developmental stage-specific 
transcription factor binding, we profiled the chromatin signatures of sites 
co-occupied by HNF4a and FOXA2 in embryonic and adult liver. Using 
ChIP-seq analysis of H3K4me1, H4ac and H3K27me3 in adult liver we 
have shown that sites co-occupied by transcription factors exhibit a clear 
bimodal distribution indicative of nucleosome displacement. Sites targeted 
only in embryonic liver show a monomodal distribution of H3K4me1 and 
H4ac, intriguingly H3K27me3 is also evident at developmentally repressed 
loci, suggesting that dynamic chromatin remodeling accompanies in vivo 
cell differentiation and differential transcription factor recruitment. 
Interestingly, developmentally distinct target genes are implicated in 
divergent biological process, for example embryonic FOXA2 associates 
with loci involved in chromatin and nucleosome remodeling while sites 
bound in the adult associate more significantly with metabolic process. 
Although transcriptional regulators are known to contribute to divergent 
processes in different tissue types, this study highlights the versatility of 
well-characterised transcription factors during tissue maturation. In 
summary our results suggest that differential binding of HNF4a and 
FOXA2 to chromatin in embryonic and adult liver may reflect the adaptive 
nature of these key transcriptional regulators during in vivo hepatoblast 
differentiation and liver formation.  
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CSR is the mechanism by which B cells replace the constant region (CR) of 
IgH with one of the other downstream CRs encoding different isotypes. 
Stimulation of resting splenic B cells by α-CD40 or LPS with IL4 results in 
CSR of IgH isotypes in which the μ constant region is replaced with a 
downstream constant region, γ1 through DNA breaks and subsequent DNA 
repair. Recent studies have identified dual roles for PTIP, a BRCT domain 
containing protein in both epigenetic regulation of gene expression and 
DNA damage repair. PTIP interacts with Pax2 during activation of 
transcription by recruiting a histone 3 lysine 4 (H3K4) methylation complex 
to a Pax2 DNA binding site. Additionally, PTIP is recruited to sites of DNA 
damage and interacts with repair complex protein PA1. ptip was 
conditionally deleted in the B cell lineage using a CD19-Cre transgene. 
Surprisingly, ptip conditional knockout (KO) B cells are able to develop 
and mature normally, but ptip KO B cells have significantly reduced CSR 
efficiency when stimulated in vitro to undergo CSR. Analysis of the ptip 
KO phenotype suggests that CSR efficiency is reduced from the loss of the 
production of germline transcripts of the γ1 downstream constant region. 
Preceding the induced DNA breaks, germline transcripts are produced 
upstream of each constant region and are necessary for CSR. Correlating 
with the loss of transcription, histone 3 lysine 4 trimethylation (H3K4me3) 
was significantly reduced at the germline transcript promoter of γ1 using 
ChIP. Pax5, a Pax2 homolog and key regulatory transcription factor in B 
cells, is enriched at the promoter of γ1 and the IgH 3' enhancer 
hypersensitive site 4 (HS4) but is reduced in ptip KO stimulated B cells. 
Additionally, Pax5, Rbbp5 (a H3K4me3 complex member) and H3K4me3 
are specifically enriched at the γ1 promoter during CSR stimulation in 
normal B cells, but enrichment is significantly reduced in ptip KO B cells. 
PTIP-dependent Pax5 enrichment at both the γ1 promoter and HS4 
enhancer which are separated by over 100 kB suggests that PTIP may be 
responsible for long-range enhancer-promoter interactions during CSR. 
Chromosomal conformation capture (3C) was performed to quantify the 
physical interactions of γ1 and HS4. In stimulated ptip KO B cells, the 
ligation efficiency measured by PCR of γ1 and HS4 was decreased 
suggesting PTIP is needed for long range promoter/enhancer interactions 
during CSR. Our model suggests that PTIP brings Pax5 and the 3' enhancer 
into close proximity of γ1 to promote H3K4me3 and germline transcription. 
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In mammals, left-right (L-R) asymmetry is established by posteriorly 
oriented cilia driving a leftwards laminar flow in the embryonic node, 
thereby activating asymmetric gene expression. The two cilia hypothesis 
argues that immotile cilia detect and respond to this flow through a Pkd2-
mediated mechanism. While Pkd2 protein is argued to comprise an ion 
channel a putative sensory partner protein in L-R development has 
remained unidentified, raising the question of whether Pkd2 is actually 
responding to nodal flow. We have identified Pkd1l1 as a critical 
component of L-R patterning in mouse. Systematic comparison of Pkd1l1 
and Pkd2 point mutants reveals strong phenocopying, evidenced by both 
morphological and molecular markers of sidedness; both mutants fail to 
activate asymmetric gene expression at either the node or in the lateral plate 
and exhibit right isomerism of the lungs. Node and cilia morphology were 
normal in mutants while cilia demonstrated typical motility, consistent with 
Pkd1l1 and Pkd2 activity downstream of nodal flow. Cell biological 
analysis reveals that Pkd1l1 and Pkd2 localise to the cilium, while 
biochemical experiments demonstrate that they can physically interact. 
Together with co-expression in the node, these data argue that Pkd1l1 is the 
elusive Pkd2 binding partner required for L-R patterning and support the 
two cilia hypothesis. 
 
* Authors contributed equally 
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Notch signalling determines cell fate in a variety of contexts. Signalling 
instructs developmental processes using different modes of action that 
include lateral inhibition, lineage segregation, inductive signalling, and 
boundary formation. Signalling is activated by cell-cell contact with ligand 
expressed on one cell, activating Notch on another cell. This trans-
activation of Notch signalling sees Notch-dependent transcriptional 
activation in the Notch-expressing, signal-receiving cell. DSL ligands of 
Notch also can inhibit signalling when expressed in the same cell as the 
Notch receptor. This cis-inhibition of Notch signalling is a more recently 
identified process and the mechanism of inhibition is not well understood. 
Trans-activation and cis-inhibition of Notch are features of all DSL ligands 
except for the divergent ligand Dll3, which inhibits but does not activate 
Notch signalling. We are using this unique attribute of Dll3 to address the 
mechanism of cis-inhibition. 
 
Somitogenesis represents a model for studying the role of Notch signalling 
in boundary formation in vertebrates. Somites are reiteratively formed from 
the presomitic mesoderm and patterned to direct vertebral column 
formation. Notch1 signalling is critical for somitogenesis, and several 
pathway components have been identified as being critical for the process in 
mammals. Moreover in humans the DLL3 ligand of Notch and three Notch 
target genes (MESP2, LFNG, HES7) are all associated with causing the 
congenital vertebral malsegmentation defect spondylocostal dysostosis. A 
specific, cyclical pattern of Notch1 activation is required in the presomitic 
mesoderm for normal somitogenesis. This Notch1 activation pattern is 
achieved through the activity of two ligands, Dll1 and Dll3. We have 
localised these ligands and the receptor in the presomitic mesoderm in order 
to evaluate how the pattern of Notch1 signalling is achieved. 
 
Elucidating how Dll3 cis-inhibits Notch1 will lead to a better understanding 
of how Notch signalling drives somitogenesis; it will also elucidate the 
mechanism of cis-inhibition of Notch generally, and increase our 
understanding of other Notch-dependent processes. 
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The germ cell lineage is discriminated from that of somatic cells via 
species-specific mechanisms by which germ cells acquire their special cell 
fate and characteristics. In mammal, germ cells are generated in the place 
far away from future gonads. Although germ cells have potency to produce 
both oogonia and spermatogonia, sexual differentiation is induced after 
their colonization with somatic cells in the embryonic gonads, in which the 
sex of germ cells is determined by signals derived from somatic cells 
surrounding germ cells. The expression of Nanos2, encoding an RNA 
binding protein is restricted in the male germ cells after colonization into 
gonads and plays a key role on the sexual differentiation of germ cells via 
promoting male fate and suppressing female fate. The NANOS2 protein 
expression is maintained in all male gonocytes during embryogenesis. 
However, the expression becomes confined only in a small population of 
spermatogonia after birth. Genetic evidence indicates that NANOS2 is 
required for the maintenance of spermatogonnial stem cells. In this meeting, 
I like to summarize functions of NANOS2 during embryogenesis and after 
birth. Finally I also show a possible molecular function of NANOS2 based 
on our recent findings. 
 134 
SUCCESSIVE ROLES OF PDGF SIGNALING IN THE 
EXTRAEMBRYONIC ENDODERM OF THE MOUSE EMBRYO 
 
Jerome Artus, Kat Hadjantonakis  
 
Sloan-Kettering Institute, Developmental Biology, New York, NY, 10065 
 
Mammal preimplantation development is mainly devoted to the production 
of extraembryonic tissues, the trophectoderm and primitive endoderm 
(PrE), essential for embryo survival in utero. While the mechanisms of 
trophectoderm specification have been extensively studied, little is known 
about PrE formation. We previously characterized in vivo an early marker 
of PrE lineage, Platelet-derived growth factor receptor alpha (PDGFRα), 
which is dynamically expressed in PrE and its derivatives, the parietal and 
visceral endoderm. 
By combining live imaging of embryos and embryo-derived stem cells 
expressing a histone H2B-GFP fusion reporter under the control of Pdgfra 
regulatory elements with the analysis of lineage-specific markers, we have 
determined that Pdgfra expression coincides with GATA6 the earliest 
expressed transcriptional regulator of the PrE lineage. In addition, our data 
show that GATA6 is required for the activation of Pdgfra expression. Based 
on these observations, we propose a model whereby initiation of Pdgfra 
expression requires GATA6, and its maintenance requires GATA4 and 
GATA6. 
Using pharmacological inhibition and genetic inactivation, we have 
addressed the role of the PDGF pathway in the PrE lineage as well as its 
derivative tissue, the visceral endoderm. Our results reveal a role for PDGF 
signaling in the establishment and proliferation of XEN cells, isolated from 
mouse blastocyst stage embryos and representing the PrE lineage. While 
implanting Pdgfra mutant blastocysts exhibit a reduced number of PrE 
cells, an effect that is exacerbated by delaying implantation. Furthermore, 
tissue-specific inactivation of Pdgfra in the visceral endoderm reveals an 
unanticipated role for PDGF signaling in early postimplantation 
development. 
Taken together, our data provide new insights into the roles of PDGF 
signaling in the establishment and propagation of ExEn lineage. 
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CDX2 MRNA TRANSPORT IN MOUSE EMBRYO DEPENDS ON 
ACTIN AND MICROTUBULE NETWORK AND A ZIP CODE 
IDENTIFIED IN THE CODING SEQUENCE. 
 
Maria Skamagki1, Krzysztof B Wicher1, Sujoy Ganguly2, Alexander W 
Bruce 1,3, Magdalena Zernicka-Goetz1  
 
1Wellcome Trust/Cancer Research UK Gurdon Institute, The Henry 
Wellcome Building of Cancer and Developmental Biology, University of 
Cambridge, Cambridge, CB2 1QN, United Kingdom, 2Department of 
Applied Mathematics and Theoretical Physics, University of Cambridge, 
Cambridge, CB3 0WA, United Kingdom, 3Dept. of Molecular Biology, 
Faculty of Science, University of South Bohemia, Ceske Budejovice, 
37005, Czech Republic 
 
Caudal type homeobox 2 (Cdx2) transcriptional factor is a major lineage 
marker and cell fate determinant of trophectoderm during early mouse 
development. Cdx2 mRNA localizes apically within blastomeres of 8- and 
16-cell stage mouse embryos. Mechanism and role of this asymmetric 
distribution are poorly understood. Here we developed a sensitive assay for 
studying the dynamics of Cdx2 mRNA localization in vivo using 
microinjection of fluorescently labeled RNA in one or more blastomeres of 
living 8-cell stage embryos. We show that the injected Cdx2 transcripts 
localize at the apical side of compacted blastomeres at 8-cell stage embryos 
in the same way as endogenous mRNA. This localization requires intact 
microtubule and actin network. We found that the cis-element responsible 
for the localization resides in the Cdx2 coding sequence. We also reveal that 
during transition from 8- to 16-cell stage the domain containing Cdx2 
mRNA undergoes dynamic reorganization. Taken together, our 
experiments, for the first time, present evidences for nonuniform inheritance 
of mRNA during preimplantation mammalian development, which could 
result in differential cell fate determination. 
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REQUIREMENT FOR FGF4 IN PRIMITIVE ENDODERM LINEAGE 
COMMITMENT IN THE MOUSE BLASTOCYST 
 
Anna Piliszek, Jerome Artus, Minjung Kang, Robert Aho, Kat 
Hadjantonakis  
 
Sloan-Kettering Institute, Developmental Biology Program, New York, NY, 
10065 
 
Preimplantation mouse development involves a critical period of 
differentiation and lineage commitment. Two lineages arise from the inner 
cell mass (ICM) of the blastocyst: the pluripotent epiblast (EPI), and 
extraembryonic primitive endoderm (PrE). Lineage choice is dictated by the 
expression of lineage-specific transcription factors. These are initially 
expressed in overlapping manner in all cells of the ICM at the early 
blastocyst stage. Then, after the 64-cell (mid-blastocyst) stage, these factors 
become mutually exclusive and specific to lineage-commited cells, and are 
organized in salt-and-pepper manner within the ICM. The mechanisms 
responsible for PrE vs. EPI specification are still poorly understood, 
however ERK signaling has been suggested as involved in this lineage 
decision. Here we show a critical requirement for FGF4, in the primitive 
endoderm specification, and in the derivation of embryo-derived stem cells.  
At the time of implantation (late blastocyst stage) Fgf4 mutant embryos lack 
primitive endoderm, and their ICM is comprised of exclusively EPI marker 
expressing cells, a phenotype that can be rescued by addition of FGF4. 
However, earlier on, at the early blastocyst stage, Fgf4 mutant embryos 
correctly express markers of both EPI and PrE. These data suggest that FGF 
signaling is not required for the initiation of lineage-specific transcription 
factor expression, but rather for the choice of specific cell fate.  
We also note that Fgf4 deficient ES cells can be derived at increased 
efficiency than wild type ES cells. By contrast, we failed to establish XEN 
cells Fgf4 mutant embryos. Further analysis suggests that the requirement 
for FGF4 in these embryo-derived stem cells lines appears to be dose-
dependent. 
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SATELLITE CELLS REQUIRE NOTCH SIGNALS TO RECOGNIZE 
THEIR 'NICHE'. 
 
Broehl Dominique1, Vasyutina Elena1,2, Birchmeier Carmen1  
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Myogenesis is a tightly regulated process that is essential in muscle 
development and regeneration. During mammalian development, phases of 
embryonic and fetal myogenic differentiation lead to the formation and 
growth of skeletal muscles. In the postnatal and adult organism, skeletal 
muscle grows and regenerates by the myogenic differentiation of stem cells, 
the satellite cells. In the developing muscle, a pool of myogenic progenitor 
cells is formed and maintained. These resident progenitors provide a source 
of cells for muscle growth in development and generate satellite cells in the 
perinatal period. In the postnatal muscle, satellite cells are activated after 
injury of the muscle. Activated satellite cells proliferate, and either self 
renew or differentiate into myoblasts capable of forming new muscle.  
 
The Notch signaling system is highly conserved in evolution. Notch 
signaling initiates when the receptor binds to its ligand presented on 
neighboring cells, which induces a conformational change resulting in 
cleavage and release of the Notch intracellular domain that moves to the 
nucleus where it interacts with the major transcriptional mediator of Notch 
signals, RBPJ. We used mouse genetics to analyze Notch functions in the 
developing and postnatal muscle. Our data show that Notch signals are 
essential for self-renewal of muscle progenitors and satellite cells, and that 
Notch target genes are required for the recognition of the satellite cell niche. 
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DISTINCT STEM/PROGENITOR CELL POPULATIONS CONTROL 
SKELETAL MUSCLE DEVELOPMENT 
 
Ramkumar Sambasivan1, Danielle Gomés1, Gérard Dumas1, Clémire 
Cimper2, Shahragim Tajbakhsh1  
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All skeletal muscles in vertebrates derive from the mesodermal germ layer 
in several distinct developmental phases. The stem/progenitor cells 
controlling these temporally defined phases are different (Biressi et al., 
2007; Hutcheson et al., 2009; Tajbakhsh, 2009). Interestingly, in the 
embryo, temporally co-inciding myogenic cell populations can be sub-
categorized based on the expression of specification and commitment genes 
such as Pax3/Pax7 (hierarchical paired-box/homeodomain transcription 
factors) and Myf5/Mrf4/Myod (muscle regulatory bHLH transcription 
factors), respectively. This scenario raises some key questions. What is the 
functional relevance of these distinguishable founder stem cells? Are they 
lineage related, to what extent do they contribute to the developmental 
myogenic waves, and subsequently to adult muscle stem/progenitor cells? 
In this context, recent findings suggested that the preponderant Myf5+ 
population is dispensable for muscle development (Gensch et al., 2008; 
Haldar et al., 2008). However, the significance of this population has not 
been addressed in detail for head myogenesis as it has been for trunk 
muscles. This is a key issue given that the embryonic source for the 
progenitors of the head muscle groups (extraocular (EOM) and jaw 
muscles) is different compared to that of trunk/limb muscles. Moreover, 
distinct genetic hierarchies control EOM, jaw and trunk muscle 
development (Sambasivan et al., 2009). Here, we show that the population 
that had expressed Mrf4, a weak muscle determination gene and a strong 
differentiation-promoting gene, acts as a reservoir for all adult muscle 
stem/progenitor cells. We show also that reflecting their unique genetic 
program, the EOMs are dependent upon the Myf5+ population in stark 
contrast to other head/trunk muscles. Therefore, divergent skeletal muscle 
founder cells in the embryo deploy different genetic networks to achieve 
myogenesis. The link between these founder stem cells and their adult 
muscle counterparts can be defined by the specification and determination 
genes they recruit for their function. Lineage and cell ablation strategies 
have provided important information on how organogenesis is achieved. 
During these studies we noted that there is reporter line dependant 
variability in the readout from the Cre driver lines. Since the Cre/loxP 
strategy is used extensively for lineage tracing and cell ablation studies, our 
findings will be of wide interest to the community. 
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DISSECTING THE MECHANISMS OF CELLULAR 
REPROGRAMMING  
 
Konrad Hochedlinger  
 
Massachusetts General Hospital, Cancer Center and Center for 
Regenerative Medicine, Harvard Stem Cell Institute, Boston, MA, 02114 
 
My lab is studying the mechanisms of cellular reprogramming using 
transcription factor-mediated conversion of somatic cells into induced 
pluripotent stem (iPS) cells. For example, we have identified biomarkers to 
track and prospectively isolate intermediate cell populations during the 
reprogramming process and are currently using these to understand the 
transcriptional, epigenetic and proteomic changes in cells undergoing 
reprogramming. In addition, we have shown that terminally differentiated 
beta cells and lymphocytes can be reprogrammed into iPS cells, thus 
demonstrating that induced pluripotency is not limited to rare adult stem 
cells as has been suggested. Interestingly, however, we discovered that 
immature hematopoietic cells give rise to iPS cells more efficiently than any 
tested mature cell types, suggesting that the differentiation stage of the 
starting cell can influence the efficiency of reprogramming. We have further 
identified the p53 and p16/p19 tumor suppressor pathways as roadblocks 
during the reprogramming process, pointing out similarities between 
pluripotent cells and cancer cells. One major roadblock for the therapeutic 
use of iPS cells is the fact that integrating viruses are used to deliver the 
reprogramming genes to cells, resulting in genetically altered iPS cells. By 
using adenoviruses expressing the reprogramming factors transiently in 
cells, we were able to produce iPS cells devoid of any viral elements and 
thus any genetic manipulation. More recently, we have developed a 
“reprogrammable mouse” carrying a single doxycycline-inducible cassette 
with the four reprogramming genes in all tissues. We are employing this 
system to perform genetic and chemical screens to identify molecules 
important during the reprogramming process as well as for comparative 
studies between iPS cells and embryonic stem cells.  
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VISITOR INFORMATION 
 
EMERGENCY                CSHL                          BANBURY 
Fire (9) 742-3300 (9) 692-4747 
Ambulance (9) 742-3300 (9) 692-4747 
Poison (9) 542-2323 (9) 542-2323 
Police (9) 911 (9) 549-8800 
Safety-Security Extension 8870  
 
Emergency Room 
Huntington Hospital 
270 Park Avenue, Huntington 
631-351-2300 
(1037)  
Dentists 
Dr. William Berg 
Dr. Robert Zeman 
 
631-271-2310 
631-271-8090 
Doctor 
MediCenter 
234 W. Jericho Tpke., Huntington Station 
631-423-5400 
(1034) 
Drugs - 24 hours, 7 days 
Rite-Aid 
391 W. Main Street, Huntington 
631-549-9400 
(1039) 
Free Speed Dial 
Dial the four numbers (****) from any tan house phone to place a 
free call. 
GENERAL INFORMATION 
 
Books, Gifts, Snacks, Clothing, Newspapers 
 BOOKSTORE   367-8837 (hours posted on door) 
 Located in Grace Auditorium, lower level. 
 
Photocopiers, Journals, Periodicals, Books, Newspapers 
 Photocopying – Main Library 
 Hours:  8:00 a.m. – 9:00 p.m. Mon-Fri 
             10:00 a.m. – 6:00 p.m. Saturday 
Helpful tips - Obtain PIN from Meetings & Courses Office  
to enter Library after hours.  See Library staff for photocopier 
code. 
 
Computers, E-mail, Internet access 
 Grace Auditorium 
 Upper level: E-mail only 
 Lower level: Word processing and printing. 
 STMP server address: mail.optonline.net 
 To access your E-mail, you must know the name of your  
 home server.    
 
Dining, Bar 
 Blackford Hall 
  Breakfast  7:30–9:00, Lunch 11:30–1:30, Dinner  5:30–7:00 
  Bar  5:00 p.m. until late  
 Helpful tip - If there is a line at the upper dining area, try the  
 lower dining room 
 
 
 
Messages, Mail, Faxes 
 Message Board, Grace, lower level 
 
Swimming, Tennis, Jogging, Hiking 
June–Sept. Lifeguard on duty at the beach. 12:00 noon–6:00 p.m.  
Two tennis courts open daily. 
 
Russell Fitness Center 
 Dolan Hall, east wing, lower level 
 PIN#:  Press 64545 (then enter #) 
 
Concierge 
 On duty daily at Meetings & Courses Office. 
After hours – From tan house phones, dial x8870 for 
assistance 
  
Pay Phones, House Phones 
Grace, lower level; Cabin Complex; Blackford Hall; Dolan Hall, 
foyer  
 
CSHL’s Green Campus 
 
Cold Spring Harbor Laboratory is pledged to operate in an 
environmentally responsible fashion wherever possible.  In the past, 
we have removed underground oil tanks, remediated asbestos in 
historic buildings, and taken substantial measures to ensure the 
pristine quality of the waters of the harbor. Water used for irrigation 
comes from natural springs and wells on the property itself.  Lawns, 
trees, and planting beds are managed organically whenever possible.  
And trees are planted to replace those felled for construction 
projects.   
 
Two areas in which the Laboratory has focused recent efforts have 
been those of waste management and energy conservation.  The 
Laboratory currently recycles most waste.  Scrap metal, electronics, 
construction debris, batteries, fluorescent light bulbs, toner cartridges, 
and waste oil are all recycled.  For general waste, the Laboratory uses 
a “single stream waste management” system, removing recyclable 
materials and sending the remaining combustible trash to a 
cogeneration plant where it is burned to provide electricity, an 
approach considered among the most energy efficient, while providing 
a high yield of recyclable materials. 
 
Equal attention has been paid to energy conservation.  Most lighting 
fixtures have been replaced with high efficiency fluorescent fixtures, 
and thousands of incandescent bulbs throughout campus have been 
replaced with compact fluorescents.  The Laboratory has also 
embarked on a project that will replace all building management 
systems on campus, reducing heating and cooling costs by as much 
as twenty-five per cent. 
 
Cold Spring Harbor Laboratory continues to explore new ways in 
which we can reduce our environmental footprint, including 
encouraging our visitors and employees to use reusable containers, 
conserve energy, and suggest areas in which the Laboratory’s efforts 
can be improved. This book, for example, is printed on recycled 
paper. 
                       1-800 Access Numbers 
 
 AT&T  9-1-800-321-0288 
 MCI  9-1-800-674-7000 
 
Local Interest 
 Fish Hatchery   631-692-6768 
 Sagamore Hill   516-922-4447 
 Whaling Museum   631-367-3418 
 Heckscher Museum  631-351-3250 
 CSHL DNA Learning  x 5170 
   Center 
 
New York City 
 Helpful tip - 
 Take Syosset Taxi to Syosset Train Station 
 ($8.00 per person, 15 minute ride), then catch Long Island  
 Railroad to Penn Station (33rd Street & 7th Avenue).   
 Train ride about one hour. 
 
   TRANSPORTATION 
Limo, Taxi 
 Syosset Limousine  516-364-9681  (1031) 
 Super Shuttle  800-957-4533  (1033) 
  To head west of CSHL - Syosset train station 
  Syosset Taxi  516-921-2141  (1030) 
 To head east of CSHL - Huntington Village  
  Orange & White Taxi 631-271-3600  (1032) 
Executive Limo  631-696-8000  (1047) 
 
Trains 
 Long Island Rail Road   822-LIRR  
 Schedules available from the Meetings & Courses Office. 
 Amtrak   800-872-7245 
 MetroNorth   800-638-7646 
 New Jersey Transit  201-762-5100 
 
Ferries 
 Bridgeport / Port Jefferson 631-473-0286 (1036) 
 Orient Point/ New London 631-323-2525 (1038) 
 
Car Rentals 
 Avis   631-271-9300 
 Enterprise   631-424-8300 
 Hertz   631-427-6106 
  
Airlines 
 American   800-433-7300 
 America West  800-237-9292 
 British Airways  800-247-9297 
 Continental   800-525-0280 
 Delta   800-221-1212 
 Japan Airlines  800-525-3663 
 Jet Blue   800-538-2583 
 KLM   800-374-7747 
 Lufthansa   800-645-3880 
 Northwest   800-225-2525 
 United   800-241-6522 
 US Airways   800-428-4322 
